: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, January 2025
Free Subscription

Abstracts
Retrieve all available abstracts of the following 1665 articles:
HTML format

Single Articles

CAMPBELL C, Singh K, Weems M, Philip R, et al
Pulmonary hypertension in infancy: a reversible cause.
BMJ Case Rep. 2025;18:e263731.
Abstract

NISHIKIMI T, Kinoshita H, Inazumi H, Kanamori T, et al
Adrenomedullin in pulmonary hypertension.
Dan Med J. 2024;71:A07240498.
Abstract

LACERDA TEIXEIRA B, Albuquerque F, Santos R, Ferreira A, et al
Right ventricular myocardial work: proof-of-concept for the assessment of pressure-strain loops of patients with pre-capillary pulmonary hypertension.
Cardiovasc Ultrasound. 2025;22:16.
Abstract

FUJII H, Taniguchi Y, Tamura Y, Sakamoto M, et al
Association between the prognosis and comorbidity of active cancer in chronic thromboembolic pulmonary hypertension.
BMC Pulm Med. 2025;25:2.
Abstract

NATHAN SD, Stinchon MR Jr, Atcheson S, Simone L, et al
Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: The latest advances in diagnosis and treatment.
J Manag Care Spec Pharm. 2025;31.
Abstract

OROZCO-LEVI M, Souza R, Bluro IM, Harley J, et al
Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.
BMJ Open. 2024;14:e087263.
Abstract

MA H, Wu H, Sun X, Wang Q, et al
The Evaluation of Right Ventricular Synchrony by Two-Dimensional Speckle Tracking Echocardiography in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Echocardiography. 2025;42:e70060.
Abstract

ZHANG Z, Liang Y, Mo S, Zhao M, et al
Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.
Physiol Rep. 2025;13:e70174.
Abstract

KOMURA N, Sugano T, Ono F, Nakayama M, et al
Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospital.
Cardiovasc Interv Ther. 2024 Dec 30. doi: 10.1007/s12928-024-01076.
Abstract

MORIIZUMI T, Hiraide T, Momoi M, Shinya Y, et al
Rapid Reversal of Pulmonary Hypertension by High-Dose Thiamine Supplementation: A Case Report.
CJC Open. 2024;6:1534-1537.
Abstract

SINGHI AK, Banerji A, Biswas N, Das S, et al
Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients.
Med J Armed Forces India. 2024;80.
Abstract

ALHARBI S, Alturaif N, Mostafa Y, Alfhaid A, et al
Pulmonary hypertension post-liver transplant: A case report.
World J Gastrointest Surg. 2024;16:3875-3880.
Abstract

ZHANG CY, Hu YS, Meng ZY, Lu CH, et al
Development and validation of a mortality predictive model for ICU patients with primary pulmonary hypertension.
Sci Rep. 2024;14:31497.
Abstract

LI C, Li C, Jiang Y, Liu M, et al
Hypoxia-induced TPC2 transcription and glycosylation aggravates pulmonary arterial hypertension by blocking autophagy flux.
Sci Rep. 2024;14:31223.
Abstract

SI Y, Huang H, Pan J, Luo X, et al
Identification of potential biomarkers and pathways involved in high-altitude pulmonary edema using GC-MS and LC-MS metabolomic methods.
Sci Rep. 2024;14:30978.
Abstract

YU H, Song H, Li J, Cui L, et al
Identification of Anoikis-related potential biomarkers and therapeutic drugs in chronic thromboembolic pulmonary hypertension via bioinformatics analysis and in vitro experiment.
Sci Rep. 2024;14:30663.
Abstract

ZHANG S, Wang N, Ma H, Jing L, et al
A stable rat model of high altitude pulmonary edema established by hypobaric hypoxia combined diurnal temperature fluctuation and exercise.
Biochem Biophys Res Commun. 2025;744:151193.
Abstract

SHI W, Han MY, Chen Z, Cheng XY, et al
[Clinical characteristics and risk factors for adverse outcomes in omphalocele].
Zhonghua Er Ke Za Zhi. 2025;63:43-49.
Abstract

AFSIN H, Afsin E, Cosgun Z
Comparison of ventilation/perfusion scintigraphy and pulmonary CT angiography: Findings in the diagnosis of CTEPH and CTED.
Hell J Nucl Med. 2024;27:188-197.
Abstract

LEITE LB, Soares LL, Portes AMO, da Silva BAF, et al
Combined exercise hinders the progression of pulmonary and right heart harmful remodeling in monocrotaline-induced pulmonary arterial hypertension.
J Appl Physiol (1985). 2025;138:182-194.
Abstract

LU S, Starr LJ, Taylor RA, Yetman AT, et al
Bullous Lung Disease in Turner Syndrome: An Underrecognized Comorbidity?
Am J Med Genet A. 2025;197:e63908.
Abstract

YE P, Jiang XM, Qian WC, Zhang J, et al
Inhibition of PCSK9 Improves the Development of Pulmonary Arterial Hypertension Via Down-Regulating Notch3 Expression.
Cardiovasc Drugs Ther. 2024;38:1223-1234.
Abstract

SONG D, Wang M, Zhao X, Zhang Y, et al
Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema.
Int J Mol Sci. 2025;26:341.
Abstract

HAMURO A, Kasuga Y, Saito S, Uchida H, et al
Pregnancy complicated by fetal goiter following lung transplantation for idiopathic pulmonary arterial hypertension: A case study.
Taiwan J Obstet Gynecol. 2025;64:131-133.
Abstract

QIANWEN W, Huangshu Y, Hong M, Xiaoxia G, et al
The Prognostic Value of Right Ventricular End-Diastolic Basal Diameter Index by Echocardiography in Connective Tissue Diseases Associated With Pulmonary Artery Hypertension.
Int J Rheum Dis. 2025;28:e70061.
Abstract

KAWASHIMA M, Konoeda C, Yamamoto K, Sato M, et al
Improved Pulmonary Hypertension and Heart Failure by Diaphragmatic Plication and Tracheal Resection.
Ann Thorac Surg Short Rep. 2024;2:636-639.
Abstract

MELZIG C, Weinheimer O, Egenlauf B, Do TD, et al
Automated volumetry of core and peel intrapulmonary vasculature on computed tomography angiography for non-invasive estimation of hemodynamics in patients with pulmonary hypertension (2022 updated hemodynamic definition).
Cardiovasc Diagn Ther. 2024;14:1083-1095.
Abstract

CAI X, Wei Z, Shen Y, Qian L, et al
Pulmonary artery denervation by noninvasive stereotactic radiotherapy: a pilot study in swine models of pulmonary hypertension.
Nat Commun. 2025;16:558.
Abstract

IVANOV SN, Chernyavsky AM, Edemsky AG, Vasiltseva OY, et al
[Chronic Thromboembolic Pulmonary Hypertension Drug Treatment].
Kardiologiia. 2024;64:77-85.
Abstract

SMITH MA, Fineman JR
New Insights Into Pediatric Pulmonary Hypertension From Bogota: Is Younger Always Better?
Pulm Circ. 2025;15:e70039.
Abstract

TOMASZEWSKI M, Styczen A, Krysa M, Michalski A, et al
Lymphocyte Involvement in the Pathology of Pulmonary Arterial Hypertension.
Int J Mol Sci. 2024;25:13455.
Abstract

JANIC M, Skrgat S, Harlander M, Lunder M, et al
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Medicina (Kaunas). 2024;60:2030.
Abstract

LEY L, Wiedenroth CB, Guth S, Gold C, et al
The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of "R V1, V2 + S I, aVL - S V1".
J Clin Med. 2024;13:7613.
Abstract

PARK DH, Fuge J, Kamp JC, Harrigfeld B, et al
Reassessing Pulmonary Hypertension Classification: Utilizing Criteria for Heart Failure with Preserved Ejection Fraction Instead of Pulmonary Arterial Wedge Pressure.
J Clin Med. 2024;13:7582.
Abstract

NEPPALA S, Chigurupati HD, Fath A, Jagirdhar GSK, et al
Impact of pulmonary hypertension on short and long-term outcome after mitral transcatheter edge-to-edge repair: A meta-analysis.
Cardiovasc Revasc Med. 2025 Jan 2:S1553-8389(24)00757.
Abstract

FARKOUH C, Chaouat A, Guillaumot A, Baptista BR, et al
Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Impact of lung hyperinflation on the response to pulmonary hypertension treatment.
Respir Med Res. 2024;87:101153.
Abstract

KOLESNIKOVA PS, Pavlova OS, Gulyaev MV, Kuropatkina TA, et al
Magnetic Resonance Imaging of Monocrotaline-Induced Pulmonary Hypertension in Rats Using Radial Scanning with Retrospective Gating.
Bull Exp Biol Med. 2025 Jan 6. doi: 10.1007/s10517-025-06316.
Abstract

WEI F, Lin Z, Lu W, Luo H, et al
Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.
Hypertension. 2025 Jan 6. doi: 10.1161/HYPERTENSIONAHA.124.22948.
Abstract

BHAT MM, Hussain MS, Bisht AS, Agrawal M, et al
Frontiers in Pulmonary Hypertension: A Comprehensive Insight of Etiological Advances.
Curr Rev Clin Exp Pharmacol. 2024.
Abstract

DENG H, Wang P, Liu M
The prognostic value of pulmonary hypertension in intensive care unit patients from Beth Israel Deaconess Medical Center (BIDMC).
J Cardiothorac Surg. 2025;20:29.
Abstract

SHI Y, Wu D, Chen L, Shi Y, et al
Analysis of the clinical characteristics and outcomes of pregnant women with different degrees of pulmonary hypertension.
J Matern Fetal Neonatal Med. 2025;38:2352090.
Abstract

HOU P, Chen H, Liang S, Guo W, et al
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension.
J Nucl Med. 2025;66:98-103.
Abstract

HOEPER MM, Rosenkranz S, Badesch DB, Humbert M, et al
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies.
Respir Med. 2025;236:107910.
Abstract

BUBER I, Aykota MR, Sevgican CI, Kaya D, et al
Impact of Laparoscopic Sleeve Gastrectomy on Pulmonary Arterial Stiffness and Right Ventricular Function in Obese Patients.
Obes Surg. 2025;35:87-92.
Abstract

LI HZ, Wen S, Huang ZH, Fei HW, et al
A prediction model of echocardiographic variables to screen for potentially correctable shunts in adult atrial septal defect-pulmonary hypertension patients.
J Chin Med Assoc. 2025;88:71-79.
Abstract

Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet Respir Med. 2025;13:69-79.
Abstract

WATZKER A, Alsumali A, Ferro C, Dieguez G, et al
Economic Burden Associated with Pulmonary Arterial Hypertension in the United States.
Pharmacoeconomics. 2025;43:83-91.
Abstract

MADONNA R, Ghelardoni S
Sotatercept in pulmonary hypertension and beyond.
Eur J Clin Invest. 2025 Jan 18:e14386. doi: 10.1111/eci.14386.
Abstract

XU Y, Liang L, Chen J, Li X, et al
Difficult airway management in a patient with severe mitral and tricuspid regurgitation, rapid atrial fibrillation, and moderate pulmonary hypertension: a case report.
BMC Anesthesiol. 2025;25:30.
Abstract

SUN S, Mao J, Ding Y, Liu L, et al
Hypoxia Combined With Interleukin-17 Regulates Hypoxia-Inducible Factor-1alpha/Endothelial Nitric Oxide Synthase Expression in Pulmonary Artery Endothelial Cells.
J Cell Mol Med. 2025;29:e70289.
Abstract

SUNGA CGG, Yang KC, Oyetunji S, Swenson ER, et al
A Triple Threat: A Case Report Detailing Surgical Management for Hypertrophic Cardiomyopathy, Flail Mitral Valve and Severe Pulmonary Hypertension(dagger).
Reports (MDPI). 2024;7:116.
Abstract

MA F, Yang L, He Y, Yang Z, et al
Symptom-related experience and sexual health of female patients with pulmonary arterial hypertension: protocol for a systematic review and qualitative meta-synthesis.
BMJ Open. 2025;15:e089095.
Abstract

MICHEL S, Pattathu J, Horer J, Kari FA, et al
Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension.
Multimed Man Cardiothorac Surg. 2025;2025.
Abstract

BARTSCH V, Gester F, Parzibut G, Maloir Q, et al
[Idiopathic pulmonary arterial hypertension revealed by right ventricular dysfunction].
Rev Med Liege. 2025;80:18-25.
Abstract

STINE AE, Parmar J, Smith AK, Cummins Z, et al
Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population.
NPJ Syst Biol Appl. 2025;11:9.
Abstract

LORENZI W, Wainstein RV, Rodrigues RP, Benedetto IG, et al
Multimodal treatment of chronic thromboembolic pulmonary hypertension: initial experience at a university hospital in southern Brazil.
J Bras Pneumol. 2025;50:e20240231.
Abstract

SOUZA FSF, Ferreira MG, Melo IA, Sa MFL, et al
Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil.
J Bras Pneumol. 2025;50:e20240147.
Abstract

LUIJTEN D, van den Hout WB, Boon GJAM, Barco S, et al
Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors.
ERJ Open Res. 2025;11:00575-2024.
Abstract

KIRILLOVA A, Sethuraman M, Dong X, Kirdar A, et al
Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.
ERJ Open Res. 2025;11:00486-2024.
Abstract

RAWLINGS GH, Bowmer G, Armstrong I, Thompson AR, et al
Update to: self-help cognitive behavioural therapy for anxiety in pulmonary hypertension.
ERJ Open Res. 2025;11:00872-2024.
Abstract

GEDEFAW A, Ayele YY, Wudie G, Tefera A, et al
Prevalence of pulmonary hypertension and associated factors among rheumatic heart disease patients in Ethiopia.
BMC Cardiovasc Disord. 2025;25:20.
Abstract

DONNAN MT, McLean C, Siemienowicz M, Keating DT, et al
Excipient lung disease with transient severe pulmonary hypertension in a healthcare professional injecting crushed oxycodone tablets.
BMJ Case Rep. 2025;18:e260988.
Abstract

LYU TT, Wang JY, Tan JS, Yang YM, et al
Causal associations between telomere length and pulmonary arterial hypertension: A two-sample Mendelian randomization study.
Medicine (Baltimore). 2024;103:e40407.
Abstract

KANG L, Han Y, Liu C, Liu X, et al
Sildenafil Attenuates Persistent Pulmonary Hypertension of the Newborn via Inhibiting the Growth and Migration of Pulmonary Artery Smooth Muscle Cells.
J Surg Res. 2025;306:249-256.
Abstract

PAKHATHIRATHIEN P, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
Mortality Prediction in Newborns With Persistent Pulmonary Hypertension: A Comparison of Four Illness Severity Scores.
Pediatr Pulmonol. 2025;60:e27484.
Abstract

FU LJ, Feng JX, Sun YJ, Xu ZM, et al
[A case of transcatheter membrane-covered stent shunt for severe pulmonary hypertension post-CHD surgery].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:69-72.
Abstract

KATO S, Minamitani Y, Hosokawa M, Nakashima T, et al
Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born <34 weeks) after 7 days of age.
BMJ Open. 2024;14:e087740.
Abstract

JIANG P, Huang H, Liu Z, Xiang G, et al
STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines.
Respir Res. 2025;26:13.
Abstract

AHMAD A, Wang X, Li L, Liu T, et al
Insights from 3D echocardiography: unveiling the prognostic value of RV function in pulmonary hypertension: a systematic review and meta-analysis.
Int J Cardiovasc Imaging. 2025 Jan 13. doi: 10.1007/s10554-025-03326.
Abstract

MOMOI M, Katsumata Y, Hiraide T, Shinya Y, et al
Chronic Thromboembolic Pulmonary Hypertension as RNF213-Associated Vascular Disease.
JACC Asia. 2024;4:1017-1019.
Abstract

WADDINGHAM MT, Tsuchimochi H, Sonobe T, Sequeira V, et al
The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension.
J Mol Cell Cardiol Plus. 2024;8:100072.
Abstract

SUN H, Liao X, Wang S, Yuan H, et al
5-Methylcytosine-modified circRNA-CCNL2 regulates vascular remdeling in hypoxic pulmonary hypertension through binding to FXR2.
Int J Biol Macromol. 2025;296:139638.
Abstract

PENG W, Wan G, Cheng S, Li G, et al
Potential role of TRAF2 in pulmonary hypertension in broiler chickens and preparation and specificity analysis of its polyclonal antibody.
Int J Biol Macromol. 2025 Jan 9:139741. doi: 10.1016/j.ijbiomac.2025.139741.
Abstract

PATSIOU V, Arvanitaki A, Farmakis IT, Anthi A, et al
Survival prospects of pulmonary arterial hypertension associated with congenital heart disease: Insights from the HOPE registry.
Int J Cardiol. 2025;421:132894.
Abstract

YANG L, Wang X, Gu B, Su D, et al
Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
Abstract

MONTEZANO AC, Kuriakose J, Hood KY, Sin YY, et al
Ang-(1-7) and ET-1 Interplay Through Mas and ET(B) Receptor Interaction Defines a Novel Vasoprotective Mechanism.
Hypertension. 2025;82:267-281.
Abstract

CAO D, Grunig E, Sirenko Y, Radchenko G, et al
SMAD5 as a novel gene for familial pulmonary arterial hypertension.
Clin Sci (Lond). 2025;139:15-27.
Abstract

YI K, Guo T, Wang WX, He SE, et al
The relationship of nitric oxide synthase 3(NOS3) gene polymorphism in the risk of pulmonary arterial hypertension: A systematic review and meta-analysis.
Nitric Oxide. 2025;154:51-76.
Abstract

DI PASQUALE G, Caione N, Di Berardino A, Di Donato G, et al
Pulmonary manifestations of juvenile vs. adult systemic sclerosis: insights into pathophysiological and clinical features.
Pediatr Pulmonol. 2025;60:e27347.
Abstract

AN Y, Xu M, Yan M, Zhang H, et al
Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension.
J Thromb Haemost. 2025;23:158-170.
Abstract

SWIETLIK EM, Fay M, Morrell NW
Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews.
Respiration. 2025;104:26-39.
Abstract

QIU JY, Huang SS, Liu C, Ding D, et al
Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension.
BMC Cardiovasc Disord. 2025;25:38.
Abstract

FORD ML, Ruwanpathirana A, Britt RD Jr
The Art(ery) of Contraction: Using Precision Cut Lung Slices to Model Pulmonary Hypertension in ARDS.
Am J Respir Cell Mol Biol. 2025 Jan 23. doi: 10.1165/rcmb.2024-0603.
Abstract

PULLAMSETTI SS, Savai R
Decoding lysosome communication.
Science. 2025;387:359-361.
Abstract

HARVEY LD, Alotaibi M, Tai YY, Tang Y, et al
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.
Science. 2025;387:eadn7277.
Abstract

GROSSO G, Tognetti R, Domenech O, Della Pina A, et al
Echocardiographic evaluation of the size of the main pulmonary artery and right pulmonary artery in dogs with pulmonary hypertension.
J Vet Intern Med. 2025;39:e17241.
Abstract

ANJUM AF, Fatima M, Anjum MB
Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.
Health Sci Rep. 2025;8:e70384.
Abstract

IKEDA N, Masaki K, Hosokawa K, Funakoshi K, et al
Insights into balloon pulmonary angioplasty and the WHO functional class of chronic thromboembolic pulmonary hypertension patients: findings from the CTEPH AC registry.
Cardiovasc Interv Ther. 2025 Jan 22. doi: 10.1007/s12928-025-01095.
Abstract

KIM HC, Chandel A, King CS, Kim MJ, et al
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.
Lung. 2025;203:27.
Abstract

CORTEZ M, Lopez B, Mamani J, de Maria Ibanez F, et al
When the heart and tumours intertwine: pulmonary hypertension associated with a neuroendocrine tumour-a case report.
Eur Heart J Case Rep. 2024;9:ytae678.
Abstract

ZHU J, Zhang Z, Lei Y, Ouyang Z, et al
The prediction value of serum anion gap for short-term mortality in pulmonary hypertension patients with sepsis: a retrospective cohort study.
Front Med (Lausanne). 2025;11:1499677.
Abstract

CHENG H, Yang H, Zhang Y, Wei Z, et al
Association of Fibrinogen Aalpha Thr312Ala (rs6050) Polymorphism with Venous Thrombosis and Chronic Thromboembolic Pulmonary Hypertension: A Meta-Analysis.
Clin Appl Thromb Hemost. 2025;31:10760296251314476.
Abstract

AL-BITAR A, Zalzaleh MA, Al Helbawi H, Morteza MH, et al
Heterotaxy syndrome, dextrocardia, ureteropelvic obstruction, endometriosis, and pulmonary hypertension in an adult with congenital heart defects: a case report.
J Med Case Rep. 2025;19:28.
Abstract

ZHANG X, Li J, Fu M, Geng X, et al
Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation.
Respir Res. 2025;26:29.
Abstract

XIA Y, Liu X
The value of lung ultrasound score combined with echocardiography in assessing right heart function in patients undergoing maintenance hemodialysis and experiencing pulmonary hypertension.
BMC Cardiovasc Disord. 2025;25:33.
Abstract

PAI TW, Huang CW
Low-dose dasatinib-induced chylothorax, pulmonary hypertension, and pericardial effusion in a patient with chronic myeloid leukemia: A case report and literature review.
Medicine (Baltimore). 2025;104:e41328.
Abstract

WANG Y, Huang R, Zhuang Y
A Qualitative Study on the Experiences of Patients with Pulmonary Hypertension Undergoing Polypharmacy.
Br J Hosp Med (Lond). 2024;85:1-17.
Abstract

UFNAL M, Connolly K, Millegard M, Surkova E, et al
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.
ESC Heart Fail. 2025 Jan 20. doi: 10.1002/ehf2.15203.
Abstract

Corrigendum: Obesity paradox in pulmonary hypertension secondary to chronic lung diseases.
Chin Med J (Engl). 2025;138:252.
Abstract

AWAD MR, Eweda II, Ismail EM, Abdeltawab AA, et al
The Role OF 3D echocardiography in prediction of pulmonary vascular resistance and its reversibility in simple congenital heart disease with secondary pulmonary hypertension.
Curr Probl Cardiol. 2025;50:102983.
Abstract

XU Y, Liao P, Song X, Guo W, et al
A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats.
Respir Res. 2025;26:26.
Abstract

SHINOHARA T, Moonen JR, Chun YH, Lee-Yow YC, et al
High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2025;45:218-237.
Abstract

AVITABILE CM, Wang Y, Ash D, Flohr SJ, et al
Ventricular Dysfunction in Patients With Congenital Diaphragmatic Hernia Who Die After Repair.
J Pediatr Surg. 2024;60:162002.
Abstract

GHOFRANI HA, Gomberg-Maitland M, Zhao L, Grimminger F, et al
Mechanisms and treatment of pulmonary arterial hypertension.
Nat Rev Cardiol. 2025;22:105-120.
Abstract

TAN J, Cao X, Zheng R, Xie S, et al
Celastrol Ameliorates Hypoxia-Induced Pulmonary Hypertension by Regulation of the PDE5-cGMP-PKG Signaling Pathway.
Phytother Res. 2025 Jan 30. doi: 10.1002/ptr.8446.
Abstract

ABDELKADER AEA, Ilonze OJ, Guglin M
Dysfunctional Implantable Pulmonary Artery Sensor Device (CardioMEMS) in Group 2 Pulmonary Hypertension.
JACC Case Rep. 2025;30:102801.
Abstract

CHI E, Chandrasekara S, Keating DT
Severe pulmonary arterial hypertension and cardiogenic shock in acute systemic lupus erythematosus.
BMJ Case Rep. 2025;18:e262651.
Abstract

KUMAR R, Nolan K, Kassa B, Chanana N, et al
Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension.
J Clin Invest. 2025 Jan 30:e176865. doi: 10.1172/JCI176865.
Abstract

WANG J, Guan L, Yu J, Ma B, et al
Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-beta1/Smad signaling pathway.
Sci Rep. 2025;15:3619.
Abstract

RIBEIRO JM, Santana AB, de Oliveira Marusso L, de Oliveira Marrafon DAF, et al
Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review.
Naunyn Schmiedebergs Arch Pharmacol. 2025.
Abstract

TORRES-ROJAS MB, Navarro-Vergara DI, Garcia-Cesar M, Acosta-Altamirano G, et al
Right Heart Catheterization Accurately Diagnoses Pulmonary Hypertension in Patients With Interstitial Lung Disease: Results From a Long-Term Cohort Study.
Pulm Circ. 2025;15:e70035.
Abstract

PRADHAN A, Tyagi R, Sharma P, Bajpai J, et al
Shifting Paradigms in the Management of Pulmonary Hypertension.
Eur Cardiol. 2024;19:e25.
Abstract

CHEN MQ, Wang A, Wan CX, Ruan BQ, et al
Prognostic value of atherogenic index of plasma in pulmonary hypertension.
Front Med (Lausanne). 2025;11:1490695.
Abstract

LIU H, Liu S, Ma P, Ma L, et al
Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension.
Int J Nanomedicine. 2025;20:871-886.
Abstract

WEI Z, Shao X, An Z, Chang Y, et al
The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis.
Front Cardiovasc Med. 2025;11:1489674.
Abstract

WANG F, Xiao W, Li J, Zhang Z, et al
p16(INK4a) promoted progress of MCT induced pulmonary hypertension via maintaining redox balance and autophagy pathway.
Biochem Biophys Res Commun. 2025;749:151385.
Abstract

JAKUBOWSKI BR, Griffiths M, Goss KN
The Role of Imaging in Pulmonary Vascular Disease: The Clinician's Perspective.
Radiol Clin North Am. 2025;63:305-313.
Abstract

AGIRLAR TRABZONLU T, Allen BD
Role of Cardiovascular MR Imaging and MR Angiography in Patients with Pulmonary Vascular Disease.
Radiol Clin North Am. 2025;63:279-291.
Abstract

HAHN LD, Chung JH
Imaging of Chronic Thromboembolic Pulmonary Hypertension.
Radiol Clin North Am. 2025;63:223-234.
Abstract

SRIDHAR S, Ebrahimzadeh S, Ahn H, Lee C, et al
Imaging Approach to Pulmonary Hypertension.
Radiol Clin North Am. 2025;63:193-205.
Abstract

CONSING-GANGELHOFF M, Sharobim M, Bodnar C, Kanne JP, et al
Pathology of Pulmonary Vascular Disease with Radiologic Correlation.
Radiol Clin North Am. 2025;63:179-191.
Abstract

LUCERO M, Lisk C, Cendali F, Swindle D, et al
TARGETING LUNG HEME IRON BY AEROSOL HEMOPEXIN ADMINSTRATION IN SICKLE CELL DISEASE PULMONARY HYPERTENSION.
Free Radic Biol Med. 2025 Jan 23:S0891-5849(25)00056.
Abstract

KRONBERGER C, Mousavi RA, Ermolaev N, Willixhofer R, et al
One-minute sit-to-stand test cut-offs for risk stratification based on six-minute walk test thresholds in pulmonary hypertension.
Eur J Prev Cardiol. 2025 Jan 25:zwaf031. doi: 10.1093.
Abstract

NAKAMURA K, Akagi S, Ejiri K, Taya S, et al
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia.
Int J Mol Sci. 2025;26:835.
Abstract

ATTARIPOUR ESFAHANI S, Baba Ali N, Farina JM, Scalia IG, et al
A Comprehensive Review of Artificial Intelligence (AI) Applications in Pulmonary Hypertension (PH).
Medicina (Kaunas). 2025;61:85.
Abstract

DRAGOI IT, Rezus C, Burlui AM, Bratoiu I, et al
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.
Medicina (Kaunas). 2024;61:19.
Abstract

YANG S, Chen Q, Yang B
Associations of cathepsins with pulmonary arterial hypertension mediated by circulating metabolites: A Mendelian randomization study.
Medicine (Baltimore). 2025;104:e41405.
Abstract

ALVES-SILVA JM, Zuzarte M, Marques C, Rodrigues T, et al
1,8-Cineole reduces pulmonary vascular remodelling in pulmonary arterial hypertension by restoring intercellular communication and inhibiting angiogenesis.
Phytomedicine. 2025;137:156334.
Abstract

SHIGEFUKU R, Iwasa M, Yoshikawa K, Tanaka H, et al
A rare case of idiopathic portal hypertension with portopulmonary hypertension occurred following splenectomy with a change in portal hemodynamics.
Clin J Gastroenterol. 2025;18:130-136.
Abstract

VIZZA CD, Klok R, Harley J, Small M, et al
Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan.
Adv Ther. 2025;42:193-215.
Abstract

GOOD SD, Lee JY, Johnson RE, Volkmann ER, et al
A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.
Curr Opin Rheumatol. 2025;37:103-112.
Abstract

VILLANUEVA J, Wade J, Torres A, Hale G, et al
Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension.
Am J Cardiovasc Drugs. 2025;25:17-24.
Abstract

RZEPKA MF, Raschzok S, Lee XA, Yazaki K, et al
Inhibition of Myocardin-related Transcription Factor A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle.
Am J Respir Cell Mol Biol. 2025;72:158-168.
Abstract

DAI J, Liu T, Zhang H, Sun X, et al
Fragmented QRS complex could predict all-cause mortality in patients with connective tissue disease-associated pulmonary arterial hypertension.
Rheumatology (Oxford). 2025;64:789-797.
Abstract

VEZINA FA, Bouchard PA, Breton-Gagnon E, Dion G, et al
Automated O(2) Titration Alone or With High-Flow Nasal Cannula During Walking Exercise in Chronic Lung Diseases.
Respir Care. 2023;69:1-14.
Abstract

COLALILLO A, Pellicano C, Ananyeva LP, Hachulla E, et al
Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort.
Arthritis Care Res (Hoboken). 2025;77:257-265.
Abstract

WANG J, Xuan B, Song B, Wang T, et al
MTMR7 attenuates the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary hypertension by suppressing ERK/STAT3 signaling.
Mol Cell Biochem. 2025 Feb 7. doi: 10.1007/s11010-025-05217.
Abstract

RAMANAND P, Indic P, Gentle SJ, Ambalavanan N, et al
Detection of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia using oxygen saturation data.
Pediatr Res. 2025 Feb 6. doi: 10.1038/s41390-025-03891.
Abstract

YAO X, Cai X, Zhang S, Yang Y, et al
Mendelian randomization study of serum uric acid levels and urate-lowering drugs on pulmonary arterial hypertension outcomes.
Sci Rep. 2025;15:4460.
Abstract

BAI J, Gao D, Mei J, Yuan H, et al
Exonic CircGUCY1A2 Inhibits Pulmonary Artery Smooth Muscle Cells Phenotypic Switching Via Regulating O-glycosylation of COL3A1 in Pulmonary Hypertension.
Eur J Pharmacol. 2025 Feb 4:177328. doi: 10.1016/j.ejphar.2025.177328.
Abstract

DIRICKX A, Levy M, Mellul K, Coignard M, et al
Infants With a Congenital Diaphragmatic Hernia Had Favourable Pulmonary Hypertension Outcomes at 1 Year of Age.
Acta Paediatr. 2025 Feb 6. doi: 10.1111/apa.70019.
Abstract

DUFLOU J
Rare but relevant: The injection of tablet preparations and pulmonary hypertension.
Addiction. 2025 Feb 6. doi: 10.1111/add.70012.
Abstract

GONG J, Li H, Cui X, Yan Y, et al
Tianlong Kechuanling Decoction Attenuates Pulmonary Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
J Ethnopharmacol. 2025 Feb 3:119395. doi: 10.1016/j.jep.2025.119395.
Abstract

PENTIKAINEN M, Simonen P, Leskela P, Harju T, et al
Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).
Pulm Circ. 2025;15:e12440.
Abstract

RUBIN LJ
Pulmonary Hypertension: A Personal Journey.
Pulm Circ. 2025;15:e70047.
Abstract

DHANANI Z, Nicholson MJ, Gayen S
Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival.
Pulm Circ. 2025;15:e70046.
Abstract

XIE X, Wang Y, Tian S, Cao D, et al
Prognostic and Diagnostic Value of Platelet Distribution Width in COPD Patients with Pulmonary Hypertension: A Retrospective Study.
Biotechnol Appl Biochem. 2025 Feb 3. doi: 10.1002/bab.2723.
Abstract

WITTIG C, Konig JM, Pan X, Aman J, et al
Shear stress unveils patient-specific transcriptional signatures in PAH: Towards personalized molecular diagnostics.
Theranostics. 2025;15:1589-1605.
Abstract

MA H, Xu F, Liu L, Kong H, et al
Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study.
Int J Cardiol Heart Vasc. 2025;56:101605.
Abstract

OGUZ M, Yilmaz I, Erdem A, Imre G, et al
Dicrotic notch index in pulmonary hypertension: correlation with hemodynamic, echocardiographic and clinical parameters.
Postepy Kardiol Interwencyjnej. 2024;20:449-454.
Abstract

ITO S, Yoshitani K, Fukushima S, Matsuda H, et al
Effect of Preoperative Pulmonary Hypertension on the Course of Right Ventricular Function: A Three-dimensional Echocardiographic Study in Valvular Surgery Patients.
J Cardiovasc Echogr. 2024;34:170-178.
Abstract

GUO L, Khobragade N, Kieu S, Ilyas S, et al
Development and Evaluation of a Deep Learning-Based Pulmonary Hypertension Screening Algorithm Using a Digital Stethoscope.
J Am Heart Assoc. 2025;14:e036882.
Abstract

ALBULUSHI A, Al-Asmi S, Al-Abri M, Al-Farhan H, et al
Elevated Lp(a) and its association with cardiac fibrosis in group II pulmonary hypertension patients.
Future Cardiol. 2025 Feb 2:1-8. doi: 10.1080/14796678.2025.2460909.
Abstract

FUJIWARA T, Ishii S, Minatsuki S, Hatano M, et al
Exploring Novel Therapeutics for Pulmonary Arterial Hypertension.
Int Heart J. 2025;66:3-12.
Abstract

GELFMAN DM
Diagnosis: Pulmonary Hypertension. Next Steps.
Am J Med. 2025 Jan 30:S0002-9343(25)00060-9. doi: 10.1016/j.amjmed.2025.
Abstract

PILARD CM, Cardouat G, Gauthereau I, Gassiat L, et al
Celastrol has beneficial effects on pulmonary hypertension associated with bronchopulmonary dysplasia: Preclinical study outcomes.
Biomed Pharmacother. 2025;184:117881.
Abstract

LI Q, Shi X, Tang Y, Fu Y, et al
Shared genes and relevant potential molecular linkages between COVID-19 and chronic thromboembolic pulmonary hypertension (CTEPH).
J Thromb Thrombolysis. 2025 Feb 1. doi: 10.1007/s11239-025-03072.
Abstract

DA COSTA RODRIGUES J, Gazarian C, Maillard J, Albu G, et al
Emergency ECMO Deployment During Liver Transplantation in Portopulmonary Hypertension Patients.
Am J Case Rep. 2025;26:e946268.
Abstract

HASSELFELD K, Hysinger E, House M
Preterm Infants With Bronchopulmonary Dysplasia and Pulmonary Hypertension.
Neoreviews. 2025;26:e132-e140.
Abstract

ZHAO Z, Sang M, Li Q, Zhang H, et al
Targeted FTO knockout in endothelial cells Boosts adhesion and lowers inflammatory infiltration to alleviate pulmonary arterial hypertension.
Biochem Biophys Res Commun. 2025;749:151339.
Abstract

TIAN XT, Peng ZY, Wu YS, Cao YY, et al
Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD-Like Receptor Family Protein 3/Gasdermin E-Mediated Pyroptosis in Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2025;14:e034726.
Abstract

TAN W, Wang Y, Li M, Zhao C, et al
A novel pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model.
Eur J Med Chem. 2025;286:117266.
Abstract

ALBIACH-DELGADO A, Pinilla-Gonzalez A, Cascant-Vilaplana MM, Solaz-Garcia A, et al
The effect of inhaled nitric oxide treatment on biomarkers of oxidative/nitrosative damage to proteins and DNA/RNA.
Free Radic Biol Med. 2025;228:350-359.
Abstract

KUNICKI PK, Grymm MT, Pawinski T, Szulczyk D, et al
A simple HPLC-UV method for monitoring therapeutic adherence in pulmonary arterial hypertension.
J Chromatogr B Analyt Technol Biomed Life Sci. 2025;1252:124443.
Abstract

KOPEC G, Skride A, Ereminiene E, Simkova I, et al
Emerging therapies and new directions in the treatment of pulmonary arterial hypertension.
Kardiol Pol. 2025;83:18-26.
Abstract

XIE S, Zhao J, Zhang F, Li X, et al
Dehydrodiisoeugenol inhibits PDGF-BB-induced proliferation and migration of human pulmonary artery smooth muscle cells via the mTOR/HIF1-alpha/HK2 signaling pathway.
Toxicol Appl Pharmacol. 2025;495:117212.
Abstract

THARWANI A, Minai O, Rao Y, Kim H, et al
The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertension.
Respir Med. 2025;237:107919.
Abstract

PARK A, Brillhart A, Sethi S, Abramor B, et al
Characteristics of Climbers with High Altitude Pulmonary Edema on Mount Aconcagua.
Wilderness Environ Med. 2025;36:113-118.
Abstract

WHITE RJ, Vizza D, Klok R, Harley J, et al
Health-related quality of life and symptom concordance between patients and physicians in pulmonary arterial hypertension in the United States, Europe, and Japan.
Respir Med. 2025;237:107869.
Abstract

SUN H, Stockbridge N, Ivy DD, Clark J, et al
Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension.
J Pediatr. 2025;277:114383.
Abstract

KUMAR KR, Ciociola EC, Skinner KR, Dixit GM, et al
Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants.
Cardiol Young. 2025;35:93-101.
Abstract

GAMI A, Jani VP, Mombeini H, Osgueritchian R, et al
Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular Disease.
J Am Soc Echocardiogr. 2025;38:115-126.
Abstract

VENET M, Malik A, Gold S, Zhang N, et al
Impact of Right Ventricular Pressure Overload on Myocardial Stiffness Assessed by Natural Wave Imaging.
JACC Cardiovasc Imaging. 2025;18:211-225.
Abstract

CHIU SN, Tseng WC, Lu CW, Lin MT, et al
Atrial flutter/fibrillation in adult congenital heart disease: Insights from a large Asian cohort.
J Formos Med Assoc. 2025;124:126-132.
Abstract

DAWES TJW, Woodham V, Sharkey E, McEwan A, et al
Predicting Peri-Operative Cardiorespiratory Adverse Events in Children with Idiopathic Pulmonary Arterial Hypertension Undergoing Cardiac Catheterization Using Echocardiography: A Cohort Study.
Pediatr Cardiol. 2025;46:475-484.
Abstract

CHEN D, Yang J, Zhang T, Li X, et al
Mechanistic Investigation of Calcium Channel Regulation-Associated Genes in Pulmonary Arterial Hypertension and Signatures for Diagnosis.
Mol Biotechnol. 2025;67:1122-1136.
Abstract

MUSCOGIURI E, Van Ballaer V, De Wever W, Di Dedda E, et al
Uncommon Causes of Pulmonary Hypertension With Associated Cardiomyopathy: Computed Tomography and Magnetic Resonance Imaging of Cardiothoracic Manifestations.
Echocardiography. 2025;42:e70103.
Abstract

PITSIOU GG
Treatment Approaches for Pulmonary Hypertension in Colombia: A Call to Action.
Clin Respir J. 2025;19:e70062.
Abstract

SHI X, Ma X, Wang H, He X, et al
Elevated serum levels of HIF-1alpha and VEGF as potential biomarkers in connective tissue disease-associated pulmonary arterial hypertension.
Sci Rep. 2025;15:5410.
Abstract

JARAMILLO C, Tabaza S, Ferguson E, Odisio E, et al
Chronic thromboembolic pulmonary hypertension: Role of imaging in diagnosis and guiding the treatment.
Clin Imaging. 2025;120:110430.
Abstract

PRASAD RR, Kumar S, Zhang H, Li M, et al
An intracellular complement system drives metabolic and proinflammatory reprogramming of vascular fibroblasts in pulmonary hypertension.
JCI Insight. 2025 Feb 13:e184141. doi: 10.1172/jci.insight.184141.
Abstract

DE VADDER A, Lemloh L, Bo B, Hale L, et al
Bosentan as adjunctive therapy in neonates with congenital diaphragmatic hernia-associated pulmonary hypertension: a case series.
Eur J Pediatr. 2025;184:198.
Abstract

CONDIT PE, Hokanson JS, Balasubramaniam V, McCulley DJ, et al
Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.
Pediatr Pulmonol. 2025;60:e27501.
Abstract

KRAMER M, Rosenkranz S, Kramer T
Depression in Pulmonary Hypertension: A Systematic Review of Clinical Outcomes, Treatment Interactions, and Emerging Technologies.
J Clin Med. 2025;14:982.
Abstract

NUCHE J, Ponz I, Sanchez Sanchez V, Bobeda J, et al
Four-Dimensional Magnetic Resonance Pulmonary Flow Imaging for Assessing Pulmonary Vasculopathy in Patients with Postcapillary Pulmonary Hypertension.
J Clin Med. 2025;14:929.
Abstract

KURZYNA P, Witowicz A, Kedzierski P, Florczyk M, et al
Sex-Specific Differences in Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
J Clin Med. 2025;14:899.
Abstract

TARRAS ES, Singh I, Kreiger J, Joseph P, et al
Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.
J Clin Med. 2025;14:804.
Abstract

WALI S, Hwej A, Welsh DJ, Wilson K, et al
Connexin 43 Affects Pulmonary Artery Reactivity via Changes in Nitric Oxide Production and Influences Proliferative and Migratory Responses in Mouse Pulmonary Artery Fibroblasts.
Int J Mol Sci. 2025;26:1280.
Abstract

AHMADI A, Klein R, Gao D, Mielniczuk LM, et al
Test-retest Assessment of Biventricular Myocardial Oxidative Metabolism and Perfusion in Pulmonary Hypertension Patients Using (11)C-acetate PET Imaging: A Pilot Study.
Mol Imaging Biol. 2025 Feb 12. doi: 10.1007/s11307-025-01987.
Abstract

GUO R, Mi L, Gao J, Yang Y, et al
Natural killer cells are decreased in systemic sclerosis and have diagnostic value for pulmonary arterial hypertension incorporation.
Sci Rep. 2025;15:5178.
Abstract

HIBBERT B, Al-Abcha A
Tricuspid Regurgitation and Pulmonary Hypertension: Putting the Cart Before the Horse.
JACC Cardiovasc Interv. 2025;18:337-338.
Abstract

MOHAMED K, Bayoumi MAA, Rahmath MR, Elmalik EE, et al
Severe pulmonary hypertension in a small-for-date neonate with skeletal dysplasia.
BMJ Case Rep. 2025;18:e264256.
Abstract

VARELA CMR, Herrero IF, Melon NM, Cebada FS, et al
Recurrent chronic thromboembolic pulmonary hypertension following balloon pulmonary angioplasty.
Rev Esp Cardiol (Engl Ed). 2025 Feb 10:S1885-5857(25)00050.
Abstract

LICHTBLAU M, Lador F, Lechartier B, Ellegast JM, et al
Pulmonary hypertension in the field of hematological and oncological diseases.
Respiration. 2025 Feb 12:1-20. doi: 10.1159/000544126.
Abstract

LYAPINA IN, Valieva ZS, Martynyuk TV
[MD, Doctor of Medical Science, Head of the Department of Pulmonary Hypertension and Heart Diseases, Myasnikov Clinical Cardiology Institute].
Kardiologiia. 2025;65:50-57.
Abstract

ANDERSEN K, Larsson B, Bjorklund E, Mathilda Bergman E, et al
[Chronic thromboembolic pulmonary hypertension].
Lakartidningen. 2025;122:24034.
Abstract

LEMAY SE, Mougin M, Sauvaget M, El Kabbout R, et al
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.
Cell Rep Med. 2025 Feb 3:101964. doi: 10.1016/j.xcrm.2025.101964.
Abstract

GILLMEYER KR, Rinne ST, Rucci JM, Klings ES, et al
Factors Associated with Referral to Expert Providers among Patients with Pulmonary Hypertension.
Ann Am Thorac Soc. 2025 Feb 11. doi: 10.1513/AnnalsATS.202408.
Abstract

QIU H, Chen J, Mei Z, Chen W, et al
Dysregulated fatty acid metabolism in pericardiac adipose tissue of pulmonary hypertension due to left heart disease mice.
FASEB J. 2025;39:e70355.
Abstract

FU G, Qiu L, Wang J, Li S, et al
Genome-wide characterization of circular RNAs in three rat models of pulmonary hypertension reveals distinct pathological patterns.
BMC Genomics. 2025;26:127.
Abstract

JIANG P, Huang H, Xie M, Liu Z, et al
Single-cell characterization of the immune heterogeneity of pulmonary hypertension identifies novel targets for immunotherapy.
BMC Immunol. 2025;26:5.
Abstract

WANG YR, Yu Y, Liang ZS, Tong L, et al
[Mechanism of L-perilla alcohol in intervening hypoxic pulmonary hypertension based on network pharmacology and experimental verification].
Zhongguo Zhong Yao Za Zhi. 2025;50:209-217.
Abstract

ZHAO L, Cunningham CM, Hong J, Agarwal S, et al
A Cross-Species and Sex-Specific Meta-Analysis of Transcriptomic Studies of Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Feb 10. doi: 10.1165/rcmb.2024-0410.
Abstract

Retraction of: Exercise pulmonary hypertension by the mPAP/CO slope in primary mitral regurgitation.
Eur Heart J Cardiovasc Imaging. 2025 Feb 10:jeaf016. doi: 10.1093.
Abstract

BACZYNSKI M, Weisz D, Thomas L, Fevrier S, et al
Response to Inhaled Nitric Oxide and Mortality Among Very Preterm Neonates With Pulmonary Hypertension.
JAMA Netw Open. 2025;8:e2458843.
Abstract

CAHYONO A, Irwanto, Rahman MA, Widjiati W, et al
Progression of pulmonary arterial hypertension: A study in model.
Open Vet J. 2024;14:3498-3504.
Abstract

ARCHAMBAULT JL, Hernandez TL, Nozik ES, Palmer C, et al
Corrigendum to "Relationship Between Urine Serotonin and Persistent Pulmonary Hypertension of the Newborn". J Pediatr 2025; 276:114290.
J Pediatr. 2025 Feb 8:114462. doi: 10.1016/j.jpeds.2025.114462.
Abstract

GAYEN S, Pescatore J, Bittner M, Naranjo M, et al
Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension.
BMC Pulm Med. 2025;25:69.
Abstract

LIU ZB, Zhu RR, Liu JL, Xu QR, et al
NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming.
Cell Signal. 2025;127:111594.
Abstract

WANG Y, Su H, Lin X, Dai C, et al
1,25-(OH)(2)D(3) improves SD rats high-altitude pulmonary edema by inhibiting ferroptosis and ferritinophagy in alveolar epithelial cells.
J Steroid Biochem Mol Biol. 2025;247:106663.
Abstract

SEIDEL LM, Thudium J, Smith C, Sapehia V, et al
Death-associated protein kinase 1 prevents hypoxia-induced metabolic shift and pulmonary arterial smooth muscle cell proliferation in PAH.
Cell Signal. 2025;127:111527.
Abstract

RATWATTE S, Cordina RL, Baker D, Lau E, et al
The importance of assessing and correcting hydration status prior to right heart catheterisation: a pilot study.
Intern Med J. 2025;55:320-324.
Abstract

NASER JA, Harada T, Reddy YN, Pislaru SV, et al
Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation.
JAMA Cardiol. 2025;10:182-187.
Abstract

FU Z, Xie W, Gao Q, Zhang S, et al
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Disease: Success Rate and Complications among Different Patient Populations.
Respiration. 2025;104:110-123.
Abstract

MUKTHAPURAM S, Donaher A, Higano NS, Rowe JA, et al
Magnetic Resonance Imaging Assessment of Pulmonary Vascularity in Preterm Infants with Bronchopulmonary Dysplasia.
Neonatology. 2024 Jul 29:1-8. doi: 10.1159/000539545.
Abstract

LI S, Chen Z, Li K, Zhang Z, et al
The Impact of Valve Surgery on the Safety and Cardiac Function of Patients with Valvular Heart Disease Complicated by Pulmonary Arterial Hypertension.
Altern Ther Health Med. 2025;31:76-83.
Abstract

BYRNE A, Al-Hindawi Y, Plit M, Yeung L, et al
The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study.
BMC Pulm Med. 2025;25:84.
Abstract

CERESER L, Borghesi A, De Martino M, Nadarevic T, et al
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists.
Eur J Radiol. 2025;185:111998.
Abstract

MORGAN CE, Woolfall K, Aikman N, Gale C, et al
Developing a Neonatal Pulmonary Hypertension Core Outcome Set (NeoPH COS)-A Study Protocol.
Pulm Circ. 2025;15:e70052.
Abstract

MACHADO-DUQUE M, Gaviria-Mendoza A, Valladales-Restrepo LF, Pacheco M, et al
Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia.
Clin Respir J. 2025;19:e70063.
Abstract

ANDERSEN S, Bjerre JV, Baekgaard K, Idorn L, et al
Severe Precapillary Pulmonary Hypertension and Right Ventricular Failure After Hematopoietic Stem Cell Transplantation: Successful Outcomes With Aggressive Upfront Triple Therapy.
Pediatr Blood Cancer. 2025 Feb 20:e31623. doi: 10.1002/pbc.31623.
Abstract

PATEL JN, Talon A, Hu C, Ma M, et al
Descriptive Analysis of Oxygen Dependency and Hemodynamic Changes Following Pulmonary Thromboendarterectomy in Chronic Thromboembolic Pulmonary Hypertension Patients.
Cureus. 2025;17:e77663.
Abstract

FUJITA S, Shimokawahara H, Kanezawa M, Matsubara H, et al
Case Report: Effective Management of Pulmonary Hypertension Associated With Takayasu Arteritis Through Both Immunosuppressive Therapy and Serial Balloon Pulmonary Angioplasty.
Int J Rheum Dis. 2025;28:e70143.
Abstract

GAO L, Zhang S, Li S, Luo M, et al
Association of insulin resistance surrogates with disease severity and adverse outcomes in chronic thromboembolic pulmonary hypertension: a multicenter cohort study.
Cardiovasc Diabetol. 2025;24:82.
Abstract

SCHULZE KM, Horn AG, Weber RE, Hageman KS, et al
Bulk and regional diaphragm blood flow during chemical hyperpnea in pulmonary hypertensive rats.
Respir Physiol Neurobiol. 2025 Feb 17:104414. doi: 10.1016/j.resp.2025.104414.
Abstract

VARZIDEH F, Forzano I, Farroni E, Mone P, et al
Macrophages Regulate Inflammatory Vascular Remodeling in Pulmonary Hypertension.
Hypertension. 2025;82:460-462.
Abstract

FIORENTU G, Bernardinello N, Giulianelli G, Cocconcelli E, et al
Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future.
Adv Ther. 2025 Feb 19. doi: 10.1007/s12325-025-03129.
Abstract

HE C, Ji Y, Zhang Y, Ou J, et al
Inhibition of Mettl3 by STM2457 and Loss of Macrophage Mettl3 Alleviate Pulmonary Hypertension and Right Heart Remodeling.
Lung. 2025;203:34.
Abstract

ZHANG R, Zhang Y, Li H, Zhang J, et al
Single-cell transcriptomic analysis reveals distinct plasma cell populations in chronic thromboembolic pulmonary hypertension.
J Thromb Haemost. 2025 Feb 16:S1538-7836(25)00105.
Abstract

ROBBINS EW, Bradley K, Badesch DB, Burger C, et al
Medication Non-Adherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
Ann Am Thorac Soc. 2025 Feb 18. doi: 10.1513/AnnalsATS.202312-1083.
Abstract

GERGES C, Jevnikar M, Brenot P, Savale L, et al
Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial.
Circ Cardiovasc Interv. 2025;18:e014785.
Abstract

SMOOD B, Vasquez CR, Olia SE, Han JJ, et al
Early Extracorporeal Membrane Oxygenation Initiation May Improve Outcomes in Select Patients With Primary Pulmonary Hypertension: An Extracorporeal Life Support Organization Registry Analysis.
ASAIO J. 2025 Feb 18. doi: 10.1097/MAT.0000000000002390.
Abstract

SCALONE EJ, Woodruff AG, Saha AK, Wright JM, et al
Inhaled Epoprostenol in Children With Pediatric Acute Respiratory Distress Syndrome: A Single-Center Retrospective Study.
Pediatr Pulmonol. 2025;60:e71010.
Abstract

PACHE-WANNAZ L, Voicu C, Boillat L, Sekarski N, et al
Case Report: severe pulmonary hypertension in a child with micronutrient deficiency.
Front Pediatr. 2025;13:1478889.
Abstract

LI HF, Li XY, Sun YQ, Zhi ZY, et al
The Role of Ion Channels in Pulmonary Hypertension: A Review.
Pulm Circ. 2025;15:e70050.
Abstract

CHEN J, Chen X, Agrawal V, Moore CS, et al
Estrogen and Cyp1b1 Regulate Ppargamma in Pulmonary Hypertension Through a Ubiquitin-Dependent Mechanism.
Pulm Circ. 2025;15:e70054.
Abstract

WANG H, Li L, Zhou G, Wang L, et al
RPL39 Was Associated With Sex Differences in Pulmonary Arterial Hypertension.
Can Respir J. 2025;2025:7139235.
Abstract

PAMUKCU E, Kaya MO
Meta-Analysis of Real-World Clinical Practice to Assess the Effectiveness of Riociguat in Treating Chronic Thromboembolic Pulmonary Hypertension.
J Clin Hypertens (Greenwich). 2025;27:e70015.
Abstract

GHILARDI S, Sala G, Locatelli C, Pravettoni D, et al
Echocardiographic Changes Related to Pulmonary Hypertension in Preweaned Dairy Calves With Bronchopneumonia: A Case-Control Study in Commercial Dairy Farms.
J Vet Intern Med. 2025;39:e70020.
Abstract

LI H, Liu Y, Shi X, Luo Y, et al
SP1/ADAM10/DRP1 axis links intercellular communication between smooth muscle cells and endothelial cells under hypoxia pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2025;1871:167720.
Abstract

WANG P, Zhang X, Yao M, Li J, et al
Targeting high mobility group protein B2 exerts antiproliferative effects in hypoxic pulmonary hypertension by modulating miR-21.
Toxicol Appl Pharmacol. 2025;497:117265.
Abstract

MENEZES TCF, Lee MH, Fonseca Balladares DC, Nolan K, et al
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance.
J Am Heart Assoc. 2025;14:e036952.
Abstract

ROH DE, Park NR, Choi BG, Kang Y, et al
TGFBI regulates pulmonary vascular remodeling through endothelial-to-mesenchymal transition in pulmonary arterial hypertension.
Biochem Biophys Res Commun. 2025;751:151435.
Abstract

COSTELLE A, Lu J, Leewiwatwong S, Westerhof B, et al
Combining hyperpolarized (129)Xe MR imaging and spectroscopy to noninvasively estimate pulmonary vascular resistance.
J Appl Physiol (1985). 2025;138:623-633.
Abstract

KLOUDA T, Kim Y, Baek SH, Bhaumik M, et al
Specialized pericyte subtypes in the pulmonary capillaries.
EMBO J. 2025;44:1074-1106.
Abstract

CHEN X, Li L, Deng Y, Liao J, et al
Inhibition of glutaminase 1 reduces M1 macrophage polarization to protect against monocrotaline-induced pulmonary arterial hypertension.
Immunol Lett. 2025;272:106974.
Abstract

AIT-OUDHIA S, Jaworowicz D, Hu Z, Gaurav M, et al
Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial Hypertension.
Clin Pharmacol Ther. 2025;117:798-807.
Abstract

STONE JN, Kuebel DJ, Guido MR, Elwing JM, et al
Dual prostacyclin infusions: A case report of a patient symptom-driven transition from high-dose intravenous epoprostenol to subcutaneous treprostinil for the treatment of pulmonary arterial hypertension.
Am J Health Syst Pharm. 2025;82:e256-e261.
Abstract

LV X, Li J, Wei R, Meng L, et al
Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling.
Mol Cell Biochem. 2025;480:1045-1054.
Abstract

TOMA M, Savonitto G, Lombardi CM, Airo E, et al
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype.
Clin Res Cardiol. 2025;114:215-226.
Abstract

HAMILTON GW, Fletcher LR, Harley W, Azzopardi R, et al
Differences in Direct Fick and Thermodilution Measurements of Cardiac Output: Impact on Pulmonary Hypertension Classification.
Pulm Circ. 2025;15:e70053.
Abstract

SANT K, Johnson J, Suepaul R, Corradini I, et al
Cor Pulmonale and Secondary Pulmonary Arteriolar Hypertension in a Red Howler (Alouatta seniculus) Associated With Klebsiella pneumoniae Pneumonia.
J Med Primatol. 2025;54:e70010.
Abstract

KERBER B, Hullner M, Maurer A, Flohr T, et al
Photon-Counting Detector CT Iodine Maps Versus SPECT/CT: Advancing Lung Perfusion Imaging in Chronic Thromboembolic Pulmonary Hypertension.
Invest Radiol. 2025 Feb 28. doi: 10.1097/RLI.0000000000001163.
Abstract

CRAMER-BOUR C, Prakash P, Venkat D, Afonso L, et al
An Interdisciplinary Pulmonary Hypertension Curriculum for Fellows.
ATS Sch. 2025 Feb 27. doi: 10.34197/ats-scholar.2024-0089.
Abstract

HEKIMSOY V, Kaya EB
Assessment of the prevalence of hypotension in precapillary pulmonary hypertension patients with preserved right ventricle function.
Blood Press Monit. 2025 Feb 24. doi: 10.1097/MBP.0000000000000747.
Abstract

CASTELLI R, Atzori E, Delitala AP, Masala SA, et al
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature.
Front Cardiovasc Med. 2025;12:1508574.
Abstract

TAKEYAMA S, Hanaoka H, Hashimoto A, Ishii Y, et al
A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study.
BMC Rheumatol. 2025;9:25.
Abstract

TU TH, Lu JW, Wu CH, Ho YJ, et al
Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation.
In Vivo. 2025;39:1211-1219.
Abstract

NEELAKANTAN S, Vang A, Mehdi RR, Phelan H, et al
Right Ventricular Stiffening and Anisotropy Alterations in Pulmonary Hypertension: Mechanisms and Relations to Right Heart Failure.
J Am Heart Assoc. 2025 Feb 26:e037126. doi: 10.1161/JAHA.124.037126.
Abstract

ZHANG C, Su X, Zhang Y, He P, et al
Triangular Causality Among Pulmonary Hypertension, Sleep Disorders, and Brain Structure at the Genetic Level: A Mendelian Randomization Study Focused on the Lung-Brain Axis.
Nat Sci Sleep. 2025;17:343-356.
Abstract

YOGESWARAN A, Funderich M, Olschewski H, Kovacs G, et al
Association of pulmonary hypertension-targeted therapy and survival in precapillary pulmonary hypertension with mean pulmonary arterial pressure between 21 and 24 mmHg.
ERJ Open Res. 2025;11:00466-2024.
Abstract

KRISHNA SVS, Rana S, Singh P, Choudhary R, et al
A Study on Prevalence of Asymptomatic Pulmonary Hypertension in Patients of Metabolic Syndrome with Obstructive Sleep Apnea.
Ann Afr Med. 2025 Feb 25. doi: 10.4103.
Abstract

KURNIK M, Bozic H, Podbregar M
Systolic Pulmonary Artery Pressure as Long-Term Mortality Predictor in Elderly Critically Ill with Severe COVID-19 Pneumonia.
Viruses. 2025;17:244.
Abstract

LYHNE MD, Yuriditsky E, Zochios V, Dragsbaek SJ, et al
Pulmonary Artery Pulsatility Index in Acute and Chronic Pulmonary Embolism.
Medicina (Kaunas). 2025;61:363.
Abstract

MORIMATSU Y, Tahara N, Okamoto M, Bekki M, et al
Sarcoidosis-Associated Pulmonary Hypertension.
Medicina (Kaunas). 2025;61:342.
Abstract

HIDA Y, Imamura T, Ushijima R, Kinugawa K, et al
Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous Epoprostenol.
Medicina (Kaunas). 2025;61:184.
Abstract

BARNIKEL M, Kneidinger N, Gerckens M, Mummler C, et al
Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease.
J Clin Med. 2025;14:1120.
Abstract

ENEA I, Vedovati MC, Scelsi L, Garascia A, et al
[Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: the results of the "FOLLOW-EP" survey promoted by the ANMCO Working Group on Pulmonary Vascular Diseases].
G Ital Cardiol (Rome). 2025;26:195-204.
Abstract

MULLEN E, McCullagh B, Gaine S, Quadery SR, et al
Recent Advances in the Diagnosis and Management of Pulmonary Arterial Hypertension.
Br J Hosp Med (Lond). 2025;86:1-13.
Abstract

KAKIZAKI R, Raber L, Gerges C, Dorfmuller P, et al
3D Reconstruction of Pulmonary Vascular Lesions in Chronic Thromboembolic Pulmonary Hypertension.
Circ Cardiovasc Imaging. 2025 Feb 25:e017935.
Abstract

SKAARA H
My journey with pulmonary hypertension: From diagnosis to thriving.
Int J Cardiol Congenit Heart Dis. 2025;19:100572.
Abstract

YOUNIS A, Reddy YNV, Miranda WR, Abdelhalim AT, et al
Temporal changes in prevalence and severity of pulmonary hypertension, and relationship to outcomes in coarctation of aorta.
Int J Cardiol Heart Vasc. 2025;57:101626.
Abstract

XU W, Xi L, Ni Y, Wang J, et al
Artificial intelligence-driven quantitative analysis of CT morphological differences between chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease.
Quant Imaging Med Surg. 2025;15:1101-1113.
Abstract

LAURIA MJ, Merelman A, Thompson JL, Braude DA, et al
Management of Critically Ill Patients With Pulmonary Arterial Hypertension in Transport: A Narrative Review.
Air Med J. 2025;44:73-82.
Abstract

KURIMURA T, Omura T, Yamamoto K, Tanaka H, et al
Prolonged Prothrombin Time due to Drug-Drug Interaction of Warfarin after the Change from Bosentan to Macitentan: A Case of Pharmacist Intervention in the Outpatient Clinic.
Kobe J Med Sci. 2025;70:E125-E129.
Abstract

LIAO Y, Wu B
Analysis of clinical features and risk factors of pulmonary hypertension associated with interstitial lung disease.
Biomed Rep. 2025;22:58.
Abstract

SIVAKUMAR N, Zhang C, Chang-Chien C, Gu P, et al
An Unsupervised Approach to Derive Right Ventricular Pressure-Volume Loop Phenotypes in Pulmonary Hypertension.
Pulm Circ. 2025;15:e70057.
Abstract

LLUCIA-VALLDEPERAS A, van Wezenbeek J, Groeneveldt JA, Smal R, et al
Bone morphogenetic protein 10 is increased in precapillary pulmonary hypertension patients.
Cardiovasc Res. 2025 Feb 24:cvaf028. doi: 10.1093.
Abstract

BRIONES-CLAUDETT KH, Briones-Zamora KH, Benites Solis JG, Huilcapi Borja DI, et al
Severe COVID-19 Pneumonia, Opportunistic Candida krusei Infection, and Acute Respiratory Distress Syndrome with Pulmonary Arterial Hypertension Treated with Bosentan: A Case Report.
Am J Case Rep. 2025;26:e946400.
Abstract

BURYSKOVA SALAJOVA K, Malik J, Kaiserova L, Hladinova Z, et al
Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications.
Ren Fail. 2025;47:2466822.
Abstract

LI M, Chen D, Fan J, Tian D, et al
The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study.
Respir Res. 2025;26:67.
Abstract

SHANAHATI D, Yang T, Fang L, Nijiati Y, et al
18beta-Glycyrrhetinic acid improves pulmonary hypertension by regulating the vascukar non-inflammatory molecule-1/L-arginine/nitric oxide signaling pathway.
Eur J Pharmacol. 2025 Feb 21:177382. doi: 10.1016/j.ejphar.2025.177382.
Abstract

CHOUGULA PV, Suryawanshi P, Bharadwaj R, Malshe N, et al
Alveolar capillary dysplasia in a neonate: emphasising the importance of early recognition and biopsy in refractory pulmonary hypertension.
BMJ Case Rep. 2025;18:e264699.
Abstract

DENG X, Que Q, Zhang K, Li B, et al
Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction.
Respir Res. 2025;26:61.
Abstract

ALBENDEA-GOMEZ T, Mendoza-Tamajon S, Castro-Mecinas R, Escobar B, et al
Vascular HIF2 Signaling Prevents Cardiomegaly, Alveolar Congestion, and Capillary Remodeling During Chronic Hypoxia.
Arterioscler Thromb Vasc Biol. 2025;45:e78-e98.
Abstract

RAMIREZ DA, Anninger WV, Scoles D
OPTIC NERVE HYPOPLASIA AND BILATERAL PERSISTENT FETAL VASCULATURE DUE TO TUBA1A TUBULINOPATHY.
Retin Cases Brief Rep. 2025;19:264-266.
Abstract

WANG D, Singh H, Miller A, VonTungeln CD, et al
Hypereosinophilic Syndrome in a Patient With Complex Pulmonary Hypertension and Sjogren's Syndrome: A Case Report.
Cureus. 2025;17:e78486.
Abstract

YAN X, Song Y, Zhang H, Guo T, et al
Improvement in oxygen dynamics after 3 months of home-based respiratory muscle rehabilitation in a patient with complex severe pulmonary hypertension: A case report.
Chronic Dis Transl Med. 2024;11:78-80.
Abstract

DEVESA A, Robson PM, Cangut B, Pyzik R, et al
Can pulmonary artery (18)F-FDG uptake serve as a risk marker in precapillary pulmonary hypertension?
Eur J Nucl Med Mol Imaging. 2025 Mar 7. doi: 10.1007/s00259-025-07181.
Abstract

GUO WJ, Liu DT, Xiao Y, Man TT, et al
[Methamphetamine-associated pulmonary arterial hypertension: a case report].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:261-266.
Abstract

JIANG Q, Yan H, Huang C, Ma R, et al
[An analysis of clinical and genetic feature in pulmonary artery sarcoma].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:256-260.
Abstract

ZHAO Y, Ding C, Su H, Wang A, et al
Single Test-Based Diagnosis and Subtyping of Pulmonary Hypertension Caused by Fibrosing Mediastinitis Using Plasma Metabolic Analysis.
Adv Sci (Weinh). 2025 Mar 6:e2416454. doi: 10.1002/advs.202416454.
Abstract

MUKHERJEE M, Rudski LG, Addetia K, Afilalo J, et al
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography.
J Am Soc Echocardiogr. 2025;38:141-186.
Abstract

TURA-CEIDE O, Oto J, Osorio J, Hervas D, et al
The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2024-0282.
Abstract

HU L, Chen F
A Novel Role for Platelet-Endothelial Crosstalk in Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2025-0044.
Abstract

SHEN Y
Will Stub1 Be the Next Target for Pulmonary Hypertension Therapy Development?
Am J Respir Cell Mol Biol. 2025 Mar 5. doi: 10.1165/rcmb.2025-0034.
Abstract

ZOULIKHA M, Zou J, Yang P, Wu J, et al
Cocrystal pleomorphism-inspired drug nanoassembly for pulmonary-endothelium targeting and pulmonary hypertension treatment.
Acta Pharm Sin B. 2025;15:557-570.
Abstract

VARON-VEGA F, J Tellez L, Tuta-Quintero E, Rincon A, et al
Impact of Pulmonary Hypertension on Posttransplant Survival of Patients With Pulmonary Fibrosis at High Altitude: A Prospective Cohort Study.
Can Respir J. 2025;2025:1861990.
Abstract

BATTILANA B, Chiffi K, Lichtblau M, Mayer L, et al
Impact of the establishment of a multidisciplinary national chronic thromboembolic pulmonary hypertension board on a monocentric surgical endarterectomy program.
Interdiscip Cardiovasc Thorac Surg. 2025.
Abstract

CHEN BX, Hu H, Gong J, Xi XY, et al
Comparison of the value of FAPI imaging and speckle?tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension.
BMC Med Imaging. 2025;25:68.
Abstract

TOLDI G
Leveraging oxygen saturation monitoring for improved detection of pulmonary hypertension in preterm infants.
Pediatr Res. 2025 Mar 3. doi: 10.1038/s41390-025-03974.
Abstract

ABOUZID MR, Kamel I, Twayana AR, Shrestha S, et al
Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis.
Int J Cardiol. 2025 Mar 1:133078. doi: 10.1016/j.ijcard.2025.133078.
Abstract

KITAOKA H, Kobayashi R, Tanaka K, Watanabe M, et al
Inhaled nitric oxide for bronchopulmonary dysplasia-associated pulmonary hypertension: A systematic review and narrative synthesis.
Neonatology. 2025 Mar 3:1-22. doi: 10.1159/000545034.
Abstract

MARINHO JT, Marafon BB
The pathological blood flow steal phenomenon limits exercise tolerance in pulmonary hypertensive rats.
J Physiol. 2025 Mar 3. doi: 10.1113/JP288421.
Abstract

TSUTSUI M, Yatera K
Significance of nitric oxide derived from the nitric oxide synthases system in cardiovascular interorgan crosstalk.
J Pharmacol Exp Ther. 2025;392:100025.
Abstract

WU J, Huang Q, Zhang Y, De Z, et al
Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis.
Respir Res. 2025;26:74.
Abstract

CZERWINSKI A, Sidlowski P, Mooers E, Liu Y, et al
Stub1 Acetylation by CBP/p300 Attenuates Chronic Hypoxic-driven Pulmonary Hypertension by Suppressing HIF-2alpha.
Am J Respir Cell Mol Biol. 2025 Feb 28. doi: 10.1165/rcmb.2024-0353.
Abstract

CHEN L, Bai Q, Tang R, Cen C, et al
GP IIb/IIIa-ICAM-1 Mediated Platelet-Endothelial Adhesion Exacerbates Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Feb 28. doi: 10.1165/rcmb.2024-0438.
Abstract

FENG J, Liu Y, Li K, Wu Y, et al
Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment.
Int J Pharm. 2025;672:125332.
Abstract

SHUSHANYAN RA, Karapetyan HM, Nadiryan EE, Avtandilyan NV, et al
Tissue remodeling during high-altitude pulmonary edema in rats: Biochemical and histomorphological analysis.
Tissue Cell. 2025;93:102727.
Abstract

BENJAMIN N, Schiffer V, Resag C, Xanthouli P, et al
Sex-Specific Differences in Echocardiographic Parameters of Risk Stratification in Pulmonary Arterial Hypertension.
J Am Soc Echocardiogr. 2025;38:273-285.
Abstract

YAGI S, Kadota M, Bando R, Miyamoto R, et al
Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation.
Intern Med. 2025;64:725-728.
Abstract

HUANG S, Li N, Yan D
Delayed treatment with endostatin displays a protective role against pulmonary hypertension by targeting VEGF pathway.
Minerva Med. 2025;116:13-21.
Abstract

HU B, Zhong H, Shi R, Chen Z, et al
A study on the genetic comorbidity between autoimmune diseases and pulmonary hypertension: an observational study and POST-GWAS analysis.
Int J Med Sci. 2025;22:1344-1362.
Abstract

RAUF R, Gibson CA, Alahmad MAM
Impact of Frailty on Inpatient Mortality and Resource Utilization for Primary Pulmonary Hypertension.
Avicenna J Med. 2025;14:204-209.
Abstract

LU Y, Yang Y, Fu Y, Xiong C, et al
Global research trends on chronic thromboembolic pulmonary hypertension: a bibliometric analysis (January 2000-January 2024).
J Thorac Dis. 2025;17:724-743.
Abstract

TORUN EG, Bagrul D, Ece I
Recanalization and interventional stenting of a closed ductus arteriosus in pulmonary hypertension associated with von Hippel-Lindau disease: a case report.
Cardiol Young. 2025 Mar 14:1-4. doi: 10.1017/S1047951125001374.
Abstract

CARDILLO C, Criner GJ, Gayen S
Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study.
Ther Adv Respir Dis. 2025;19:17534666251326743.
Abstract

TANG Z, Yang F, Wu H, Zhao Y, et al
Alterations in nailfold videocapillaroscopy among patients with connective tissue diseases combined with pulmonary arterial hypertension: A cross-sectional study.
Sci Rep. 2025;15:8647.
Abstract

PENG TY, Lu JM, Zheng XL, Zeng C, et al
The role of lactate metabolism and lactylation in pulmonary arterial hypertension.
Respir Res. 2025;26:99.
Abstract

WEI Y, Wu H, Guo J, Sun X, et al
A patient with Eradheim-Chester disease presenting with progressive cystic lung lesions and confirmed pulmonary artery hypertension: a case report.
BMC Pulm Med. 2025;25:110.
Abstract

RODRIGUEZ JV, Zhang H, Mesfin N, Klings ES, et al
Contribution of QRS Prolongation to Transplant-Free Survival in Sarcoidosis-Related Pulmonary Hypertension.
Pulm Circ. 2025;15:e70021.
Abstract

MEKOV EV, Yanev NA, Kurtelova N, Mihalova T, et al
Prevalence and Prognostic Value of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
Cureus. 2025;17:e78769.
Abstract

LEY L, Wiedenroth CB, Guth S, Gold C, et al
A simple electrocardiographic model for an improved detection of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
J Electrocardiol. 2025;90:153908.
Abstract

LIAN H, Chen R, Zeng Y, Guo R, et al
Exploring the causal relationship between PAH and some autoimmune diseases using bidirectional Mendelian randomization analyses.
Medicine (Baltimore). 2025;104:e41737.
Abstract

CONTE L, Amodeo I, De Nunzio G, Raffaeli G, et al
A machine learning approach to predict mortality and neonatal persistent pulmonary hypertension in newborns with congenital diaphragmatic hernia. A retrospective observational cohort study.
Eur J Pediatr. 2025;184:238.
Abstract

ADU-AMANKWAAH J, You Q, Liu X, Jiang J, et al
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.
MedComm (2020). 2025;6:e70134.
Abstract

ASANO R, Nagase S, Aoki T, Ueda J, et al
Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study)?- Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial.
Circ Rep. 2025;7:212-215.
Abstract

JIANG W, Wu Z, Huang C, Lu T, et al
Reverse Potts shunt in severe pulmonary hypertension: A 20-year retrospective review.
Int J Cardiol. 2025;428:133129.
Abstract

IBARRA-RIOS D, Mantilla-Uresti JG, Barrios-Bautista DM, Penarrieta-Daher A, et al
Hemodynamic phenotypes in congenital diaphragmatic hernia and their association with morbidity and mortality.
Bol Med Hosp Infant Mex. 2025;82:54-62.
Abstract

YANG X, Liu H, Wu X
High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.
Clin Exp Med. 2025;25:79.
Abstract

MA W, Ma Y, Bai Y, Su X, et al
Changes in Macrophages in Pulmonary Hypertension: A Focus on High-altitude Pulmonary Hypertension.
Anatol J Cardiol. 2025 Mar 10. doi: 10.14744/AnatolJCardiol.2025.5013.
Abstract

LACERDA TEIXEIRA B, Grazina A, Morais LA, Galrinho A, et al
Pulmonary Hypertension and Acute Heart Failure Following Lumbar Disc Surgery.
J Soc Cardiovasc Angiogr Interv. 2024;4:102453.
Abstract

ZHANG C, Zhong B, Jiang Q, Lu W, et al
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.
BMC Med. 2025;23:148.
Abstract

SUGIYAMA Y, Tahara N, Honda A, Koga Y, et al
Utility of liver stiffness for the classification of portopulmonary hypertension in precapillary pulmonary hypertension.
Int J Cardiol. 2025 Mar 7:133126. doi: 10.1016/j.ijcard.2025.133126.
Abstract

COPPI F, Cavalletti A, Pagnoni G, Campani C, et al
Pulmonary hypertension in patients with Sjogren's syndrome: Gender differences in cardiovascular risk factors and instrumental data.
Int J Cardiol. 2025;428:133131.
Abstract

PAEZ-CARPIO A, Zarco FX, Serrano E, Vollmer I, et al
Cone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period.
Clin Radiol. 2025;84:106847.
Abstract

TAKANO R, Fujisaki S, Endo H, Nishi N, et al
The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis.
Respir Investig. 2025;63:326-333.
Abstract

AKBARI A, Raji H, Islampanah M, Barati S, et al
Sleep apnea in pulmonary hypertension patients: a systematic review and meta-analysis sleep disorders and pulmonary hypertension.
Sleep Breath. 2025;29:120.
Abstract

BLANCO I, Kovacs G
Diagnostic and Therapeutic Innovations in Pulmonary Hypertension: News From the 2024 World Symposium on Pulmonary Hypertension.
Arch Bronconeumol. 2025 Feb 21:S0300-2896(25)00064.
Abstract

ALI HJ, Cui S, Sahay S, Grosu HB, et al
Pulmonary Tumor Thrombotic Microangiopathy: A Rapidly Progressive Form of Pulmonary Hypertension in Cancer Patients.
JACC Case Rep. 2025;30:103194.
Abstract

ROBINSON E, Logan C, Chiu S, Husain N, et al
Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Secondary to Expanded Polytetrafluoroethylene Valved Pulmonary Conduit Thrombosis.
JACC Case Rep. 2025;30:103069.
Abstract

GUPTA A, Zaghloul N, Thulasingam SK, Robbins IR, et al
Tailored CD4+ lymphocytes expressing human CHAT protein as a novel vasodilator in attenuating RV pressure in PAH animal model.
Transl Res. 2025;278:22-35.
Abstract

LI HS, Liu HJ, Zhang Y, Zhang J, et al
Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis.
Arch Biochem Biophys. 2025;767:110340.
Abstract

ZENG Z, Wang X, Wang H, Tian L, et al
Role of Xuefu Zhuyu decoction in improving pulmonary vascular remodeling by inhibiting endothelial-to-mesenchymal transition.
Vascul Pharmacol. 2025;158:107467.
Abstract

VERSTRAETEN M, Lefere S, Raevens S
Pulmonary vascular complications of cirrhosis: hepatopulmonary syndrome and portopulmonary hypertension.
Acta Clin Belg. 2024;79:384-391.
Abstract

BERNARDI N, Neep BF, Garibaldi S, Bianconi E, et al
The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway.
Vascul Pharmacol. 2025;158:107464.
Abstract

ALEXANDER L, Burnie S, Rossiter C, Isles C, et al
Do low-risk patients really need follow-up after a pulmonary embolism?
J R Coll Physicians Edinb. 2025;55:14-18.
Abstract

FARHA S, Asosingh K, Hassoun PM, Barnard J, et al
Alterations in Mitochondrial Function in Pulmonary Vascular Diseases.
Antioxid Redox Signal. 2025;42.
Abstract

LI J, Villar-Calle P, Chiu C, Reza M, et al
Spiral cardiac quantitative susceptibility mapping for differential cardiac chamber oxygenation-Initial validation in relation to invasive blood sampling.
Magn Reson Med. 2025;93:2029-2039.
Abstract

MISEROCCHI G
Physiopathology of High-Altitude Pulmonary Edema.
High Alt Med Biol. 2025;26:1-12.
Abstract

GROSSMAN M, Walker S, Ramsey EZ
Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension.
Pediatr Cardiol. 2025;46:902-907.
Abstract

ONG JYS, Yap JJY, Dashraath P, Low TT, et al
Pulmonary hypertension in pregnancy: two sides to a coin.
Singapore Med J. 2025;66:167-171.
Abstract

ONG JYS, Yap JJY, Choolani M, Poh KK, et al
Cardiovascular-obstetric state-of-the-art review: pulmonary hypertension in pregnancy.
Singapore Med J. 2025;66:130-140.
Abstract

SELVAN KC, Teerapuncharoen K, Bag R
Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease.
J Clin Med Res. 2025;17:153-163.
Abstract

STRANGE GA, Maron BA, Zeder K, Chan YK, et al
Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertension.
J Glob Health. 2025;15:04098.
Abstract

HOSOKAWA K, Abe K
Milestones in therapeutic and antithrombotic strategies for chronic thromboembolic pulmonary hypertension.
J Cardiol. 2025 Mar 18:S0914-5087(25)00081-4. doi: 10.1016/j.jjcc.2025.
Abstract

HE J, Liao JH
Potential Role of Hesperidin in Improving Experimental Pulmonary Arterial Hypertension in Rats via Modulation of the NF-kappaB Pathway.
Chem Biol Drug Des. 2025;105:e70068.
Abstract

KISHIKAWA R, Kodera S, Setoguchi N, Tanabe K, et al
An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide.
Eur Heart J Digit Health. 2025;6:209-217.
Abstract

EL KOOFY N, Okasha SH, Agha HM, Ali N, et al
Prevalence and Predictors of Pulmonary Hypertension in Children with Portal Hypertension: A Single Center Study.
Pediatr Gastroenterol Hepatol Nutr. 2025;28:101-112.
Abstract

KINOSHITA M, Tasaka T, Fujimoto K, Saito M, et al
Impaired Left Atrial Reservoir Strain Causes Exercise-Induced Pulmonary Hypertension in Patients With Preserved Left Ventricular Ejection Fraction.
Echocardiography. 2025;42:e70139.
Abstract

WU X, Suo S, Su X, Sun L, et al
Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990-2021.
BMJ Open. 2025;15:e095348.
Abstract

MALDONADO-VELEZ G, Mickler EA, Cook TG, Aldred MA, et al
Loss of Tbx4 Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Mar 19. doi: 10.1165/rcmb.2024-0459.
Abstract

STEPPAN J, Berkowitz DE
Channeling Hope in the Expanding Landscape of Therapy for Pulmonary Hypertension: Potential Role for Piezo2.
Hypertension. 2025;82:598-600.
Abstract

KRIEGEL ER, Srinivasan A, Mammen L, Venkataganesh H, et al
Airway Anomalies Predict Risk of Pediatric Pulmonary Hypertension.
Pediatr Pulmonol. 2025;60:e71028.
Abstract

CULLIVAN S, Genecand L, El-Merhie N, MacKenzie A, et al
Inhaled treprostinil in group 3 pulmonary hypertension associated with lung disease: results of the INCREASE and PERFECT studies.
Breathe (Sheff). 2025;21:240242.
Abstract

LEON-ROMAN F, Pintado-Cort B, Barbera JA, Sellares J, et al
[Diagnosis and Treatment of Pulmonary Embolism and Pulmonary Hypertension in Patients With Interstitial Lung Disease].
Open Respir Arch. 2025;7:100406.
Abstract

MARTIN DE MIGUEL I, Cruz Utrilla A, Segura de La Cal T, Sarnago Cebada F, et al
Haemodynamic spectrum in heritable pulmonary arterial hypertension: a continuum from pre-capillary to combined pulmonary hypertension-case series.
Eur Heart J Case Rep. 2025;9:ytaf109.
Abstract

LI Y, Qian J, Deng X, Ma L, et al
Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension.
Respir Res. 2025;26:106.
Abstract

MOLLA FA, Ayalew DG, Astatk HA, Teshager AW, et al
Prevalence and determinants of pulmonary hypertension in rheumatic heart disease patients at university of Gondar comprehensive specialized hospital: a retrospective study from 2018 to 2023.
BMC Cardiovasc Disord. 2025;25:193.
Abstract

WANG Z, Li L, Lyu Y, Guo Y, et al
Correlation between T-lymphocyte subsets and hemodynamics in patients with congenital heart disease-associated pulmonary arterial hypertension.
Medicine (Baltimore). 2025;104:e41834.
Abstract

MARKIEWITZ ND, Wang Y, Berg RA, Yehya N, et al
Right Atrial Dysfunction Is Prevalent in Pediatric Acute Respiratory Distress Syndrome and Reflects Pulmonary Hypertension and Right Ventricular Dysfunction.
Crit Care Explor. 2025;7:e1230.
Abstract

MURAKAMI N, Asano D, Tokushige N, Omura J, et al
Diagnostic Delays and Quality of Life in Japanese Patients with Pulmonary Hypertension: A Nationwide Survey.
Pulm Ther. 2025 Mar 18. doi: 10.1007/s41030-025-00290.
Abstract

CHU Z, Li Y, Ge J
Identification of nitric oxide-related key genes in pulmonary hypertension via bioinformatics and in vitro validation for therapeutic target discovery.
Comput Methods Biomech Biomed Engin. 2025.
Abstract

NAGATA Y, Nagaoka T, Terayama Y, Suzuki Y, et al
The Potential of Pulmonary Vasodilators as a Bridging Therapy for Lung Transplantation: Two Cases of Interstitial Pneumonia With Pulmonary Hypertension During the Waiting Period for Lung Transplantation.
Respirol Case Rep. 2025;13:e70136.
Abstract

CHANG SA, Yang JH, Jung DS, Kim NH, et al
Recent Advances in Chronic Thromboembolic Pulmonary Hypertension: Expanding the Disease Concept and Treatment Options.
Korean Circ J. 2025 Feb 10. doi: 10.4070/kcj.2024.0423.
Abstract

KIM BJ, Thomas JD
Echocardiographic Parameters of the Right Ventricle in Patients With Pulmonary Hypertension: A Review.
Korean Circ J. 2025 Jan 31. doi: 10.4070/kcj.2024.0313.
Abstract

FRAGER MR, Frishman WH, Aronow WS
Advances in Atrial Septal Defect Closure: Managing Pulmonary Hypertension and Expanding Treatment Criteria Applicability.
Cardiol Rev. 2025 Mar 17. doi: 10.1097/CRD.0000000000000896.
Abstract

KRISHNAN S, Adigopula S, Gadeela N
Delayed Diagnosis of Partial Anomalous Pulmonary Venous Return in an Adult With Pulmonary Hypertension.
J Investig Med High Impact Case Rep. 2025;13:23247096251326474.
Abstract

PATEL R, Pescatore J, Gayen S
The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective Analysis.
J Clin Med. 2025;14:1606.
Abstract

HORVAT D, Orzan RI, Agoston-Coldea L
A Non-Invasive Approach to Pulmonary Hypertension.
J Clin Med. 2025;14:1473.
Abstract

MACKINTOSH C, Dreixler J, Tung A, Mueller A, et al
Plasma Levels of Activin A and Follistatin-Like-3 as Biomarkers for Pulmonary Hypertension in Advanced Heart Failure.
medRxiv [Preprint]. 2025 Mar 7:2025.03.06.25323530.
Abstract

SPIEKERKOETTER E
Macrophages: key conductors behind perivascular inflammation and vascular remodeling in hypoxia-induced pulmonary hypertension.
J Clin Invest. 2025;135:e190957.
Abstract

MIHASHI Y, Miki K, Yanagi H, Maekura T, et al
Exercise-induced Right-to-left Shunt in a Patient with Combined Pulmonary Fibrosis and Emphysema.
Intern Med. 2025;64:899-903.
Abstract

WANG J, Hu S, Xu Y, Wang T, et al
Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension.
Respir Res. 2025;26:102.
Abstract

CARTON M, O'Driscoll D, Marsh B, Gaine S, et al
Elevated right ventricular systolic pressure and outcomes after emergency hip surgery: a case control study.
BMC Anesthesiol. 2025;25:128.
Abstract

RATHOD SN, Ropski P, Glowala J, Quinn CM, et al
Overlap and correlation of reperfusion lung injury with postoperative pneumonia following pulmonary thromboendarterectomy: incidence, characteristics, and outcomes in chronic thromboembolic pulmonary hypertension.
BMC Pulm Med. 2025;25:119.
Abstract

SU L, Wang X, Lin Y, Zhang Y, et al
Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization.
J Am Heart Assoc. 2025;14:e038150.
Abstract

MILANO G, Reinero M, Puyal J, Tozzi P, et al
Inhibition of Sodium/Hydrogen Exchanger-1 in the Right Ventricle and Lung Dysfunction Induced by Experimental Pulmonary Arterial Hypertension in Rats.
J Am Heart Assoc. 2025;14:e036859.
Abstract

SUN X, Yegambaram M, Lu Q, Garcia Flores AE, et al
Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2.
Redox Biol. 2025;81:103529.
Abstract

LI X, Hegarty K, Lin F, Chang JL, et al
Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing Endothelial-Mesenchymal Transition.
Adv Sci (Weinh). 2025;12:e2415824.
Abstract

KWARTENG OWUSU S
Sickle Lung Disease Long-Term Consequences and Prevention.
Pediatr Pulmonol. 2025;60 Suppl 1:S102-S103.
Abstract

SELVADURAI Y, Le Fevre ER, Mervis J, Fitzgerald DA, et al
Hereditary haemorrhagic telangiectasia: A primer for the paediatrician.
Paediatr Respir Rev. 2025;53:30-34.
Abstract

COLEMAN RD, Cohen SP, Eghtesady P, Grady RM, et al
Summary for Clinicians: Clinical Practice Guideline on Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy.
Ann Am Thorac Soc. 2025 Mar 28. doi: 10.1513/AnnalsATS.202501.
Abstract

JAXA-KWIATKOWSKA K, Janus M, Graczyk MM, Szabatowska K, et al
Hoarseness as a Rare Symptom of Idiopathic Pulmonary Arterial Hypertension Due to Ortner Syndrome: A Case Report.
Am J Case Rep. 2025;26:e947011.
Abstract

GAUDIO A, Giordano N, Elhilali M, Schmidt S, et al
Pulmonary Hypertension Detection from Heart Sound Analysis.
IEEE Trans Biomed Eng. 2025;PP.
Abstract

MADONNA R, Montemaggi E
Pulmonary hypertension and associated heart failure: New insights on emerging signalling pathways.
Eur J Clin Invest. 2025 Mar 28:e70038. doi: 10.1111/eci.70038.
Abstract

FAROOQUI A, Alama M, Antoun I
Draining Large Pericardial Effusion in a Pulmonary Hypertension Patient: Between a Rock and a Hard Place.
Clin Case Rep. 2025;13:e70370.
Abstract

DRAGU R, Abramovici A, Abu Zeid K
The Effect of Pulmonary Hypertension on Renal Function Dynamics in Left-Heart Failure Patients.
Biomedicines. 2025;13:684.
Abstract

PENTIKAINEN M, Simonen P, Tuunanen H, Leskela P, et al
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH).
JHLT Open. 2024;7:100191.
Abstract

KVITTING JE, Ravnestad H, Andersen R, Gjonnaess E, et al
Chronic thromboembolic pulmonary hypertension.
Tidsskr Nor Laegeforen. 2025;145.
Abstract

NICHOLSON MJ, Dhanani Z, Gayen S
Pulmonary hypertension and lung transplantation waitlist outcomes for hypersensitivity pneumonitis.
JHLT Open. 2024;6:100157.
Abstract

SWAMINATHAN AC, Meservey A, Parish A, Green CL, et al
Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil.
JHLT Open. 2024;6:100131.
Abstract

BAMBRICK M, Grafham G, Lajkosz K, Donahoe L, et al
Computed tomography identifies sex-specific differences in surgical chronic thromboembolic pulmonary hypertension.
JHLT Open. 2024;6:100130.
Abstract

EL-KERSH K, Bag R, Bhatt N, King C, et al
Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease.
JHLT Open. 2025;7:100206.
Abstract

VON ALVENSLEBEN I, Graham BB, Balanza GA, Brockmann C, et al
High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease.
Pulm Circ. 2025;15:e70049.
Abstract

IZHAKIAN S, Korlansky M, Rosengarten D, Bruckheimer E, et al
Pulmonary artery stent thrombosis and symptomatic pulmonary hypertension following COVID-19 infection in Alagille patient: A case report.
World J Clin Cases. 2025;13:96897.
Abstract

ADIB C, Modi S, Ramsammy V, Rosenheck J, et al
Do not forget about the left ventricle after lung transplantation for pulmonary hypertension.
JHLT Open. 2024;5:100112.
Abstract

ZHONG H, Yao L, An H, Fang L, et al
MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2025 Mar 27. doi: 10.1161/ATVBAHA.124.322337.
Abstract

KATTIH Z, Kim HC, Aryal S, Nathan SD, et al
Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).
J Clin Med. 2025;14:2029.
Abstract

YILDIRIM U, Taskin G, Baser MH, Tugmen B, et al
Evaluation of Coronary Artery Luminal Diameters in Patients with Pulmonary Arterial Hypertension.
Medicina (Kaunas). 2025;61:381.
Abstract

GAO X, Fan Y, Wang G, Xu J, et al
Combined analysis of single-cell and bulk transcriptome sequencing data identifies critical glycolysis genes in idiopathic pulmonary arterial hypertension.
J Transl Med. 2025;23:373.
Abstract

SCHAFER K
Decorin and Right Ventricular Failure in Pulmonary Hypertension: A Proteoglycan Controlling TGF-beta Signaling in the Heart.
JACC Basic Transl Sci. 2025;10:342-344.
Abstract

AKAZAWA Y, Vaidyanathan S, Dewar MB, Yazaki K, et al
Homeostatic Role of Decorin in Right Ventricular Pressure Overload and Pulmonary Hypertension Induced Remodeling.
JACC Basic Transl Sci. 2025;10:323-341.
Abstract

ZHANG H, Lu X, Guo Z, Jiang X, et al
Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism.
Thromb Res. 2025;249:109310.
Abstract

MATHAI SC, Mukherjee M
When Incidence Leads to Precedence: A Call for Early Detection Protocols for Pulmonary Hypertension in Heart Failure and COPD.
Ann Am Thorac Soc. 2025 Mar 25. doi: 10.1513/AnnalsATS.202503.
Abstract

STEGER M, Canuet M, Martin G, Labani A, et al
Pulmonary hypertension associated with COPD: a phenotype analysis.
ERJ Open Res. 2025;11:00716-2024.
Abstract

WANG R, Wang J, Yu J, Li Z, et al
Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension.
J Transl Med. 2025;23:366.
Abstract

COPPI F, Pagnoni G, Campani C, Grossule F, et al
Sjogren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease.
Int J Cardiol. 2025;430:133185.
Abstract

THAKKAR B, Da Cunha T, Hagen R, Bath R, et al
Pulmonary Hypertension and Downhill Varices: An Incidental Finding.
Cureus. 2025;17:e79385.
Abstract

XIE W, Yu Y, Huang Q, Yan X, et al
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China: a systematic literature review and meta-analysis.
Chin Med J (Engl). 2025 Mar 24. doi: 10.1097/CM9.0000000000003580.
Abstract

JAHNGIR MU, De Antonis C, Rabbani R, Ashiq A, et al
Associations Between Type of Hemodialysis Access and Pulmonary Hypertension: A Single-Center Retrospective Cohort.
Hemodial Int. 2025 Mar 23. doi: 10.1111/hdi.13231.
Abstract

GENECAND L, Wacker J, Guerreiro I, Lechartier B, et al
Pulmonary hypertension associated with interstitial lung disease - a review on diagnosis and treatment with a focus on emerging therapies.
Respiration. 2025 Mar 21:1-23. doi: 10.1159/000544800.
Abstract

ZHOU XZ, Guo RH, Yang YL, Wei JC, et al
Application of factor D and other complement factors as systemic sclerosis-associated pulmonary hypertension: Comment of the article by Petrow et al.
Semin Arthritis Rheum. 2025;72:152713.
Abstract

JENY F, Valeyre D, Lower EE, Baughman RP, et al
Advanced pulmonary sarcoidosis.
J Autoimmun. 2025;152:103397.
Abstract

STRACQUALURSI M, Nemola G, Santangelo G, Moscardelli S, et al
Monitoring SGLT2 inhibition effectiveness on pulmonary systolic pressure in heart failure with reduced ejection fraction.
Int J Cardiol. 2025;428:133136.
Abstract

VAN KAN C, van Es J, Idrissi HE, Ruigrok D, et al
Clinical and radiologic characteristics of chronic thromboembolic pulmonary hypertension patients without a history of acute venous thromboembolism.
J Thromb Haemost. 2025 Mar 6:S1538-7836(25)00132.
Abstract

CHEN W, Chen J, Peng M, Luo J, et al
Long-term survival of shunt closure in atrial septal defects with pulmonary arterial hypertension.
Int J Cardiol. 2025;428:133094.
Abstract

SONG X, Xu Y, Li M, Guan X, et al
SRSF4-Associated ca-circFOXP1 Regulates Hypoxia-Induced PASMC Proliferation by the Formation of R Loop With Host Gene.
Arterioscler Thromb Vasc Biol. 2025;45:e118-e135.
Abstract

TATSUOKA Y, He Z, Lin HM, Notarianni AP, et al
The role of right ventricular systolic pressure and ARISCAT score in perioperative pulmonary risk assessment.
Braz J Anesthesiol. 2025;75:844597.
Abstract

PERISETLA N, Miranda C, Louis J, Omoike O, et al
Inhaled epoprostenol via high-flow nasal cannula and intravenous treprostinil for management of severe pulmonary arterial hypertension during cesarean delivery with epidural anesthesia: a case report.
Int J Obstet Anesth. 2025;61:104295.
Abstract

FAGHIHI-KASHANI S, Yoshida A, Bozan F, Zanframundo G, et al
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
Arthritis Rheumatol. 2025;77:477-489.
Abstract

LIU PY, Hsing SC, Tsai DJ, Lin C, et al
A Deep-Learning-Enabled Electrocardiogram and Chest X-Ray for Detecting Pulmonary Arterial Hypertension.
J Imaging Inform Med. 2025;38:747-756.
Abstract

GRYGIEL-GORNIAK B, Lucki M, Daroszewski P, Lucka E, et al
Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.
Rheumatol Int. 2025;45:87.
Abstract

ADELPARVAR F, Fakhrolmobasheri M, Qorbani F, Shafie D, et al
Sodium-Glucose Cotransporter 2 Inhibitors and Pulmonary Hypertension: A Systematic Review.
Cardiol Rev. 2025 Apr 4. doi: 10.1097/CRD.0000000000000888.
Abstract

CASH M, Giambra B, Stone L, Magness M, et al
Hank the Heart and Animation-Based Education for Pulmonary Hypertension.
Pulm Circ. 2025;15:e70072.
Abstract

KIRKPATRICK EC, Handler S, Liegl M, Pan AY, et al
Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP.
Pulm Circ. 2025;15:e70068.
Abstract

LV G, Li A, Zhai Y, Li L, et al
Assessment of right ventricle-to-pulmonary artery coupling by three-dimensional echocardiography in pre-capillary pulmonary hypertension: comparison with tricuspid annular plane systolic excursion /systolic pulmonary artery pressure ratio.
BMC Med Imaging. 2025;25:108.
Abstract

RATWATTE S, Stewart S, Playford D, Strange G, et al
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction.
Open Heart. 2025;12:e003174.
Abstract

LIMA LNG, Veronez V, Mendes PRA, Kiyota TA, et al
Relationships that perceived barriers to physical activity have with functional capacity and quality of life in patients with pulmonary hypertension.
J Bras Pneumol. 2025;51:e20240195.
Abstract

ZHANG J, Zhang W, Yang Z, Fan B, et al
Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway.
Clin Exp Hypertens. 2025;47:2486829.
Abstract

ZHOU D, Wang T, Chen Y, Zheng Y, et al
Characteristics and sex differences in bronchopulmonary dysplasia-related pulmonary hypertension.
BMC Pulm Med. 2025;25:148.
Abstract

GUO L, Ji K, Yin Y
SIRT5 Inhibits Mitophagy and Inflammation of Hypoxia-Induced Pulmonary Hypertension by Regulating the Desuccinylation of PDK1.
Mol Biotechnol. 2025 Apr 1. doi: 10.1007/s12033-025-01430.
Abstract

YUAN X, Guo X, Luo Y, Guan X, et al
PHNet: A pulmonary hypertension detection network based on cine cardiac magnetic resonance images using a hybrid strategy of adaptive triplet and binary cross-entropy losses.
IEEE Trans Med Imaging. 2025;PP.
Abstract

WANG L, Wang W, Wu T, Chen L, et al
Mesenchymal Stem Cell-based Apelin Gene Therapy Improves Pulmonary Artery Remodeling in Monocrotaline-induced Pulmonary Hypertension Through PI3K/AKT/eNOS and ERK1/2 Signaling Pathways.
J Cardiovasc Transl Res. 2025 Apr 1. doi: 10.1007/s12265-025-10612.
Abstract

YOGESWARAN A, Petermann R, Kremer NC, Schafer S, et al
Right ventricular-pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension.
ERJ Open Res. 2025;11:00685-2024.
Abstract

JEFFREYS E, Arattu Thodika FMS, Bell A, Greenough A, et al
Mechanisms of hypoxaemia in late pulmonary hypertension associated with bronchopulmonary dysplasia.
J Perinat Med. 2025 Apr 2. doi: 10.1515/jpm-2025-0058.
Abstract

OGURA Y, Imai E, Taito S, Tsuji T, et al
Inhaled vs. Intravenous Vasodilators in Perioperative Pulmonary Hypertension during Chest Surgery Using Cardiopulmonary Bypass: A Systematic Review and Meta-analysis.
Pulm Pharmacol Ther. 2025 Mar 29:102357. doi: 10.1016/j.pupt.2025.102357.
Abstract

NG IKS, Thong C, Singh GD, Daniel P, et al
Diagnostic evaluation and management of pulmonary hypertension with concomitant incidental partial anomalous pulmonary venous return.
Oxf Med Case Reports. 2025;2025:omae214.
Abstract

BATOOL Z, Amjad Kamal M, Shen B
Advanced treatment strategies for high-altitude pulmonary hypertension employing natural medicines: A review.
J Pharm Anal. 2025;15:101129.
Abstract

WANG Y, Wang Y, Zhang W
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs.
Rev Cardiovasc Med. 2025;26:25781.
Abstract

MATUSOV G, Shams M, Ibrahim K, Hovsepyan A, et al
Risk Factors for Adverse Outcomes in Connective Tissue Disease-Associated Pulmonary Hypertension.
Rev Cardiovasc Med. 2025;26:26877.
Abstract

SUN WL, Chen YH
[Impact and management of comorbidities in patients with chronic obstructive pulmonary disease and obstructive sleep apnea].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:392-395.
Abstract

LIU C, Meng F
Identification of potential causal genes and drug targets in pulmonary hypertension based on transcriptomic analysis and Mendelian randomization.
Postgrad Med J. 2025 Mar 29:qgaf044. doi: 10.1093.
Abstract

LOPES JL, Ferreira F
Pulmonary arterial aneurysm in a pulmonary hypertension patient.
Rev Port Cardiol. 2025 Mar 26:S0870-2551(25)00095.
Abstract

PAEZ-CARPIO A, Gomez FM, Maschke S, Warren B, et al
Cone Beam-CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A review of technical parameters and benefits.
Eur J Radiol. 2025;186:112047.
Abstract

KVITTING JP, Ravnestad H, Andersen R, Gjonnaess E, et al
[Correction: Chronic thromboembolic pulmonary hypertension].
Tidsskr Nor Laegeforen. 2025;145.
Abstract

LIANG J, Ba X, Wan L, Cui X, et al
Risk factors and predictive model for pulmonary arterial hypertension in adult idiopathic-inflammatory-myopathy patients: A cross-sectional study.
Clinics (Sao Paulo). 2025;80:100621.
Abstract

ALTIN CELIK P, Aytekin M
Extracellular matrix dynamics in a rat model of pulmonary arterial hypertension: unveiling the role of hyaluronan in disease pathology.
J Hypertens. 2025 Jan 17. doi: 10.1097/HJH.0000000000003967.
Abstract

PATA R, Kosuru B, Kristeva J
Schistosomiasis-associated pulmonary arterial hypertension (Sch-PAH): A comprehensive review of diagnosis and management.
Respir Med. 2025;240:108026.
Abstract

SATO H, Nagano T, Suraya R, Hazama D, et al
Reduction in circulating Endothelin-1 levels by inhaled COPD medications.
Respir Med. 2025;240:108027.
Abstract

ZHANG C, Ding H, Li J, Ramey DR, et al
Epidemiology, disease burden of pulmonary arterial hypertension in China: A systematic literature review.
Respir Med. 2025;240:108007.
Abstract

RAHAGHI FF, Humbert M, Hoeper MM, White RJ, et al
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.
Lancet Respir Med. 2025;13:364-370.
Abstract

CACCIAPAGLIA F, De Angelis R, Ferri C, Bajocchi G, et al
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry.
J Rheumatol. 2025;52:375-382.
Abstract

ALBANELL-FERNANDEZ M, Mestre MM, Lopez B, Gonzalez-Garcia R, et al
Treatment patterns and factors associated with adherence in pulmonary arterial hypertension.
Farm Hosp. 2025;49:T72-T78.
Abstract

DAIGO K, Hiraide T, Momoi M, Shinya Y, et al
Pulmonary arterial hypertension therapies in patients with obesity hypoventilation syndrome: a case series.
J Clin Sleep Med. 2025;21:723-732.
Abstract

FELLOWS AL, Chen CN, Xie C, Iyer N, et al
ARF6 as a Novel Activator of HIF-2alpha in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2025;72:380-392.
Abstract

BURGER CD, Saunders H, Hodge DO, Safford RE, et al
Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant Evaluation.
Mayo Clin Proc. 2025;100:668-679.
Abstract

HARI GOPAL S, Tillman R, Hammond Ii JD, Hagan JL, et al
Association between Time with Open Ductus Arteriosus and Outcomes in Congenital Diaphragmatic Hernia.
Neonatology. 2024 Nov 6:1-8. doi: 10.1159/000541385.
Abstract

YILDIZELI SO, Arikan H, Gungor S, Tufan A, et al
Pulmonary Endarterectomy: Risk Factors for Early and Late Mortality.
Thorac Cardiovasc Surg. 2025;73:230-236.
Abstract

ALBANELL-FERNANDEZ M, Mestre MM, Lopez B, Gonzalez-Garcia R, et al
Treatment patterns and factors associated with adherence in pulmonary arterial hypertension.
Farm Hosp. 2025;49:72-78.
Abstract

ICHIMURA K, Gross A, Mathew RO, Salman L, et al
Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function.
Cardiovasc Drugs Ther. 2025;39:373-384.
Abstract

KAUR G, Ahuja A, Sen A, Singhal P, et al
An extremely rare case of Rogers syndrome or thiamine responsive megaloblastic anemia.
Indian J Pathol Microbiol. 2025;68:158-160.
Abstract

WIEDENROTH CB, Steinhaus K, Rolf A, Breithecker A, et al
Patient-Reported Long-Term Outcome of Balloon Pulmonary Angioplasty for Inoperable CTEPH.
Thorac Cardiovasc Surg. 2025;73:237-243.
Abstract

BARENCO-MARINS TS, Seara FAC, Ponte CG, Nascimento JHM, et al
Pulmonary Circulation Under Pressure: Pathophysiological and Therapeutic Implications of BK Channel.
Cardiovasc Drugs Ther. 2025;39:415-433.
Abstract

MITSUYAMA Y, Goda A, Takeuchi K, Kikuchi H, et al
Prevalence and Determinants of Depression and Anxiety in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Circ Rep. 2025;7:285-292.
Abstract

UEDA J, Tsuji A, Aoki T, Asano R, et al
Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension?- Protocol for the PHiNO Study.
Circ Rep. 2025;7:308-312.
Abstract

LV W, Gu X, Zeng L, Liu K, et al
Endothelial SMAD4 Deficiency Promotes Pulmonary Hypertension by Impairing Cell Adhesion and Extracellular Matrix Organization.
Hypertension. 2025 Apr 11. doi: 10.1161/HYPERTENSIONAHA.124.22782.
Abstract

CHEUNGPASITPORN W, Krisanapan P, Suppadungsuk S, Thongprayoon C, et al
Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis.
Ren Fail. 2025;47:2487212.
Abstract

MAZUREK JA, Germack HD, Gauthier-Loiselle M, Satija A, et al
Impact of treatment escalation on rehospitalization among patients with pulmonary arterial hypertension.
Sci Rep. 2025;15:12235.
Abstract

TOBITA K, Sakamoto H, Inami T, Fujisawa D, et al
Preference for advance care planning in patients with pulmonary hypertension.
Heart Vessels. 2025 Apr 10. doi: 10.1007/s00380-025-02542.
Abstract

LI Y, Liu Y, Liang Z, Jia S, et al
Plasma IL4 Levels Linked to Pulmonary Hypertension Severity and Outcome.
Clin Exp Pharmacol Physiol. 2025;52:e70040.
Abstract

CRNKOVIC S, Thekkekara Puthenparampil H, Mulch S, Biasin V, et al
Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease.
Elife. 2025;13:RP98558.
Abstract

KHOURY WEI, Chan SY
When cell teamwork turns toxic.
Elife. 2025;14:e106689.
Abstract

WANG Z, Li N, Qiao N, Li L, et al
ACVRL1 variation-induced hereditary hemorrhagic telangiectasia presenting with pulmonary arterial hypertension: clinical and genetic analyses of three case studies.
BMC Cardiovasc Disord. 2025;25:271.
Abstract

ZHAO W, Huang Z, Diao X, Yang Z, et al
Development and validation of multimodal deep learning algorithms for detecting pulmonary hypertension.
NPJ Digit Med. 2025;8:198.
Abstract

WACKER J, Beghetti M
Pulmonary hypertension in pediatrics: from clinical suspicion to management.
Eur J Pediatr. 2025;184:288.
Abstract

CODULLO V, Acquaro M, Greco A, Lia M, et al
Right atrial reservoir strain as an early predictor of pulmonary hypertension development in Systemic Sclerosis: a single center pilot study.
Rheumatology (Oxford). 2025 Apr 9:keae628. doi: 10.1093.
Abstract

XIONG G
Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research.
Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093.
Abstract

FAUVEL C, Lamblin N
Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of << hasard >>.
Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093.
Abstract

NICCUM M, Avitabile CM, Albizem D, Meluskey H, et al
Pulmonary Vascular Compromise is Associated with Survival in Pediatric Pulmonary Hypertension: A New Computational Model.
medRxiv [Preprint]. 2025 Mar 26:2025.03.25.25324654.
Abstract

KRISHNATHASAN K, Rafiq I, Dimopoulos K
Editorial: Pulmonary hypertension in atrial septal defect.
Front Cardiovasc Med. 2025;12:1589305.
Abstract

WANG Y, Sun L, Jia X, Yang M, et al
miR-29 inhibits endothelial-to-mesenchymal transition in pulmonary hypertension of the newborn by regulating LRP6.
FASEB J. 2025;39:e70502.
Abstract

SALEY TP, Coleman RD
Shedding Light on the Dark Side of the Moon-Understanding Pediatric Right Ventricular Work in Pulmonary Hypertension.
Pulm Circ. 2025;15:e70070.
Abstract

LI SS, Guo M, Zhao Y, Fan F, et al
Intranasal delivery of R8-modified circNFXL1 liposomes ameliorates Su5416-induced pulmonary arterial hypertension in C57BL/6 mice.
Respir Res. 2025;26:127.
Abstract

BREINIG S, Ehlinger V, Roze JC, Storme L, et al
Neurodevelopmental outcomes at age 5 years among children born very preterm and surviving after persistent pulmonary hypertension of the newborn: EPIPAGE-2 cohort study.
Eur J Paediatr Neurol. 2025;55:103-110.
Abstract

WU Q, Li D, Ye H, Zhou Z, et al
Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity.
Arthritis Res Ther. 2025;27:79.
Abstract

DAI J, Ma L, Zhang Y, Shan L, et al
The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study.
BMC Cardiovasc Disord. 2025;25:258.
Abstract

REIMANN L, Preiss H, Muller J, Huber P, et al
Medication adherence and clinical outcome in patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension.
BMJ Open Respir Res. 2025;12:e003023.
Abstract

ZHOU X, Ren L, Meng X
Considerations on patient age in the study of pulmonary hypertension and interstitial lung disease in Sjogren's syndrome.
Int J Cardiol. 2025;431:133243.
Abstract

DAUNGSUPAWONG H, Wiwanitkit V
Sjogren's syndrome and pulmonary hypertension: Correspondence.
Int J Cardiol. 2025;431:133242.
Abstract

ZHANG RS, Jin L, Falco G, Axman R, et al
Prognostic value of the right ventricular to left ventricular volume ratio on cardiac magnetic resonance imaging in predicting adverse outcomes for adults with pulmonary hypertension.
Prog Cardiovasc Dis. 2025 Apr 2:S0033-0620(25)00046.
Abstract

BENAVIDES-CORDOBA V, Palacios M, Vonk-Noordegraaf A
Historical milestones and future horizons: exploring the diagnosis and treatment evolution of the pulmonary arterial hypertension in adults.
Expert Opin Pharmacother. 2025;26:743-753.
Abstract

ELBAZ MSM, Shafeghat M, Freed BH, Sarnari R, et al
3D Vortex-Energetics in the Left Pulmonary Artery for Differentiating Pulmonary Arterial Hypertension and Pulmonary Venous Hypertension Groups Using 4D Flow MRI.
J Magn Reson Imaging. 2024 Oct 28. doi: 10.1002/jmri.29635.
Abstract

PALICI C, Florentin Vreju A, Bita CE, Dinescu SC, et al
Capillaroscopic insights: exploring the connection between microvascular changes and pulmonary manifestations in systemic sclerosis.
Rom J Intern Med. 2025;63:39-48.
Abstract

CHEN B, Xia Y, Jiang Y, Sun Z, et al
Non-Coding RNA Networks in Pulmonary Arterial Hypertension.
Pharmacology. 2025;110:110-121.
Abstract

GESANG L, Suona Y, Danzeng Z, Ci B, et al
A machine learning-based severity stratification tool for high altitude pulmonary edema.
BMC Med Inform Decis Mak. 2025;25:171.
Abstract

REMY-JARDIN M, Duhamel A, Delobelle M, Bervar JF, et al
Lung microvasculopathy in chronic thromboembolic pulmonary hypertension: high-resolution findings with photon-counting detector CT in 29 patients.
Eur Radiol. 2025 Apr 18. doi: 10.1007/s00330-025-11561.
Abstract

QIN Y, Zhang J, Wang A, Sun W, et al
Multi-omics analysis of two rat models reveals potential role of vesicle transport and autophagy in right ventricular remodeling.
Sci Rep. 2025;15:13401.
Abstract

ERRINGTON N, Zhou L, Rhodes CJ, Fong YL, et al
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.
Circ Genom Precis Med. 2025 Apr 18:e004862. doi: 10.1161/CIRCGEN.124.004862.
Abstract

GRIMBERGEN E, van Aarssen SPM, Staal DP, Peper J, et al
Diagnostic Accuracy of the Malnutrition Universal Screening Tool and Mini Nutritional Assessment Short-Form in Outpatients With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70075.
Abstract

COPPI F, Pagnoni G, Campani C, Grossule F, et al
Reply to "Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjogren's Syndrome".
Int J Cardiol. 2025 Apr 15:133285. doi: 10.1016/j.ijcard.2025.133285.
Abstract

COPPI F, Pagnoni G, Campani C, Grossule F, et al
Reply to " Sjogren's syndrome and pulmonary hypertension: Correspondence".
Int J Cardiol. 2025 Apr 15:133286. doi: 10.1016/j.ijcard.2025.133286.
Abstract

EL KHOURY W, Chan SY
TBX4 in Pulmonary Hypertension: Linking Lung Development to Precision Therapy.
Am J Respir Cell Mol Biol. 2025 Apr 17. doi: 10.1165/rcmb.2025-0164.
Abstract

HONDA S, Yamano M, Kawasaki T
Systolic Ejection Murmur in a Case of Patent Ductus Arteriosus and Pulmonary Hypertension With Liver Cirrhosis.
Cureus. 2025;17:e80691.
Abstract

HAO SY, Muhetaer Y, Zheng X, Long YL, et al
Rapid improvement in postpartum pulmonary hypertension associated with hereditary hemorrhagic telangiectasia: A case report and review of literature.
World J Clin Cases. 2025;13:98128.
Abstract

PAN J, Wu Q, Chen S, Wang H, et al
Clinical outcomes of pregnancy in patients with pulmonary hypertension: A single center observational study.
J Cardiothorac Surg. 2025;20:199.
Abstract

ZHANG J, Song Y, Wang X, Wang X, et al
The transcription factor PITX1 cooperates with super-enhancers to regulate the expression of DUSP4 and inhibit pyroptosis in pulmonary artery smooth muscle cells.
Respir Res. 2025;26:149.
Abstract

KIKO T, Asano R, Ishibashi T, Endo H, et al
Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.
J Am Heart Assoc. 2025 Apr 16:e039002. doi: 10.1161/JAHA.124.039002.
Abstract

WU SH, Wu YJ
Precision Medicine in Chronic Thromboembolic Pulmonary Hypertension: Unraveling the Genetic Impact of RNF213 p.Arg4810Lys on Balloon Pulmonary Angioplasty Outcomes.
J Am Heart Assoc. 2025 Apr 16:e041544. doi: 10.1161/JAHA.125.041544.
Abstract

SRIDHAR M, Tauquir A, Sahay S, Tonelli AR, et al
Frailty in Pulmonary Hypertension: A Multidimensional Comorbidity.
Ann Am Thorac Soc. 2025 Apr 16. doi: 10.1513/AnnalsATS.202410-1009.
Abstract

ZHAO Z, He X, Xiong R, Cui Y, et al
Association of echocardiographic pulmonary hypertension with all-cause mortality in hospitalized AECOPD patients.
Int J Cardiol Heart Vasc. 2025;58:101661.
Abstract

HARPER RL, Zhou X, Marciano DP, Cao A, et al
Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension.
Respir Res. 2025;26:148.
Abstract

ZHANG Y, Song HX, Qi YJ, Sun NN, et al
Ultrasound-guided transbronchial biopsy in the diagnosis of fibrosing mediastinitis-associated pulmonary hypertension.
Orphanet J Rare Dis. 2025;20:180.
Abstract

LIU Z, Bai Z, Chen X, Chen Y, et al
Advances and applications of biosensors in pulmonary hypertension.
Respir Res. 2025;26:147.
Abstract

CONDE-CAMACHO R, Tuta-Quintero E, Bastidas-Goyes A, Giraldo-Cadavid LF, et al
Survival rates at one and five years for patients with group 1 pulmonary arterial hypertension at high altitude: A retrospective cohort study.
Sci Prog. 2025;108:368504251336066.
Abstract

ABDELMASSIH AF, ElAnwary S, Taha N, Radwan N, et al
Circulating Intercellular Adhesion Molecule as a Novel Marker of Pulmonary Hypertension in Newborn.
Indian Pediatr. 2025 Apr 15. doi: 10.1007/s13312-025-00037.
Abstract

NAVARRO-GARCIA JA, Osborne AJ, Wehrens XHT
MicroRNA-210-5p - a New Druggable Target for Pulmonary Hypertension?
Cardiovasc Drugs Ther. 2025 Apr 15. doi: 10.1007/s10557-025-07701.
Abstract

DIAZ GF, Diaz-Castrillon CE, Marquez Garcia A, Hopper RK, et al
Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patients.
Pulm Circ. 2025;15:e70017.
Abstract

OKHRIMENKO G, Borovikova I, Dankovtseva E, Zamyatin V, et al
The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysis.
Respir Res. 2025;26:146.
Abstract

KURONUMA K, Shimokawahara H, Matsubara H
An overview of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Expert Rev Respir Med. 2025 Apr 14. doi: 10.1080/17476348.2025.2491721.
Abstract

KOGA Y, Tahara N, Fukumoto Y
Balloon pulmonary angioplasty with inotropic agent and pulmonary vasodilators for chronic thromboembolic pulmonary hypertension.
Eur Heart J Case Rep. 2025;9:ytaf153.
Abstract

LIU Y, Wang R, Jiang T
RNA-binding proteins as a molecular link between COPD and pulmonary hypertension.
Int J Med Sci. 2025;22:1979-1991.
Abstract

BERRAJAA M, Babakhouya A, El Minaoui M
Right cardiac failure and pulmonary hypertension secondary to tonsil hypertrophy in a 3-year-old boy: a case report.
Pan Afr Med J. 2025;50:2.
Abstract

EL SHAER A, Garcia-Arango M, Abed A, Heffernan S, et al
Breaking down the recovery of O(2) pathway: Peripheral extraction recovery pattern defines exercise capacity and clinical outcomes.
Physiol Rep. 2025;13:e70337.
Abstract

RODRIGUEZ-CHIARADIA DA, Torres-Castro R, Piccari L, Garcia-Ortega A, et al
A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
Arch Bronconeumol. 2025 Mar 28:S0300-2896(25)00112.
Abstract

LUZ JM, Ferreira F, Alegria S, Vieira AC, et al
Can my echo work as a crystal ball? - Echocardiographic parameters predicting residual pulmonary hypertension after pulmonary endarterectomy.
Rev Port Cardiol. 2025 Apr 11:S0870-2551(25)00119.
Abstract

XU J, Wang Y, Gong Y, Wang L, et al
A nomogram model based on clinical and 3D-EIT parameters for CTEPH diagnosis.
Respir Res. 2025;26:137.
Abstract

SHI J, Liang J, Wang J, Wang H, et al
Assessment of biomechanical properties in pulmonary arterial hypertension: a computational fluid dynamics study of the extensive pulmonary arterial tree.
BMC Pulm Med. 2025;25:175.
Abstract

LEITE LB, Soares LL, Guimaraes-Ervilha LO, Costa SFF, et al
Blueberry Extract and Resistance Training Prevent Left Ventricular Redox Dysregulation and Pathological Remodeling in Experimental Severe Pulmonary Arterial Hypertension.
Nutrients. 2025;17:1145.
Abstract

SHANCUOJI, Liao Y, Li J, Chen M, et al
The Prognostic Value of Pulmonary Hypertension in Patients with Mitral Regurgitation Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair: A Systematic Review and Meta-Analysis.
Diagnostics (Basel). 2025;15:852.
Abstract

OLIVEROS E, Jonnalagadda A, Vaidya A
Pulmonary Hypertension: Updates in Diagnosis and Management.
J Clin Med. 2025;14:2400.
Abstract

DOU LZ, Li SS, Wang S, Jiang H, et al
Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with pulmonary hypertension associated with left heart disease.
J Cardiothorac Surg. 2025;20:185.
Abstract

JIN Y, Mao F, Wang X, Zhang J, et al
The sonic hedgehog signaling inhibitor cyclopamine improves pulmonary arterial hypertension via regulating the bone morphogenetic protein receptor 2 pathway.
Sci Rep. 2025;15:12512.
Abstract

CHANG TC, Wang CM, Ho CH, Chen YC, et al
A prevalence study focusing on hospitalized COPD related pulmonary hypertension.
Sci Rep. 2025;15:12426.
Abstract

MENG Y, Zheng C, Zhang X, Gao Z, et al
xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKalpha suppression of mTOR activation.
Biochem Pharmacol. 2025;236:116897.
Abstract

HUANG H, Xue H, Cai A, Yuan H, et al
Discovery of novel azetidine-based imidazopyridines as selective and orally bioavailable inhibitors of phosphodiesterase 10A for the treatment of pulmonary arterial hypertension.
Eur J Med Chem. 2025;290:117537.
Abstract

FAN F, Davis S, Burbridge C, Chin K, et al
Single-Tablet Combination Therapy of Macitentan/Tadalafil for Patients with Pulmonary Arterial Hypertension: Qualitative Interview Study of the A DUE Phase 3 Trial.
Adv Ther. 2025;42:2298-2313.
Abstract

ZHOU JJ, Jing-Li, Luo CL, He YH, et al
NEK2 inhibition reverses vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Cell Signal. 2025;131:111720.
Abstract

NABATY NL, Tobin JA
Utility of acetazolamide for headaches in the setting of pulmonary arterial hypertension - A case report.
Headache. 2025;65:892-896.
Abstract

AKIN MS, Kas G, Aydin E, Cetinkaya AK, et al
Association between early pulmonary arterial pressure measurements and bronchopulmonary dysplasia or mortality in very preterm infants: a prospective cohort study.
Arch Dis Child Fetal Neonatal Ed. 2025;110:291-296.
Abstract

HINDMARCH CCT, Potus F, Al-Qazazi R, Ott BP, et al
Tet Methylcytosine Dioxygenase 2 (TET2) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype.
Compr Physiol. 2025;15:e70011.
Abstract

MURTA MS, Duarte RLM, Waetge D, Gozal D, et al
Exercise-induced oxyhemoglobin desaturation is an independent risk factor for sustained nocturnal hypoxemia in adults with precapillary pulmonary hypertension: A cross-sectional study.
Heart Lung. 2025;73:26-32.
Abstract

CHEN J, Jiang C, Hu X, Zhang Y, et al
Mechanism of pulmonary arterial vascular cell dysfunction in pulmonary hypertension in broiler chickens.
Avian Pathol. 2025 Apr 24:1-12. doi: 10.1080/03079457.2025.2480802.
Abstract

MATSUO S, Ozaki K, Kashimura T, Matsuo Y, et al
Left main compression syndrome caused by pulmonary hypertension due to peripheral pulmonary artery stenosis complicated with moyamoya disease.
J Cardiol Cases. 2025;31:29-34.
Abstract

MIRANI B, Dauz JD, Yazaki K, Latifi N, et al
Right Ventricular Stiffening and Function Are Associated With Main Pulmonary Artery Remodeling in a Rat Model of Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2025 Apr 24. doi: 10.1161/ATVBAHA.124.321354.
Abstract

AOKI T, Miyamoto T, Kizaki K, Ueshima A, et al
Ante-mortem diagnosis of unilateral pulmonary vein stenosis in a cat: a case report.
Acta Vet Scand. 2025;67:21.
Abstract

HATIPOGLU US, Smith M, Arrossi AV, Tonelli AR, et al
Pulmonary veno-occlusive disease: atypical presentation with unexplained exertional dyspnoea and hypoxaemia.
BMJ Case Rep. 2025;18:e265170.
Abstract

HU XQ, Song R, Dasgupta C, Twum-Barimah S, et al
MicroRNA-210 Mediates Hypoxic Pulmonary Hypertension in the Newborn Lamb.
Hypertension. 2025 Apr 23. doi: 10.1161/HYPERTENSIONAHA.124.23061.
Abstract

CHRISTOPHER MALAISRIE S, Chiu S, Schimmel D, Samant M, et al
Outcomes of Multidisciplinary Care at a Chronic Thromboembolic Pulmonary Hypertension Center.
Pulm Circ. 2025;15:e70085.
Abstract

SHIDA Y, Takahashi T, Aoyama R, Seki S, et al
Dasatinib-induced pulmonary hypertension presenting with hoarseness: Ortner's syndrome.
BMJ Case Rep. 2025;18:e263874.
Abstract

YOSHIDA T, Adin D, Matsuura K
Clinical Outcomes of Mitral Valve Repair in Dogs With Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease.
J Vet Intern Med. 2025;39:e70106.
Abstract

ALMUBAREK M, Louw EH, Griffith-Richards S, Ackermann C, et al
Computed tomography chest imaging for the detection of pulmonary hypertension in patients with post-tuberculosis lung disease.
Afr J Thorac Crit Care Med. 2025;31:e1948.
Abstract

SATO J, Hino H, Watanabe R, Mori T, et al
Severe pulmonary hypertension in weaning from cardiopulmonary bypass following double Ozaki procedure: a case report.
JA Clin Rep. 2025;11:23.
Abstract

WANG H, Peng LJ, Lu W, Li GR, et al
Acacetin reverses hypoxic pulmonary hypertension by inhibiting hypoxia-induced proliferation of pulmonary artery smooth muscle cells via SIRT1-HMGB1 pathway.
Eur J Pharmacol. 2025 Apr 19:177650. doi: 10.1016/j.ejphar.2025.177650.
Abstract

SUOLITIKEN D, Han X, Feng C, Wang Y, et al
Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms.
Ann Hematol. 2025 Apr 21. doi: 10.1007/s00277-025-06334.
Abstract

GHEYTASPOUR P, Bahadoran S, Hassanpour H
The Impact of Dietary Melatonin on Heart and Lung Telomere Length and Shelterin Protein Gene Expression of Pulmonary Hypertensive Broiler Chickens.
Vet Med Sci. 2025;11:e70355.
Abstract

ABDALLAH N, Alsayed M
Pulmonary hypertension and outcomes following left atrial appendage occlusion device placement for atrial fibrillation: A population-based analysis.
J Arrhythm. 2025;41:e70071.
Abstract

KING MH, Li C, Bond VC, Ford D, et al
Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population.
Pulm Circ. 2025;15:e70060.
Abstract

STRICK DJ, Tanba C, Kaplan MA, Hill NS, et al
A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension.
Pulm Circ. 2025;15:e70078.
Abstract

DASGUPTA S
Drug Design in the Age of Network Medicine and Systems Biology: Transcriptomics Identifies Potential Drug Targets Shared by Sarcoidosis and Pulmonary Hypertension.
OMICS. 2025 Apr 21. doi: 10.1089/omi.2025.0031.
Abstract

SOMA S, Yaoita N, Satoh T, Nochioka K, et al
The difference of gas exchange pulmonary arterial capacitance with postural change between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
J Cardiol. 2025 Apr 17:S0914-5087(25)00102-9. doi: 10.1016/j.jjcc.2025.
Abstract

GOOSSEN CJ, Kufner A, Dustin CM, Al Ghouleh I, et al
Redox regulation of lung endothelial PERK, unfolded protein response (UPR) and proliferation via NOX1: Targeted inhibition as a potential therapy for PAH.
Redox Biol. 2025;82:103554.
Abstract

PAGNESI M, Riccardi M, Savonitto G, Ameri P, et al
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.
Int J Cardiol. 2025;430:133180.
Abstract

LI W, Shang W, Huang J
Pulmonary artery systolic pressure associated with inflammatory factors among pediatric congenital heart disease with pulmonary arterial hypertension after cardiopulmonary bypass.
J Pediatr (Rio J). 2025;101:438-444.
Abstract

MUNNEKE AG, Lumens J, Delhaas T
Diagnostic value of reversed differential cyanosis in (supra)cardiac total anomalous pulmonary venous return.
Pediatr Res. 2025;97:809-817.
Abstract

HJALMARSSON C, Lindgren M, Bergh N, Hornestam B, et al
Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study.
J Am Heart Assoc. 2025 May 2:e037418. doi: 10.1161/JAHA.124.037418.
Abstract

WU D, Xiong J, Huang Y, Yuan Y, et al
Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications.
Clin Exp Hypertens. 2025;47:2500383.
Abstract

DAS BB
Mechanism and Treatment of Right Ventricular Failure Due to Pulmonary Hypertension in Children.
Children (Basel). 2025;12:476.
Abstract

ALTARABSHEH SE, Crestanello JA, Saran N, Daly RC, et al
Impact of pulmonary hypertension and right ventricular function on outcomes of isolated tricuspid valve surgery.
JTCVS Open. 2025;24:115-126.
Abstract

YANG B, Zaki A, Oh N, Umana-Pizano J, et al
Role of a multidisciplinary team approach in the management of chronic thromboembolic pulmonary hypertension.
JTCVS Open. 2025;24:147-155.
Abstract

JINNO S, Yamada A, Kawashima M, Izawa H, et al
Clinical utility of right atrial strain to estimate pulmonary hypertension in comparison with right ventricular free wall longitudinal strain.
Fujita Med J. 2025;11:86-90.
Abstract

SHIN A, Asaker JC, Abbott JD, Mullin CJ, et al
Cardiac Tamponade in Pulmonary Hypertension: Management Using Right Heart Catheterization Guidance.
J Soc Cardiovasc Angiogr Interv. 2025;4:102619.
Abstract

YUAN Z, Wang Y, Wang J, Lai Y, et al
Meta-analysis of targeted drugs for pulmonary hypertension to improve exercise tolerance and associated factors in eisenmenger syndrome.
J Cardiothorac Surg. 2025;20:224.
Abstract

SCHAEFFER SF, Omer B, Vachharajani A, Panchangam C, et al
Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: Screening and Management.
Neoreviews. 2025;26:e316-e327.
Abstract

YU Y, Wang Y, Yang Z, Li Z, et al
Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function.
Biomed Pharmacother. 2025;187:118109.
Abstract

SANTI A, Ngah V, Robbins EW, Maron BA, et al
The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries.
Pulm Circ. 2025;15:e70089.
Abstract

LI J, Wan J
[Pulmonary vascular interventions: innovating through adaptation and advancing through differentiation].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:401-404.
Abstract

CRINER RN, Naranjo M, D'Alonzo G, Weaver S, et al
Pulmonary Hypertension-Related Interstitial Lung Disease: An Expert Opinion with a Real-World Approach.
Biomedicines. 2025;13:808.
Abstract

RYSZKIEWICZ P, Schlicker E, Malinowska B
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?
Antioxidants (Basel). 2025;14:377.
Abstract

FU H, Geng L, Chen J, Fan Q, et al
Postoperative Care of a Paediatric Patient With Common Arterial Trunk Associated With Ventricular Septal Defect and Pulmonary Arterial Hypertension: A Rare Case Report.
Nurs Crit Care. 2025;30:e70048.
Abstract

KOGA Y, Tahara N, Sugiyama Y, Maeda-Ogata S, et al
Glucose and insulin actions after glucose loading on myocardial glucose metabolism in pulmonary hypertension.
Eur Heart J Imaging Methods Pract. 2025;3:qyaf044.
Abstract

SARA JDS, Ishikawa K, Li Y, Anisuzzaman DM, et al
Acoustic features are independently associated with heart failure and pulmonary hypertension.
ESC Heart Fail. 2025 Apr 28. doi: 10.1002/ehf2.15309.
Abstract

LORENZATTI D, Motwani M
Cardiovascular magnetic resonance in pulmonary hypertension: Keeping it simple.
Prog Cardiovasc Dis. 2025 Apr 26:S0033-0620(25)00064.
Abstract

JANSA P, Sadushi-Kolici R, Skoro-Sajer N, Kopec G, et al
Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension).
Pulm Circ. 2025;15:e70080.
Abstract

TONDO P, Tricarico L, Galgano G, Varlese MPC, et al
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension.
Bioengineering (Basel). 2025;12:408.
Abstract

KOMORI T, Sato T, Tsujino I, Tamatsuki D, et al
Two cases of bronchial artery aneurysms in patients with long-standing precapillary pulmonary hypertension.
Respir Investig. 2025;63:521-523.
Abstract

MOSCATELLI A, Buffoni I, Derchi ME, Bagnasco F, et al
Ductus Arteriosus Patency for the Hemodynamic Management of Newborns With Pulmonary Hypertension on Veno-Venous Extracorporeal Membrane Oxygenation.
ASAIO J. 2025 Apr 25. doi: 10.1097/MAT.0000000000002437.
Abstract

BEHRENDT PO, Ley L, Ghofrani HA, Bandorski D, et al
Bradycardias in Patients with Pulmonary Hypertension-Prevalence, Pathophysiology and Clinical Relevance.
J Cardiovasc Dev Dis. 2025;12:120.
Abstract

BUTROUS G
Global Landscape of Infection-Induced Pulmonary Hypertension.
Infect Dis Rep. 2025;17:35.
Abstract

XIONG J, Chen J, Zhou J, Li C, et al
Exploring hypoxia driven subtypes of pulmonary arterial hypertension through transcriptomics single cell sequencing and machine learning.
Sci Rep. 2025;15:14251.
Abstract

LUO G, Wan H, Ji ZX, Ren YY, et al
[Clinical analysis and follow-up study of transcatheter closure of secundum atrial septal defect in infants].
Zhonghua Er Ke Za Zhi. 2025;63:518-523.
Abstract

KEAM SJ
Macitentan: Pediatric First Approval.
Paediatr Drugs. 2025;27:377-382.
Abstract

LV X, Tang M, Li W, Liu K, et al
A predictive model for early postoperative hypoxemia after mitral valve replacement combined with pulmonary arterial hypertension.
Surgery. 2025;181:109280.
Abstract

HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al
Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension.
J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613.
Abstract

AYYAD SIE, Refeat MM, Ashaat EA, Abdel-Ghaffar AB, et al
Genetic screening in cohort of Egyptian patients with pulmonary arterial hypertension disease.
Ir J Med Sci. 2025;194:641-648.
Abstract

MOHAMED NF, Zaki El Feky OAEF, Saad El Din El Ganady HM, Abd El Halim WAE, et al
Comparative study between nebulized and intravenous magnesium sulfate for treatment of persistent pulmonary hypertension in neonates.
J Neonatal Perinatal Med. 2025;18:246-254.
Abstract

LEE MH, Menezes TCF, Reisz JA, Cendali FI, et al
Physiologic relevance of the transpulmonary metabolome in connective tissue disease-associated pulmonary vascular disease.
JCI Insight. 2025;10:e187911.
Abstract

WIEWIORA M, Nowowiejska-Wiewiora A, Gasior M, Piecuch J, et al
Noncardiac surgery for severe pulmonary hypertension: two surgeries in one patient and a review of the literature.
Ann Med Surg (Lond). 2025;87:2963-2969.
Abstract

DE PINTO M, Spinella A, Cerri S, Orlandi M, et al
Role of COVID-19 in the Progression of Scleroderma Interstitial Lung Disease and New Onset Pulmonary Hypertension: A Challenging Case Report.
Respirol Case Rep. 2025;13:e70197.
Abstract

SUN C, Wen Y, Chen Y
Successful treatment of pulmonary hypertension due to HIV infection and amphetamine snorting: a case report.
Front Med (Lausanne). 2025;12:1556041.
Abstract

LOVEY O, Garin N, Geiser-Hirschler A
[Not Available].
Rev Med Suisse. 2025;21:990-992.
Abstract

YUEN AD, Zaffiri L, Tapson V, Rampolla R, et al
Use of Inhaled Treprostinil in Lung Transplant Candidates With Pulmonary Hypertension Associated With Interstitial Lung Disease.
Respir Care. 2025 May 7. doi: 10.1089/respcare.12900.
Abstract

YEGAMBARAM M, Pokharel MD, Sun X, Lu Q, et al
Restoration of pp60(Src) Re-Establishes Electron Transport Chain Complex I Activity in Pulmonary Hypertensive Endothelial Cells.
Int J Mol Sci. 2025;26:3815.
Abstract

LI M, Zhang W, Zhang M, Li L, et al
LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension.
Clin Sci (Lond). 2025 May 7:CS20255922. doi: 10.1042/CS20255922.
Abstract

VOLKOV AV, Yudkina NN, Nasonov EL
Long-Term Prospective Observation Study of Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases.
Kardiologiia. 2025;65:23-30.
Abstract

GUARNIERI G, Briguglia D, Conte E, Andreini D, et al
Pulmonary embolism with pulmonary hypertension or something far worse? Unveiling a rare and lethal pulmonary artery angiosarcoma: a case report.
Eur Heart J Case Rep. 2025;9:ytaf207.
Abstract

LI L, Zhou W, Ji Q, Zhang X, et al
Role of MiR-542-3p/Integrin-Linked Kinase/Myocardin Signaling Axis in Hypoxic Pulmonary Hypertension.
Pulm Circ. 2025;15:e70094.
Abstract

BUTROUS G
Pulmonary hypertension aetiologies in different parts of the world.
Int J Cardiol Congenit Heart Dis. 2025;20:100586.
Abstract

YAMASHITA S, Hiraide T, Shiraishi Y, Katsumata Y, et al
Exercise hemodynamic evaluation in the management of dasatinib-related pulmonary arterial hypertension: a case report.
J Med Case Rep. 2025;19:209.
Abstract

DAVIS S, Skalicky A, Beaudet A, Bayer B, et al
Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact for Clinical Use (SYMPACT-CP): a qualitative interview study.
BMC Pulm Med. 2025;25:217.
Abstract

SATI SK, Rana U, Joshi C, Teng RJ, et al
Decreased endothelial micro-RNA-30b-5p impairs angiogenesis in fetal lambs with persistent pulmonary hypertension.
Pediatr Res. 2025 May 6. doi: 10.1038/s41390-025-04098.
Abstract

OSOKINA AK, Rodnenkov OV, Martynyuk TV
[Historical milestones in the study of pulmonary hypertension].
Ter Arkh. 2025;97:289-295.
Abstract

CHAZOVA IE, Martynyuk TV, Avdeev SN, Valieva ZS, et al
[Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension].
Ter Arkh. 2025;97:279-288.
Abstract

SHOGENOVA LV
[Efficiency and safety of the integrated use of medical gases thermal heliox, nitric oxide and molecular hydrogen in patients with exacerbation of chronic obstructive pulmonary disease complicated by hypoxemic, hypercapnic respiratory failure and seco
Ter Arkh. 2025;97:242-249.
Abstract

HUNGERFORD S, Kapur N, Rich S, Burkhoff D, et al
The pulmonary resistance-compliance relationship: Real or mathematical artifact?
Physiol Rep. 2025;13:e70355.
Abstract

O'NEILL E, Lu DY, Ramakrishna S, Ingram D, et al
Methamphetamine-Associated Pulmonary Arterial Hypertension Is Associated With Worse Right Ventricular Function Than Idiopathic Pulmonary Arterial Hypertension: A Matched Study.
Echocardiography. 2025;42:e70180.
Abstract

PAUDYAL V, Thapa R, Basnet S, Sharma M, et al
Updates on Pulmonary Hypertension.
Open Respir Med J. 2025;19:e18743064344024.
Abstract

AYDIN S, Temur B, Tire Y, Ilgaz Kocyigit O, et al
[MSB-43] Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension: Our Initial Experience.
Turk Gogus Kalp Damar Cerrahisi Derg. 2024;32.
Abstract

OKOYE AG, Khawash A, Nanjundappa M, Jones M, et al
Persistent pulmonary hypertension of the newborn infant (PPHN) due to premature closure of the ductus arteriosus (DA).
Case Rep Perinat Med. 2024;13:20240001.
Abstract

LE BON CHAMI B, Charif F, Semaan C, Bironneau V, et al
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review.
Respir Med Res. 2025;87:101165.
Abstract

ABRAMOV AA, Lakomkin VL, Prosvirnin AV, Kuzmin VS, et al
Pulmonary Arterial Hypertension Induces Compensatory Increase of Left Ventricular Contractility Indexes in Rats in Response to Its Filling Insufficiency.
Bull Exp Biol Med. 2025;178:586-592.
Abstract

PAEZ-CARPIO A, Cornellas L, Domenech-Ximenos B, Serrano E, et al
Non-contrast dual-energy CT iodine quantification for lung injury characterization after balloon pulmonary angioplasty.
Eur J Radiol. 2025;187:112129.
Abstract

YUAN M, Hu X, Xing W, Wu X, et al
Corrigendum to: B2M is a Biomarker Associated With Immune Infiltration In High Altitude Pulmonary Edema.
Comb Chem High Throughput Screen. 2025;28:913.
Abstract

XU C, Bao Y, Ding H, Wang K, et al
The association between antenatal indomethacin exposure and persistent pulmonary hypertension of the newborn in extremely preterm infants.
Sci Rep. 2025;15:16962.
Abstract

LEIVA O, Soo S, Liu O, Smilowitz NR, et al
Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms.
Haematologica. 2025 May 15. doi: 10.3324/haematol.2025.287497.
Abstract

VARIAN F, Burney R, Pearson C, Goh ZM, et al
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework.
Eur Respir Rev. 2025;34:250006.
Abstract

KRUSZONA S, Aburahma K, de Manna ND, Bobylev D, et al
Pulmonary Hypertension and Lung Transplantation.
Zentralbl Chir. 2025 May 14. doi: 10.1055/a-2590-2620.
Abstract

MARGOLIS G, Hafner OM, Kazatsker M, Roguin A, et al
Pre-Existing Pulmonary Hypertension Impact on In-Hospital Outcomes of Cardiac Implantable Electrical Device Implantation.
JACC Adv. 2025;4.
Abstract

GABIZON-PERETZ S, Yerushalmi R, Vaturi M, Nardi Agmon I, et al
Emergent Pulmonary Hypertension and Right Ventricular Impairment Following Gemcitabine Therapy for Metastatic Breast Cancer.
Isr Med Assoc J. 2025;27:319-321.
Abstract

BAI J, He S, Wang X, Zhang L, et al
Mitochondrial Genome-Encoded lncND5 Regulates Mitophagy in Hypoxic Pulmonary Artery Smooth Muscle Cell.
FASEB J. 2025;39:e70618.
Abstract

DAI J, Chen H, Fang J, Wu S, et al
Vascular Remodeling: The Multicellular Mechanisms of Pulmonary Hypertension.
Int J Mol Sci. 2025;26:4265.
Abstract

CHENG HF, Chang YP, Chai JW
Investigating Patients with Pulmonary Hypertension Under Detector-Based Spectral Computed Tomography.
Diagnostics (Basel). 2025;15:1069.
Abstract

PAPADOPOULOS GE, Arvanitaki A, Mouratoglou SA, Gourgiotis P, et al
Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post- and Precapillary Pulmonary Hypertension: A Propensity Score-Matched Analysis From the Hellenic Pulmonary Hypertension Registry.
Pulm Circ. 2025;15:e70099.
Abstract

VERHAEGEN J, Willems L, Wagenaar A, Spreuwers R, et al
Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets?
Pulm Circ. 2025;15:e70096.
Abstract

NIGLAS M, Baxan N, Ashek A, Zhao L, et al
Automated Bi-Ventricular Segmentation and Regional Cardiac Wall Motion Analysis for Rat Models of Pulmonary Hypertension.
Pulm Circ. 2025;15:e70092.
Abstract

SALEHI M, Alabed S, Sharkey M, Maiter A, et al
Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension.
ERJ Open Res. 2025;11:00592-2024.
Abstract

DZUDOVIC B, Djuric I, Matijasevic J, Jovic Z, et al
Coronary-type stent implantation in chronic thromboembolic pulmonary hypertension: a national registry case series.
Cardiol J. 2025 May 13. doi: 10.5603/cj.103142.
Abstract

SAKURAI M, Hosokawa S, Yamaguchi Y, Kirimura S, et al
Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications of Hedgehog Signaling Involvement for the Pathophysiology.
FASEB J. 2025;39:e70628.
Abstract

WIDJAJA SL, Anniazi ML, Artiko B, Moelyo AG, et al
BMPR-II, caspase-3, HIF-1alpha, and VE-cadherin profile in Down syndrome children with and without congenital heart disease and pulmonary hypertension.
Narra J. 2025;5:e1244.
Abstract

SOFIA SN, Bahrudin U, Uddin I, Sobirin MA, et al
Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional class of patients with pulmonary hypertension: A randomized, double-blind, placebo-controlled trial.
Narra J. 2025;5:e1301.
Abstract

KNAUSS HM, Ambatipudi M, Kosyakovsky LB, Herzig MS, et al
Trans-right ventricle metabolite gradients in obesity highlight multiple metabolic pathways.
Physiol Rep. 2025;13:e70323.
Abstract

XIONG XJ
[Connotation of deficiency-induced chest impediment and Renshen Decoction based on severe cases and modern pathophysiological mechanisms and its application in treatment of coronary heart disease, rheumatic heart disease, heart failure, hypotension, p
Zhongguo Zhong Yao Za Zhi. 2025;50:1706-1714.
Abstract

HAN J, Wang L, Wang L, Lei H, et al
5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance.
Biol Pharm Bull. 2025;48:555-562.
Abstract

KIM HC, King CS, Thomas C, Khangoora V, et al
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey.
BMC Pulm Med. 2025;25:231.
Abstract

DONG Z, Xue Z, Zhang M, Wang L, et al
Lingguizhugan decoction inhibit pulmonary hypertension by regulating macrophage IL-6 secretion via IL-33/ST2 pathway.
Phytomedicine. 2025;143:156822.
Abstract

NAGAOKA T
Inhaled treprostinil for pulmonary hypertension due to interstitial lung disease.
Respir Investig. 2025;63:608-609.
Abstract

CARDOSO NL, de Sa JF, do Nascimento LFE, Mendes LA, et al
Psychometric properties of the sit-to-stand test for patients with pulmonary hypertension: A systematic review.
Braz J Phys Ther. 2025;29:101223.
Abstract

JIAO Q, Xu X, Xu L, Wang Y, et al
Knockdown of eIF3a alleviates pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition via TGFbeta1/SMAD pathway.
J Transl Med. 2025;23:524.
Abstract

KLOUDA T, Tsikis ST, Hirsch TI, Kim Y, et al
Smooth muscle Cxcl12 contributions to vascular remodeling in flow and hypoxia-induced pulmonary hypertension.
J Biol Chem. 2025 May 7:110207. doi: 10.1016/j.jbc.2025.110207.
Abstract

LARSEN BS, Biering-Sorensen T, Olsen FJ
Exploring the Link Between Left Atrial Strain and Exercise-Induced Pulmonary Hypertension.
Echocardiography. 2025;42:e70187.
Abstract

HARMON AC, Carroll-Turpin MA, Jennings MH, Jelesijevic T, et al
Environmental Aromatic Amine Induces Pulmonary Arterial Hypertension Associated With Estrogen Signaling and Serpine1.
J Appl Toxicol. 2025;45:948-963.
Abstract

LIU X, Tan X, Su Y, Zou L, et al
Anthocyanin attenuates pulmonary arterial hypertension and associated heart failure via improving mitochondrial function through Nrf2-dependent mechanism.
Clin Exp Hypertens. 2025;47:2503805.
Abstract

JAKUBOWSKI B, Yager A, Madsen K, Schwalk A, et al
Safety of Robotic-Assisted Bronchoscopy for Pulmonary Lesions in Patients With Pulmonary Hypertension on Vasodilator Therapy: A Single-Centre Experience.
Respirol Case Rep. 2025;13:e70205.
Abstract

MERCAN R, Gokten DB, Kara SP, Uzum NM, et al
Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?
Turk J Med Sci. 2025;55:404-412.
Abstract

MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al
Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019.
Respir Med. 2025;242:108110.
Abstract

XU D, Liu H, Yang J
Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis.
J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000004003.
Abstract

GUO X, Qian J, Lai J, Wang H, et al
Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension.
J Hypertens. 2025 Mar 21. doi: 10.1097/HJH.0000000000004010.
Abstract

ZENG X, Ma Z, Wen S, Zhou L, et al
Imatinib aggravates pressure-overload-induced right ventricle failure via JNK/Runx2 pathway.
Br J Pharmacol. 2025;182:2560-2581.
Abstract

HOU J, Liu K, Zhang MJ, Xu XH, et al
Integrated Transcriptomic and Metabolomic Analysis of Rat PASMCs Reveals the Underlying Mechanism for Pulmonary Arterial Hypertension.
Am J Hypertens. 2025 Feb 4:hpaf015. doi: 10.1093.
Abstract

ZHANG M, Bu C, Jiang K, Long X, et al
Image Findings from Dual-phase Computed Tomography Pulmonary Angiography for Diagnosing Tuberculosis-associated Fibrosing Mediastinitis.
Curr Med Imaging. 2025;21:e15734056324457.
Abstract

KERN AL, Park DH, Fuge J, Hohlfeld JM, et al
Loss of pulmonary capillaries in idiopathic pulmonary arterial hypertension with low diffusion capacity is accompanied by early diffuse emphysema detected by (129)Xe MRI.
Eur Radiol. 2025;35:3010-3020.
Abstract

CALDEIRA D, Cazeiro DI, Placido R, Ferreira F, et al
The Placebo Effect in Chronic Thromboembolic Pulmonary Hypertension Trials: A Systematic Review and Meta-Analysis.
Med Sci (Basel). 2025;13:57.
Abstract

ESTRADA RA, Sahay S, Tonelli AR
Treatment of pulmonary hypertension after seven world symposia.
Ther Adv Respir Dis. 2025;19:17534666251342898.
Abstract

TANIGUCHI Y, Sakamoto M, Fujii H, Miwa K, et al
Nocturnal desaturation in patients with non-operable chronic thromboembolic pulmonary hypertension.
BMC Pulm Med. 2025;25:254.
Abstract

PHAM AT, Virk S, Oliveira AC, Alves MD, et al
Opposing role for myeloid and smooth muscle cell STING in pulmonary hypertension.
JCI Insight. 2025 May 22:e184792. doi: 10.1172/jci.insight.184792.
Abstract

PARIKH K
Pulmonary hypertension in 2025: next steps?
Curr Opin Cardiol. 2025 May 2. doi: 10.1097/HCO.0000000000001228.
Abstract

LEE PL, Acero LMR, Nanna M
Ultrasound-Based assessment of systemic congestion in pulmonary hypertension.
Curr Opin Cardiol. 2025 May 2. doi: 10.1097/HCO.0000000000001227.
Abstract

LIU B, Yi D, Li S, Ramirez K, et al
Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173.
Abstract

AHMADIPOUR B, Isfahani MH, Abaszadeh S, Hassanpour H, et al
Dietary L-carnitine modulates oxidative stress, lipid metabolism, and pulmonary hypertension in chickens raised at high-altitude under cold stress.
BMC Vet Res. 2025;21:369.
Abstract

ZHANG J, Luo MY, Li NP, Liang N, et al
Histone lactylation-derived prelamin A accelerates pulmonary arterial smooth muscle cells senescence in hypoxia-induced pulmonary hypertension rats.
Int Immunopharmacol. 2025;159:114871.
Abstract

MIRA JJ, Torres DG, Santina M
Patient experience with pulmonary hypertension in Spain.
Orphanet J Rare Dis. 2025;20:239.
Abstract

LIN Y, Li M, Xie S
Diagnostic value of fully automated CT pulmonary angiography in patients with chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease.
Eur Radiol. 2025 May 20. doi: 10.1007/s00330-025-11698.
Abstract

BAEK K, Kim M, Seo M, Jung JW, et al
Evaluation of the left ventricular eccentricity index for assessing dogs classified by pulmonary hypertension probability.
Am J Vet Res. 2025 May 20:1-8. doi: 10.2460/ajvr.24.11.0339.
Abstract

CONG Y, Sun N, Deng RW, Wu BX, et al
[Current researches and influencing factors of health-related quality of life in patients with pulmonary hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:547-552.
Abstract

COSKUN M, Yildirim A, Cetin AE, Pacaci E, et al
Peripheral venous pressure measurements to evaluate congestion in pulmonary arterial hypertension.
Medicine (Baltimore). 2025;104:e42422.
Abstract

LU M, Wang B, Rong C, Wang Y, et al
Therapeutic challenges and new therapeutic targets for combined capillary pulmonary hypertension: a review.
Front Med (Lausanne). 2025;12:1579112.
Abstract

YANG N, Huayu M, Su S, Hou B, et al
Bioactive compound combinations from Rhodiola tangutica alleviate pulmonary vascular remodeling in high-altitude pulmonary hypertension rats through the PI3K-AKT pathway.
Front Pharmacol. 2025;16:1582677.
Abstract

SHINYA Y, Kimura M, Momoi M, Hiraide T, et al
Efficacy and Long-term Mortality after Balloon Pulmonary Angioplasty in Older Patients with Chronic Thromboembolic Pulmonary Hypertension.
Can J Cardiol. 2025 May 15:S0828-282X(25)00340.
Abstract

ANTIGNY F, Luo R, Perrier R, Masson B, et al
Ca(2+) Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction.
Circ Heart Fail. 2025;18:e012293.
Abstract

CHEN Y, Chen Z, Liang L, Li J, et al
Multi-kingdom gut microbiota dysbiosis is associated with the development of pulmonary arterial hypertension.
EBioMedicine. 2025;115:105686.
Abstract

ROTHMAN AMK, Florentin A, Zink F, Quigley C, et al
Therapeutic potential of allosteric HECT E3 ligase inhibition.
Cell. 2025;188:2603-2620.
Abstract

WU LW, Chen M, Jiang DJ, Jiang CY, et al
TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells.
Respir Res. 2025;26:202.
Abstract

ZHANG X, Tao L, Yin X, Huang W, et al
Long-term maternal and fetal outcomes of pulmonary hypertension in pregnancy in the southwest plateau area of China: a retrospective study.
BMC Pulm Med. 2025;25:272.
Abstract

SHIRAZI SP, Negretti NM, Jetter CS, Sharkey AL, et al
Bronchopulmonary dysplasia with pulmonary hypertension associates with semaphorin signaling loss and functionally decreased FOXF1 expression.
Nat Commun. 2025;16:5004.
Abstract

WANG A, Pan Q, Zhang J, Gong S, et al
Role of inflammation in endothelial responses in Pulmonary Hypertension.
Biomed Pharmacother. 2025;188:118206.
Abstract

SZEWCZUK K, Dzikowska-Diduch O, Golebiowski M
The use of imaging in the diagnosis and treatment of thromboembolic pulmonary hypertension.
Cardiol J. 2025 May 29. doi: 10.5603/cj.102716.
Abstract

REDDY YNV, Frantz RP, Hassoun PM, Hemnes A, et al
Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
Circ Heart Fail. 2025 May 29:e012912. doi: 10.1161/CIRCHEARTFAILURE.125.012912.
Abstract

ZEESHAN M, Pearl GJ, Chakinala MM, Kotkar KD, et al
Multidisciplinary Management and Staged Surgical Treatment for Chronic Thromboembolic Pulmonary Hypertension and Subclavian Vein Thrombosis Caused by Venous Thoracic Outlet Syndrome.
Cureus. 2025;17:e84953.
Abstract

ZHANG R, Liu Z, Li R, Ai L, et al
Construction and Validation of a Nomogram Model for Predicting Pulmonary Hypertension in Patients with Obstructive Sleep Apnea.
Nat Sci Sleep. 2025;17:1049-1066.
Abstract

KATAGIRI J, Homma J, Takagi R, Sekine H, et al
Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model.
Stem Cell Res Ther. 2025;16:258.
Abstract

LIN Y, Su Y, Cheng Z, Zhu B, et al
Clinical Pharmacokinetics of Inhaled Drugs for Pulmonary Hypertension.
Clin Pharmacokinet. 2025 May 28. doi: 10.1007/s40262-025-01525.
Abstract

GUO J, He J, Wang J, Liang Y, et al
A novel nurse-led, multidisciplinary, and guideline-directed disease intensive management program improves long-term survival of pulmonary hypertension patients.
Heart Lung. 2025;73:190-196.
Abstract

OROZCO-LEVI M, Londono A, Conde R, Gallego MCP, et al
Pulmonary artery pressure assessed by catheterization and its concordance with transthoracic echocardiographic estimates in patients with pulmonary arterial hypertension: experience of the Colombian Pulmonary Hypertension Network in a real-life study.
Crit Care Sci. 2025;37:e20250182.
Abstract

SONG R
Attention to a Distinct Subtype of Pulmonary Hypertension: Methamphetamine-Associated Pulmonary Arterial Hypertension.
Echocardiography. 2025;42:e70205.
Abstract

CARTA AF, Saxer S, Mayer L, Schneider SR, et al
Acute effect of acetazolamide on exercise haemodynamics in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension: a randomised controlled trial.
ERJ Open Res. 2025;11:00782-2024.
Abstract

RATTANAKANOKCHAI S, Fungbun N, Senaphan K, Jitpean S, et al
Evaluation of Plasma Nitric Oxide and Serum Endothelial Nitric Oxide Synthase in Pulmonary Hypertensive Dogs: A Clinical and Echocardiography Investigation.
Vet Sci. 2025;12:486.
Abstract

MADONNA R, Ghelardoni S
Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood.
Int J Mol Sci. 2025;26:4851.
Abstract

LEE HW, Huang CH, Chin CH, Chou PC, et al
Changes in Pulmonary Hypertension Following Transcatheter Aortic Valve Implantation: Implications for Prognosis.
J Clin Med. 2025;14:3463.
Abstract

AVCI BK, Basarici I, Akbulut M, Atas H, et al
Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome.
Medicina (Kaunas). 2025;61:827.
Abstract

GENG Y, Wang H, Bai Z, Ge R, et al
Iron Replacement Attenuates Hypoxic Pulmonary Hypertension by Remodeling Energy Metabolism via Regulating the HIF2alpha/Mitochondrial Complex I, III/ROS Axis.
Biomolecules. 2025;15:742.
Abstract

VAN WESTERING-KROON E, Hundscheid TM, Van Mechelen K, Bartos F, et al
Sex differences in the risk of bronchopulmonary dysplasia and pulmonary hypertension: a Bayesian meta-analysis.
Pediatr Res. 2025 May 27. doi: 10.1038/s41390-025-04145.
Abstract

HOPKINS S, Hall J, Saunders H, Bashir R, et al
Sarcopenia in Patients with Chronic Thromboembolic Pulmonary Hypertension.
J Cardiovasc Dev Dis. 2025;12:162.
Abstract

PAGNAMENTA S, Muller C, Meunier S, Dennler M, et al
Transfusion related acute lung injury and associated transient pulmonary hypertension in a dog.
Schweiz Arch Tierheilkd. 2025;167:352-360.
Abstract

ZHU XX, Zhao CY, Lu QB, Zhang AY, et al
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.
Front Pharmacol. 2025;16:1510275.
Abstract

SUN K, Guo F, Xu X, Liu Y, et al
Case Report: a 28-year-old female with anomalous origin of the left coronary artery from the pulmonary artery syndrome presented as atrial fibrillation and pulmonary hypertension.
Front Cardiovasc Med. 2025;12:1573539.
Abstract

STAAL DP, van Thor MCJ, Keijsers RGM, van Buul MMC, et al
Assessment of perfusion on ventilation/perfusion scan after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: expert opinion versus guidance by reference chart.
Nucl Med Commun. 2025 May 27. doi: 10.1097/MNM.0000000000001996.
Abstract

DA FONTOURA FF, Roncato G, Meyer GMB, da Luz Goulart C, et al
Inspiratory Muscle Training on Exercise Capacity, Dyspnoea and Health Status in Pulmonary Hypertension: A Randomised Controlled Trial.
Respirology. 2025 May 26. doi: 10.1111/resp.70054.
Abstract

KUMAR S, Kumar RK
Common shunt lesions with pulmonary hypertension-who will benefit from surgery?
Indian J Thorac Cardiovasc Surg. 2025;41:718-729.
Abstract

SHOAIBI A, Ostropolets A, Weaver J, Rao GA, et al
Variation in Phenotype Definitions in Observational Clinical Research: A Review of Three Conditions.
AMIA Annu Symp Proc. 2025;2024:1021-1029.
Abstract

DENG X, Qiu P, Li X, Hu Y, et al
Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification and Mechanistic Exploration.
Drug Des Devel Ther. 2025;19:4123-4138.
Abstract

CHEN X, Xu L, Shi H
Emerging biomaterials and bio-nano interfaces in pulmonary hypertension therapy: transformative strategies for personalized treatment.
Front Bioeng Biotechnol. 2025;13:1567783.
Abstract

SUGIMOTO K, Mochizuki Y, Itoi T, Tsuji K, et al
Successful treatment of patent ductus arteriosus and severe pulmonary hypertension using sildenafil and beraprost sodium in two dogs.
J Vet Med Sci. 2025 May 26. doi: 10.1292/jvms.25-0097.
Abstract

HAO X, Li H, Zeng Q, Cheng Z, et al
Ero1a, the most strongly hypoxia-induced protein in PASMCs, promotes the development of hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
Life Sci. 2025;376:123754.
Abstract

NIU Q, Li Q, Chen S, Xiao L, et al
First nomogram for predicting interstitial lung disease and pulmonary arterial hypertension in SLE: a machine learning approach.
Respir Res. 2025;26:197.
Abstract

ARAUJO P, Cale R, Pereira E, Ferreira F, et al
Balloon Pulmonary Angioplasty and riociguat in the management of chronic thromboembolic pulmonary hypertension: a systematic review.
Respir Med. 2025 May 22:108154. doi: 10.1016/j.rmed.2025.108154.
Abstract

GUEST R, Dhaliwal D, Kinnear D, Kearney D, et al
Lethal Neonatal Pulmonary Hypertension in Trisomy 21 (T21) Likely Due to Congenital Portosystemic Shunts.
Pediatr Dev Pathol. 2025 May 24:10935266251343287.
Abstract

GUO Y, Zhao S, Zhang X, Gou R, et al
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension among PD patients.
Int Urol Nephrol. 2025 May 23. doi: 10.1007/s11255-025-04580.
Abstract

SILVA CLM, Puthanveetil PN, Oliveira SD
Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.
Am J Physiol Gastrointest Liver Physiol. 2025;328:G791-G800.
Abstract

WAN C, Chen M, Tong J, Wang A, et al
Prognostic effect of left ventricular-pulmonary arterial coupling indicator in pulmonary arterial hypertension.
Int J Cardiol. 2025;434:133347.
Abstract

YILMAZ USTA D, Olgac S, Demirel MA, Kula S, et al
Performance of oral Bosentan-loaded SNEDDS and S-SNEDDS tablets: Biodistribution in mice, echocardiography and histology studies in pulmonary arterial hypertension rat model.
Eur J Pharm Biopharm. 2025;212:114725.
Abstract

PAOLI CJ, Zhang C, Tang X, Panjabi S, et al
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension.
Respir Med. 2025;243:108112.
Abstract

ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
Abstract

DROMA Y, Ota M, Kobayashi N, Ito M, et al
Genetic Associations with the Susceptibility to High-Altitude Pulmonary Edema in the Japanese Population.
High Alt Med Biol. 2025;26:215-226.
Abstract

THOREAU B, Renaud A, Chafey P, Clary G, et al
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD).
Rheumatology (Oxford). 2025;64:4041-4050.
Abstract

BJORKEKJAER HJ, Bruni C, Broch K, Brunborg C, et al
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.
Rheumatology (Oxford). 2025;64:3643-3656.
Abstract

SUN X, Zhang Y, Liu T, Zhang H, et al
Clinical characteristics of primary SS- and overlap SS-associated pulmonary arterial hypertension: a multicentre retrospective study.
Rheumatology (Oxford). 2025;64:3618-3625.
Abstract

MONTANI D
[Pulmonary hypertension: 10 key messages].
Rev Prat. 2025;75:65.
Abstract

LACOSTE-PALASSET T, Jevnikar M, Jais X
[Chronic thromboembolic pulmonary hypertension].
Rev Prat. 2025;75:60-64.
Abstract

NOEL-SAVINA E, Turquier S, Chaouat A
[Pulmonary hypertension associated with chronic lung diseas].
Rev Prat. 2025;75:56-59.
Abstract

FAUVEL C, Lamia B, Lamblin N
[Pulmonary hypertension due to left heart disease].
Rev Prat. 2025;75:50-55.
Abstract

RIOU M, Salinas S, Sitbon O
[Algorithm for the management of pulmonary arterial hypertension].
Rev Prat. 2025;75:43-49.
Abstract

BOUCLY A, Pringuez H, Tromeur C
[Screening and diagnosis of pulmonary hypertension].
Rev Prat. 2025;75:36-42.
Abstract

LECHARTIER B, Jutant EM, Montani D
[Revised definition and classification of pulmonary hypertension].
Rev Prat. 2025;75:32-35.
Abstract

HUMBERT M, Simonneau G, Delcroix M
[Consensus on pulmonary hypertension].
Rev Prat. 2025;75:3.
Abstract

TAN Y, Dai J, Ran B, Su Q, et al
Pathogensis and treatments for high altitude pulmonary hypertension: an updated review.
Am J Med Sci. 2025 Jun 3:S0002-9629(25)01067-5. doi: 10.1016/j.amjms.2025.
Abstract

GRAZIANO N, Gommeren K, Valcke A, Burnotte P, et al
Retrospective evaluation of left ventricular eccentricity index in the assessment of precapillary pulmonary hypertension in dogs (2017-2021): 145 cases.
Front Vet Sci. 2025;12:1548417.
Abstract

AKAO M, Kubota K, Miyanaga S, Mitsuyoshi K, et al
A young man diagnosed with chronic thromboembolic pulmonary hypertension after COVID-19 infection: A case report.
J Cardiol Cases. 2025;31:121-124.
Abstract

DING S, Deng Y, Hao L, Qiu W, et al
Long-term outcome of CblC deficiency complicated with pulmonary hypertension.
Orphanet J Rare Dis. 2025;20:276.
Abstract

COLMSEE H, Leuchte HH
[Diagnosis and treatment of pulmonary hypertension].
MMW Fortschr Med. 2025;167:56-63.
Abstract

XIONG T, Li Y, Chen H, Jiang DS, et al
Nuclear receptors in pulmonary hypertension: From pathophysiological mechanisms to clinical implications.
Cytokine Growth Factor Rev. 2025 May 30:S1359-6101(25)00054.
Abstract

ABUDUKEREMU A, Aikemu A, Yang T, Fang L, et al
Mechanism of ferroptosis in hypoxia-induced pulmonary vascular remodeling in hypoxia pulmonary hypertension: a study based on the ACE2-Ang-(1-7)-Mas axis.
Chem Biol Interact. 2025 Jun 2:111596. doi: 10.1016/j.cbi.2025.111596.
Abstract

LEBAR K, Roth K, Liu W, Garcia B, et al
Insights of right ventricular anisotropic hysteresis behavior with pulmonary hypertension development.
Biomed Mater. 2025 Jun 4. doi: 10.1088/1748.
Abstract

YANG F, Yan Y, Jiang W, Wang Z, et al
Impaired right atrial function preceding right ventricular systolic dysfunction: clinical utility and long-term prognostic value in pulmonary hypertension.
Insights Imaging. 2025;16:115.
Abstract

MORA-CUESTA VM, Martinez-Menaca A, Iturbe-Fernandez D, Tello-Mena S, et al
Lung Transplant Outcomes in Patients With Preoperative Catheterization Indicating Group 2 Pulmonary Hypertension.
Pulm Circ. 2025;15:e70107.
Abstract

YAN XD, Chen YY, Tao L
[NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report].
Zhongguo Dang Dai Er Ke Za Zhi. 2025;27:609-612.
Abstract

KURONUMA K, Miyagi A, Takahashi K, Mukai T, et al
Utility of Lung Volume-normalized SUV on Lung Perfusion SPECT in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Clin Nucl Med. 2025;50:623-630.
Abstract

RIUDOR GURI A, Luna Lopez R, Blanco I
Arterial Tortuosity Syndrome: A Rare Cause of Pulmonary Hypertension.
Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00143.
Abstract

ZHENG YJ, Yuan PP, Zhang ZK, Liu YL, et al
[Effects of total extract of Anthriscus sylvestris on immune inflammation and thrombosis in rats with pulmonary arterial hypertension based on TGF-beta1/Smad3 signaling pathway].
Zhongguo Zhong Yao Za Zhi. 2025;50:2472-2483.
Abstract

LINDBERG L
The rationale of using angiotensin receptor blocker instead of pulmonary vasodilators to treat pulmonary hypertension in bronchopulmonary dysplasia: a case report and literature review.
Front Pediatr. 2025;13:1504180.
Abstract

XU J, Cui F, Zhang H
Diagnose underlying diseases in patients with high probability of pulmonary hypertension by combined echocardiography.
BMC Cardiovasc Disord. 2025;25:428.
Abstract

ABOU-ELMAGD T, Narechania S
Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
Cleve Clin J Med. 2025;92:339-343.
Abstract

D'ARSIGNY CL
Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: What's age got to do with it?
Can J Cardiol. 2025 May 31:S0828-282X(25)00376.
Abstract

MALEV EG, Malikov KN, Goncharova NS, Simakova MA, et al
[Echocardiography in the Diagnosis of Pulmonary Hypertension: From Basic to Advanced].
Kardiologiia. 2025;65:58-69.
Abstract

TOKGOZ HC, Hakgor A, Tanyeri Uzel S, Kultursay B, et al
Deep Dive into the Cardio-Pulmonary-Renal Interactions in Patients with Pulmonary Hypertension: Serum Creatinine Levels Even Within the Normal Range Related to Long-Term Survival.
Anatol J Cardiol. 2025 May 29. doi: 10.14744/AnatolJCardiol.2025.3759.
Abstract

TAKAMA N, Ishibashi Y, Naidankhoo B, Ishio S, et al
High Prevalence of Thyroid Gland Dysfunction after Pulmonary Arterial Hypertension Treatment According to Real-World Data.
Int Heart J. 2025;66:443-448.
Abstract

ZHANG T, Jiang X, Diana C, Zhao X, et al
YTHDF1-mediated m6A modification of TOP2A drives pulmonary hypertension via the PI3K/Akt/mTOR pathway.
Cell Signal. 2025 May 30:111917. doi: 10.1016/j.cellsig.2025.111917.
Abstract

JEVNIKAR M, Montani D, Fadel E, Jais X, et al
The evolution of management in chronic thromboembolic pulmonary hypertension in a non-surgical / balloon pulmonary angioplasty center.
Respir Med Res. 2025;87:101043.
Abstract

FLANAGAN LS, Sadek A, Oliveros E
Vitamin C Deficiency as a Readily Reversible Cause of Pulmonary Hypertension.
JACC Case Rep. 2025;30:103424.
Abstract

GENG Y, Hu Y, Wang H, Zhang F, et al
Reduced iron bioavailability drives acute high?altitude lung injury through HIF1alpha activation and mitophagy.
Mol Med Rep. 2025;32:215.
Abstract

ZHANG S, Gao L, Li S, Luo M, et al
Association of Ambient Air Pollution With Invasive Pulmonary Hemodynamics and Long-Term Outcomes in Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2025;14:e039343.
Abstract

ROSEN DT, Kolb TM, Mathai SC, Suresh K, et al
Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular Disease.
J Am Heart Assoc. 2025;14:e041127.
Abstract

ZHOU GX, Luo G, Pan SL
[Progress in surgical treatment for pediatric pulmonary arterial hypertension].
Zhonghua Er Ke Za Zhi. 2025;63:688-691.
Abstract

SHAN L, Tang X, Liu Y, Qi W, et al
Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension.
Cell Signal. 2025;133:111880.
Abstract

FLORES CV, Chan SY
Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape.
Expert Opin Ther Targets. 2025;29:327-343.
Abstract

SUN Z, Jiang W, Lu G, Ding Y, et al
Loss of ALDH2 accelerates the progression of pulmonary arterial hypertension through the 4-HNE/ERK1/2-p16(INK4a) signaling pathway.
Biochim Biophys Acta Mol Basis Dis. 2025;1871:167863.
Abstract

TANG H, Ning K, Wu B, Wang X, et al
Scutellarein ameliorates pulmonary arterial hypertension via sirtuin 1 mediated deacetylation of nicotinamide nucleotide transhydrogenase.
Biochem Pharmacol. 2025;237:116932.
Abstract

NOWAK S, Jaffuel D, Morel J, Ahmed E, et al
Phenotypes and prognosis of systemic sclerosis: A cluster analysis.
Respir Med Res. 2025;87:101168.
Abstract

KAWASAKI H, Nakabayashi K, Ikeda M, Onda T, et al
Familial Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins Caused by Paternal FOXF1 Upstream Enhancer Deletion: A Case Report.
Am J Med Genet A. 2025;197:e64056.
Abstract

NI R, Xie M, Zhang J, Zhong M, et al
Expression and Predictive Value of Angiopoietin-2 in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
COPD. 2025;22:2512749.
Abstract

LIU Z, Mo L, Cao W, Wang K, et al
Global, regional, and national trends in pulmonary arterial hypertension burden, 1990-2021: findings from the global burden of disease study 2021.
Front Public Health. 2025;13:1516365.
Abstract

ALBULUSHI A, El-Sharnouby K, Soror K, Alhajri N, et al
GLP-1 receptor agonists and pulmonary hypertension in diabetes: A promising therapeutic strategy.
Am Heart J Plus. 2025;55:100555.
Abstract

ABEER F, Wani AA, Javid B, Mahmood A, et al
Severe Early-Onset Pulmonary Hypertension in a Six-Month-Old With Down Syndrome and Isolated Secundum Atrial Septal Defect.
Cureus. 2025;17:e84019.
Abstract

YAMADA K, Satoh T, Yaoita N, Chiba N, et al
CTRP7 as a molecular biomarker associating with responsiveness to pulmonary vasodilators: insights from human and animal studies in pulmonary arterial hypertension.
Cardiovasc Res. 2025;121:929-942.
Abstract

ZHAO H, Ma X, Chen P, Liu B, et al
Enhanced Spatial Transcriptomics Analysis of Mouse Lung Tissues Reveals Cell-Specific Gene Expression Changes Associated with Pulmonary Hypertension.
J Respir Biol Transl Med. 2025;2:10004.
Abstract

VILLARREAL ES, Marinho Y, Loya O, Aboagye SY, et al
Endothelial c-IAP2 Loss Amplifies P2X7 Receptor-Driven Inflammation and Worsens Infection-Associated Pulmonary Hypertension.
bioRxiv [Preprint]. 2025 May 27:2025.05.22.655387.
Abstract

Correction to "Treatment Approaches for Pulmonary Hypertension in Colombia: A Call to Action".
Clin Respir J. 2025;19:e70148.
Abstract

STARK ASL, Rawlings GH, Gregory JD, Armstrong I, et al
A randomized controlled trial of self-help cognitive behavioural therapy for depression in adults with pulmonary hypertension.
Br J Health Psychol. 2025;30:e12800.
Abstract

MCNAIR BD, Satyanarayana SB, Matthews JM, Polson SM, et al
Incomplete reverse remodeling in pulmonary hypertension-induced right ventricular dysfunction in aged mice.
Physiol Rep. 2025;13:e70422.
Abstract

EKICI M, Sari A, Armagan B, Unaldi E, et al
Patients with suspected pulmonary hypertension based on echocardiography in Behcet's disease: a 5-year follow-up study.
Orphanet J Rare Dis. 2025;20:299.
Abstract

SULTAN D, Brundel BJJM, Kurakula K
The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview.
Cells. 2025;14:839.
Abstract

CHEN G, Pollak M
New-Onset Mania With Psychotic Features in a Patient With DiGeorge Syndrome, HIV, Syphilis, and Pulmonary Hypertension.
Cureus. 2025;17:e83883.
Abstract

GUO Y, Gao Z, Zhang R, Long H, et al
Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.
Adv Sci (Weinh). 2025 Jun 10:e04397. doi: 10.1002/advs.202504397.
Abstract

LEIVA O, Soo S, Smilowitz NR, Reynolds H, et al
Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms.
Circ Cardiovasc Imaging. 2025 Jun 10:e017986.
Abstract

DASGUPTA S
TFF3 Gene as a Molecular Target Potentially Shared by Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Drug Repurposing Prospect with Aminoglutethimide.
OMICS. 2025 Jun 10. doi: 10.1089/omi.2025.0066.
Abstract

JIANG Q, Wen D, Peng F, Hong W, et al
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis.
J Vis Exp. 2025;.
Abstract

LI D, Wang C, Su Z, Ma J, et al
Hypobaric hypoxia promotes the production of IL-10 of lung NKT cells in HAPE rats to fight inflammation.
Exp Lung Res. 2025;51:38-49.
Abstract

CUI TT, Guo XX, Chen M
[Advances in pulmonary hypertension related to chronic hemolytic anemia].
Zhonghua Nei Ke Za Zhi. 2025;64:571-576.
Abstract

WANG Z, Wang Q, Xu H, Zhang H, et al
Pulmonary hypertension induced right heart failure via upregulation of serum Dickkopf-1 expression.
Int J Cardiol. 2025;437:133481.
Abstract

YANG J, Liu J, Gu H, Song W, et al
Gut microbiota, metabolites, and pulmonary hypertension: Mutual regulation and potential therapies.
Microbiol Res. 2025;299:128245.
Abstract

KIM J, Choi YS, Kim J, Wahab R, et al
Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment.
Biomaterials. 2025;323:123438.
Abstract

WAHAB R, Keshavarz A, Azam Z, Islam T, et al
Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension.
Biomaterials. 2025;323:123429.
Abstract

KIRK ME, Dragsbaek SJ, Merit VT, Lyhne MD, et al
Cardiopulmonary remodeling following repetitive acute pulmonary emboli and inhibition of endogenous fibrinolysis in a porcine model.
Int J Cardiol. 2025 May 17:133398. doi: 10.1016/j.ijcard.2025.133398.
Abstract

HUANG S, Qiu J, Wang A, Ma Y, et al
Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: Findings from Global Burden of Disease Study 2021.
Chin Med J (Engl). 2025;138:1324-1333.
Abstract

IGARASHI-SUGIMOTO A, Tsujino I, Shima H, Nakamura J, et al
Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology.
Respir Investig. 2025;63:600-607.
Abstract

GU S, Kopecky BJ, Pena B, Vagnozzi RJ, et al
Sex-dependent Pathophysiology and Therapeutic Considerations in Right Heart Disease.
Can J Cardiol. 2025;41:1038-1053.
Abstract

LI J, Zhou Y, Shu T, Lei W, et al
Differentiation of lung tissue-resident c-Kit(+) cells into microvascular endothelial cells alleviates pulmonary vascular remodeling.
Dev Cell. 2025;60:1601-1617.
Abstract

TASCA S, Turck P, Drosdowski D, Campos Carraro C, et al
Melatonin improves adverse vascular remodelling and redox homeostasis in monocrotaline-induced pulmonary arterial hypertension.
Arch Physiol Biochem. 2025;131:455-466.
Abstract

CHENG LH, Sun X, Elliot C, Condliffe R, et al
Mean pulmonary artery pressure prediction with explainable multi-view cardiovascular magnetic resonance cine series deep learning model.
J Cardiovasc Magn Reson. 2025;27:101133.
Abstract

GENECAND L, Simian G, Lichtblau M, Fellrath JM, et al
The Impact of Cardiac Output Methods on the Classification of Pulmonary Hypertension.
Pulm Circ. 2025;15:e70112.
Abstract

CHEN Y, Li J, Qiao Q, Zhou Y, et al
Intravascular ultrasound evaluation of pulmonary hypertension in high-altitude patients with ventricular septal defect: a case report.
J Med Case Rep. 2025;19:284.
Abstract

HUANG Y, Yang T, Liang X, Chen Y, et al
Global, regional and national trends in the burden of persistent pulmonary hypertension of the newborn and essentials of its management from 1993 to 2023: a scoping review.
Front Pediatr. 2025;13:1502385.
Abstract

HAN MZ, Wang Y, Sun KX, Zhang YJ, et al
Upregulating vascular endothelial K(Ca)2.3 channels alleviates pulmonary hypertension in mice.
Mol Pharmacol. 2025;107:100048.
Abstract

RIOS G, Perez-Rios N
Association of 6-Minute Walk Test (6MWT) Data with Cardiopulmonary Factors in Hispanic Systemic Sclerosis Patients.
P R Health Sci J. 2025;44:111-115.
Abstract

HUANG X, Fan R, Lu Y, Yu C, et al
Correction: Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.
Mol Biol Rep. 2025;52:609.
Abstract

MOTSCHWILLER C, Morales D, Sulica R
Connective tissue disease-related interstitial lung disease and pulmonary hypertension.
Breathe (Sheff). 2025;21:240173.
Abstract

RAWLINGS GH, Stark A, Armstrong I, Costin V, et al
The Role of Psychological Distress on Health-Related Quality of Life, Fatigue, and Pain in Adults With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70101.
Abstract

LIU CY, Wang H, Jing ZC
[Anxiety and depression in patients with pulmonary hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:708-712.
Abstract

SINGH E, Bisserier M
Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertension.
J Transl Med. 2025;23:665.
Abstract

DURBIN MD, Tingay DG, Kua KL
Deciphering epigenetic control of Notch signaling in persistent pulmonary hypertension of the newborn.
Pediatr Res. 2025 Jun 17. doi: 10.1038/s41390-025-04234.
Abstract

SILBERKASTEN M, San Martin E, Cuello JV, Britto MV, et al
Pulmonary hypertension secondary to vitamin C deficiency: A case report.
Arch Argent Pediatr. 2025 Jun 19:e202510643. doi: 10.5546/aap.2025-10643.
Abstract

TAWA M, Abe S, Fujita A, Ando R, et al
Beneficial effects of magnesium nitrate on disease severity in male rats with monocrotaline-induced pulmonary hypertension.
Physiol Rep. 2025;13:e70416.
Abstract

RISCHARD FP, Hemnes AR
Right Ventricular Function, Inflammation, and the Gut Microbiome in Pulmonary Hypertension: A Translational Frontier.
Circ Heart Fail. 2025 Jun 17:e013198. doi: 10.1161/CIRCHEARTFAILURE.125.013198.
Abstract

LANCELLOTTI P, Budts W, Vachiery JL
Echocardiographic practices in pulmonary hypertension: survey results and literature review.
Acta Cardiol. 2025 Jun 17:1-4. doi: 10.1080/00015385.2025.2518645.
Abstract

HUANG X, Balasubramanian A, Moutchia J, Williams K, et al
Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry.
Ann Am Thorac Soc. 2025 Jun 16. doi: 10.1513/AnnalsATS.202501.
Abstract

KALTSOGIANNI O, Bhat R, Greenough A, Dassios T, et al
Tachycardia and persistent pulmonary hypertension of the newborn.
Front Pediatr. 2025;13:1607907.
Abstract

LEONG ZP
A pilot study investigating renal biomarkers in dogs with pulmonary hypertension: a comparison between cystatin-C, symmetric dimethylarginine, and creatinine.
J Vet Med Sci. 2025 Jun 13. doi: 10.1292/jvms.25-0034.
Abstract

TEMPLE FT, Simonova G, Passmore MR, Foley SR, et al
Storage duration of packed red blood cells transfused during veno-venous extracorporeal membrane oxygenation is associated with elevated pulmonary artery pressure and lung injury in a sheep model.
Crit Care. 2025;29:240.
Abstract

MARASCO E, Dusing C, Keymel S, Bortoluzzi A, et al
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort.
Lupus Sci Med. 2025;12:e001471.
Abstract

ZHENG X, Zhao J, Jia X, Pan J, et al
Fucoxanthin Ameliorates Vascular Remodeling via Attenuating Oxidative Stress in Hypoxic Pulmonary Hypertension Rats.
J Nutr Biochem. 2025 Jun 11:110002. doi: 10.1016/j.jnutbio.2025.110002.
Abstract

LI M, Hao Y, Song X, Liu H, et al
ca-circSCN8A Promotes HPASMCs Ferroptosis via LLPS Initiated R-Loop.
Hypertension. 2025;82:e114-e128.
Abstract

RAMANI G, Bali V, Black H, Bond D, et al
Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review.
Pharmacoeconomics. 2025;43:741-760.
Abstract

SU X, Sun Y, Dai A
New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.
Apoptosis. 2025;30.
Abstract

KLEPPINGER C, Ivy D, Stockbridge N, Bates A, et al
Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study.
AAPS J. 2025;27:114.
Abstract

AMIN SR, Loo EZ, Almazedi B, Bowker A, et al
Selective embolisation for renal arteriovenous fistula-induced pulmonary hypertension.
BMJ Case Rep. 2025;18:e265669.
Abstract

SEKII R, Kato S, Nakayama N, Fukui K, et al
Atrial Septal Defect With Right-to-Left Shunt Without Pulmonary Hypertension: Diagnosis Through Multimodality Imaging.
JACC Case Rep. 2025;30:103853.
Abstract

VLACHAKIS PK, Nyktari E, Apostolos A, Theofilis P, et al
Segmental Pulmonary Hypertension in Complex Congenital Heart Disease: The Role of Multimodality Imaging.
JACC Case Rep. 2025;30:104249.
Abstract

YANG Y, Gong S, Liang N, Li Z, et al
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets.
Vascul Pharmacol. 2025 Jun 25:107519. doi: 10.1016/j.vph.2025.107519.
Abstract

MENDOZA-ZAMBRANO E, Ballaz-Quincoces A, Lobo JL, Gomez-Cuervo C, et al
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts.
Thromb Res. 2025;252:109379.
Abstract

PATHAN M, Kido K, Kamal KM
Cost analysis of a clinical pharmacist-led multidisciplinary iron deficiency treatment clinic for patients with heart failure or pulmonary hypertension.
Am J Health Syst Pharm. 2025 Jun 19:zxaf113. doi: 10.1093.
Abstract

OTOMI Y, Otsuka H, Kasai R, Morishita J, et al
The clinical utility of ventilation-perfusion scintigraphy in the classification of pulmonary hypertension.
Jpn J Radiol. 2025 Jun 27. doi: 10.1007/s11604-025-01822.
Abstract

BISHOP RS, Doan TT, Lara C, Eilers LF, et al
Echo-Derived Right Ventricular Strain Identifies Pulmonary Hypertension in Pediatric Ventricular Assist Device Patients.
ASAIO J. 2025 Jun 27. doi: 10.1097/MAT.0000000000002489.
Abstract

ZHANG H, Yan M, Li F, Chen Q, et al
Exercise-Induced Oxygen Desaturation and Heart Rate Response During 6-Min Walk Test Predict Pulmonary Hypertension in Exertional Dyspnea: A Retrospective Cohort Study.
Pulm Circ. 2025;15:e70120.
Abstract

XIE Z, Chen Y, Xie J, Lei Y, et al
Mechanistic Insight into the Enhanced Anti-Pulmonary Hypertension Efficacy of Wogonin Co-Amorphous.
Pharmaceutics. 2025;17:724.
Abstract

PILIERO N, Salvat M, Bertoletti L, Bouvaist H, et al
Iron deficiency in chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty.
Respir Med. 2025 Jun 24:108219. doi: 10.1016/j.rmed.2025.108219.
Abstract

GARCIA-HERNANDEZ ML, Rangel-Moreno J, Xu Q, Jeong YJ, et al
TNF drives aberrant BMP signaling to induce endothelial and mesenchymal dysregulation in pulmonary hypertension.
JCI Insight. 2025 Jun 26:e174456. doi: 10.1172/jci.insight.174456.
Abstract

LI S, Gao L, Zhang S, Zhao Q, et al
Association of Systemic Inflammatory Response Index with Disease Severity and Adverse Outcome in Chronic Thromboembolic Pulmonary Hypertension.
J Inflamm Res. 2025;18:8217-8231.
Abstract

PARKER C, Whalen E, Smith MA, Becerra J, et al
Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study.
Pulm Circ. 2025;15:e70117.
Abstract

MAHAJAN A, Chandran S, Kumar A, Chen L, et al
LncRNA-536 and RNA-Binding Protein RBM25 Interactions in Pulmonary Artery Smooth Muscle Cells: Implications in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2025 Jun 26. doi: 10.1161/ATVBAHA.125.322734.
Abstract

CHENG Y, Tian YN, Huang M, Xu JP, et al
[Hydrogen sulfide ameliorates hypoxic pulmonary hypertension in rats by inhibiting aerobic glycolysis-pyroptosis].
Sheng Li Xue Bao. 2025;77:465-471.
Abstract

NIKLAS K, Sikorska D, Mularek-Kubzdela T, Witoszynska-Sobkowiak J, et al
Antibody Profile of Systemic Sclerosis and Mixed Connective Tissue Disease and Its Relationship with Lung Fibrosis and Pulmonary Hypertension.
Int J Mol Sci. 2025;26:5684.
Abstract

MENDOZA-ZAMBRANO E, Sanchez-Lopez V, Gomez-Rodriguez B, Garcia-Lunar I, et al
Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients.
Biomedicines. 2025;13:1499.
Abstract

YEH FC, Tsai IT, Chyuan IT
Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review.
Biomolecules. 2025;15:772.
Abstract

MASUDA T, Akita K, Sato R, Ikoma T, et al
The Efficacy and Safety of Outpatient Exercise Training for Patients with Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty.
J Cardiovasc Dev Dis. 2025;12:216.
Abstract

CHEN ZW, Li YF, Qiu HL, Xie W, et al
Maternal Electronic Cigarette Exposure Induces Dysregulation of Autophagy via Oxidative Stress/DNA Methylation in Pulmonary Hypertension Offspring.
Curr Med Sci. 2025 Jun 24. doi: 10.1007/s11596-025-00074.
Abstract

EGENLAUF B, Braun M, Schiffer V, Marra AM, et al
Right ventricular function in pulmonary hypertension and obesity: a cross-sectional cohort study with survival follow-up.
Clin Res Cardiol. 2025 Jun 24. doi: 10.1007/s00392-025-02682.
Abstract

ABDULAAL L, Maiter A, Dwivedi K, Sharkey MJ, et al
Lung parenchymal and cardiac appearances on computed tomography pulmonary angiography impact survival in chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.
ERJ Open Res. 2025;11:00732-2024.
Abstract

OH SB, Jeon YK, Choi N, Yoo HY, et al
Effects of in vivo treatment with K(v)7.4 activator, URO-K10, on the impaired relaxation of pulmonary arteries in the monocrotaline-induced pulmonary hypertensive rats.
Korean J Physiol Pharmacol. 2025;29:475-485.
Abstract

GOLDIN G, Mombeini H, Mercurio V, Hsu S, et al
Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease.
Curr Cardiol Rep. 2025;27:100.
Abstract

REHMAN R, Dieffenbach P, Vellarikkal SK, Corcoran AM, et al
PINK1/Parkin Deficiency Enhances Vascular Remodeling and Aggravates Hypoxia-induced Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2025 Jun 23. doi: 10.1165/rcmb.2024-0349.
Abstract

SIMPKIN CT, Frank BS, Liu Y, Pan Z, et al
Echocardiographic Prediction of Hemodynamics During Acute Vasoreactivity Testing in Pediatric Pulmonary Arterial Hypertension.
Echocardiography. 2025;42:e70232.
Abstract

ZHOU J, Xu Z, Peng DB, Li X, et al
Macrophage-Derived LCN2 Promotes Methamphetamine-Induced Pulmonary Hypertension.
Hypertension. 2025 Jun 23. doi: 10.1161/HYPERTENSIONAHA.124.24548.
Abstract

VALIZADEH P, Jannatdoust P, Shojaei S, Mousavi A, et al
The diagnostic performance of dual-energy CT in detecting chronic thromboembolic pulmonary hypertension: A systematic-review and Meta-analysis.
Clin Imaging. 2025;125:110552.
Abstract

STUDLEY WR, Lamanna E, Nold-Petry CA, Qin CX, et al
Insights from precision-cut lung slices-investigating mechanisms and therapeutics for pulmonary hypertension.
Respir Res. 2025;26:220.
Abstract

SWISHER JW, Weaver E
Therapeutic options for patients with pulmonary hypertension and interstitial lung disease.
Ther Adv Respir Dis. 2025;19:17534666251335815.
Abstract

SMITH CF, Ding KL, Seedorf GJ, Galambos C, et al
Postnatally induced TBX4 insufficiency confers pulmonary hypertension and impairs lung development in infant mice.
Pediatr Res. 2025 Jun 20. doi: 10.1038/s41390-025-04127.
Abstract

ALTURAIF N, Attanasio U, Mercurio V
Pulmonary arterial hypertension: sex-specific differences and outcomes.
Ther Adv Respir Dis. 2025;19:17534666251350493.
Abstract

DUBROCK H, Small M, Scott M, Harley J, et al
Clinical characteristics, treatment patterns and healthcare resource utilisation for portopulmonary hypertension patients in the USA: a real-world study.
BMJ Open. 2025;15:e089223.
Abstract

KACHABI A, Altieri Correa S, Chesler NC, Colebank MJ, et al
Bayesian parameter inference and uncertainty quantification for a computational pulmonary hemodynamics model using Gaussian processes.
Comput Biol Med. 2025;194:110552.
Abstract

WEBER SC, Alvensleben IV, Vadiunec V, Iben A, et al
Ebstein Repair in a High-Altitude Setting >/=2,500 m: First Experience from Bolivia.
Thorac Cardiovasc Surg. 2025;73.
Abstract

KIM NH, Chin KM, McLaughlin VV, Ong R, et al
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS.
Adv Ther. 2025;42:3306-3333.
Abstract

COBER ND, Chaudhary KR, Deng Y, Lee CJ, et al
Single-cell microencapsulation improves lung retention of endothelial colony-forming cells after intravascular delivery and unmasks therapeutic benefit in severe pulmonary arterial hypertension.
Cytotherapy. 2025;27:723-732.
Abstract

BIONDI F, Alberti M, Montemaggi E, D'Alleva A, et al
Not just CTEPH: a narrative review on the spectrum approach to post pulmonary embolism conditions.
Thromb Haemost. 2024 Sep 19. doi: 10.1055/a-2418-7895.
Abstract

TANAKA TD, Shiraishi Y, Kang R, Kohno T, et al
Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction.
Eur J Heart Fail. 2025 Jul 4. doi: 10.1002/ejhf.3755.
Abstract

VENKATESH G, Kurup H, Raghuram K, Sasikumar D, et al
Pulmonary Arterial Hypertension After Repair of Classical Tetralogy of Fallot.
Turk Kardiyol Dern Ars. 2025;53:358-361.
Abstract

ALKADHEM SM, Alattas AT, AlJubab H, AlJubab AS, et al
Critical Care Dilemma: Complex Congenital Pulmonary Airway Malformation With Pulmonary Hypertension in a Neonate.
Cureus. 2025;17:e85279.
Abstract

GORICA E, Spezzini J, Papadopoulou I, Telesca M, et al
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension.
Cardiovasc Diabetol. 2025;24:268.
Abstract

HOU B, Su S, Ji L, Huayu M, et al
Luteolin alleviates right ventricular hypertrophy in high altitude pulmonary hypertension rats by regulating PI3K/AKT/mTOR signalling pathway.
Eur J Pharmacol. 2025 Jul 1:177898. doi: 10.1016/j.ejphar.2025.177898.
Abstract

GAO C, Li J, Feng F, Fu J, et al
EDIL3 regulates pulmonary artery smooth muscle cell proliferation and migration via integrin alphaVbeta3/ERK1/2 axis in pulmonary hypertension.
Eur J Pharmacol. 2025 Jul 1:177901. doi: 10.1016/j.ejphar.2025.177901.
Abstract

DU D, Qin J, Hu X, Xu D, et al
Linking obstructive sleep apnea with pulmonary hypertension via pooled prevalence and causal association: A systematic review, meta-analysis and Mendelian randomization.
Heart Lung. 2025;74:82-89.
Abstract

SARVANANDA S, Earnshaw S, Hughes I, Sivakumaran P, et al
Effect of positive airway pressure treatment on pulmonary artery pressure in obstructive sleep apnoea and/or obesity hypoventilation syndrome with pulmonary hypertension: a systematic review and meta-analysis.
Intern Med J. 2025 Jul 2. doi: 10.1111/imj.70137.
Abstract

HE Y, Li Q, Zhang C, Keller BB, et al
The genetic epidemiology and genotype-phenotype correlations among Chinese children with idiopathic and heritable pulmonary arterial hypertension.
Respir Res. 2025;26:231.
Abstract

DONG M, Song M, Liu J
Atrial septostomy in the management of pulmonary arterial hypertension: past, present, and future.
Eur J Med Res. 2025;30:552.
Abstract

CHEN C, Xie Z, Ao D, Chen Y, et al
Transcription factor EB improves hypoxic pulmonary hypertension in fetal rats by suppressing NLRP3 inflammasome activation via induction of mitophagy.
Sci Rep. 2025;15:20356.
Abstract

ALDAY-RAMIREZ SM, Gomez-Rodriguez CA, Damas-de-Los-Santos F, Zebadua-Torres R, et al
Venous excess ultrasound and right heart catheterization in pre-capillary pulmonary hypertension.
J Ultrasound. 2025 Jul 2. doi: 10.1007/s40477-025-01050.
Abstract

ALENEZI F, Costelle A, Lee S, Driehuys B, et al
The emerging role of hyperpolarized (129)Xe MRI in pulmonary hypertension.
Expert Rev Respir Med. 2025 Jul 2. doi: 10.1080/17476348.2025.2529543.
Abstract

ALI HJ, Guha A
Pulmonary hypertension: diagnostic aspects-what is the role of imaging?
Curr Opin Cardiol. 2025 Jun 27. doi: 10.1097/HCO.0000000000001241.
Abstract

XU Y, Zhou C, Liu X, Guo W, et al
[Application of Animal Models in Research on Hypoxia-Related Diseases].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:331-338.
Abstract

LAMMI M, Kolstad KD, Saketkoo LA, Khatri A, et al
Response to "Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension".
Arthritis Care Res (Hoboken). 2025 Jul 1. doi: 10.1002/acr.25589.
Abstract

WANG Y, Jiang W, Bai S, Zhu Y, et al
Association between prealbumin levels and pulmonary hypertension in peritoneal dialysis patients: a single-center retrospective cohort study.
BMC Nephrol. 2025;26:329.
Abstract

SUN T, Che H, Zhang J, Lv Y, et al
Maternal outcomes among pregnant women with shunt-related congenital heart disease-associated pulmonary hypertension: a retrospective study.
BMC Anesthesiol. 2025;25:299.
Abstract

DU J, Zhang Y, Hao D, Wang H, et al
Serum proteomics identify biomarkers and pathogenesis of portopulmonary hypertension diagnosed based on echocardiography.
Sci Rep. 2025;15:21075.
Abstract

AZAD T, Li L, Wang S, Yue S, et al
Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life.
Sci Rep. 2025;15:22517.
Abstract

AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Nuralieva GS, et al
NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD.
Sci Rep. 2025;15:21169.
Abstract

LONG GM, Giourdas AD, Fisher AJ, Lahm T, et al
Effect of Pre-exercise Dietary Nitrate on Skeletal Muscle Blood Flow in a Rat Model of Pulmonary Hypertension.
Am J Physiol Regul Integr Comp Physiol. 2025.
Abstract

CROQUETTE M, Larrieu Ardilouze E, Beaufort C, Jutant EM, et al
Femoral venous stasis index predicts elevated right atrial pressure and mortality in pulmonary hypertension.
ERJ Open Res. 2025;11:01027-2024.
Abstract

CHEN A, Chen Z, Huang B, Lian G, et al
Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension.
Mol Cell Biochem. 2025 Jun 30. doi: 10.1007/s11010-025-05342.
Abstract

ADU-AMANKWAAH J, Shi Y, Song H, Ma Y, et al
Signaling pathways and targeted therapy for pulmonary hypertension.
Signal Transduct Target Ther. 2025;10:207.
Abstract

VAN SPIJK JN, Junge HK, Eberhardt C, Wolf N, et al
Evaluation of Subjective Assessment of Right Heart Size and Function Using Standard 2D-Echocardiographic Recordings in Horses With and Without Pulmonary Hypertension.
J Vet Intern Med. 2025;39:e70145.
Abstract

IBRAHIM R, Habib A, Olson A, Shrourou F, et al
Location of Terminal Care in Pulmonary Hypertension.
CJC Open. 2025;7:832-839.
Abstract

ASHWANT KUMAR D, Mahadevan S
Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension.
Arthritis Care Res (Hoboken). 2025 Jun 30. doi: 10.1002/acr.25586.
Abstract

NIU LC, Zhang R, Qi Q, Tang BL, et al
Astragaloside IV Improves Pulmonary Vascular Endothelial Dysfunction in Pulmonary Arterial Hypertension by Inhibiting Ferroptosis through Modulation of the Calpain-1/TGF-beta/TFRC Pathway.
Am J Chin Med. 2025;53:1181-1206.
Abstract

YIN Q, Peng W, Yang J, Fan C, et al
Nobiletin alleviates hypoxia-induced pulmonary hypertension by inhibiting calcium-sensing receptor.
J Nat Med. 2025 Jun 29. doi: 10.1007/s11418-025-01921.
Abstract

DIAS MAIA P, Seedorf G, Gonzalez T, Bye E, et al
Development of late pulmonary hypertension after antenatal inflammation in experimental bronchopulmonary dysplasia.
Pediatr Res. 2025 Jun 28. doi: 10.1038/s41390-025-04223.
Abstract

MURUGESAN P, Zhang Y, Zhang Y, Youn JY, et al
Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides.
Redox Biol. 2025;85:103710.
Abstract

OBEIDAT M, Vignarajah A, Abdel-Razeq R, Nathir A, et al
Effects of sodium-glucose cotransport-2 inhibitors treatment in patients with pulmonary hypertension.
Ther Adv Respir Dis. 2025;19:17534666251351443.
Abstract

TURNER R, Connolly D, Brodbelt D, Cortellini S, et al
The long-term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation.
J Small Anim Pract. 2025 Jun 27. doi: 10.1111/jsap.13893.
Abstract

SUN X, Hu G, Li Y, Li W, et al
Gut opportunistic pathogens contribute to high-altitude pulmonary edema by elevating lysophosphatidylcholines and inducing inflammation.
Microbiol Spectr. 2025;13:e0305724.
Abstract

ALAJBEGOVIC L, Lang IM
Interventional strategies to unload the right ventricle: a systematic review.
Expert Rev Respir Med. 2025;19:741-757.
Abstract

BZDEGA K, Deutsch GH, Rydzanicz M, Blaz W, et al
Decreased Level of TMEM100 in Neonates With Lethal Lung Developmental Disorders due to Abnormalities in SHH-FOXF1 and TBX4-FGF10 Signaling Pathways.
Am J Med Genet A. 2025 Mar 27:e64071. doi: 10.1002/ajmg.a.64071.
Abstract

LICHTBLAU M, Schwarz EI, Ulrich T, Schneider SR, et al
Effect of an Overnight Stay at 2,500 Meters on Nocturnal Hypoxemia and Sleep-disordered Breathing in Patients with Pulmonary Vascular Disease: A Randomized Clinical Trial.
Ann Am Thorac Soc. 2025;22:1053-1061.
Abstract

ZHANG Y, Wang X, Sun X, Zhou Z, et al
Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study.
Rheumatology (Oxford). 2025;64:4154-4163.
Abstract

RAKO ZA, Cekay M, Yogeswaran A, Yildiz S, et al
Echocardiographic Measure of Right Ventricular-Pulmonary Arterial Coupling Predicts Survival in Lung Cancer.
Ann Am Thorac Soc. 2025;22:1071-1078.
Abstract

YANG Y, Liang L, Pei W, Sun Y, et al
Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension.
Front Cardiovasc Med. 2025;12:1611449.
Abstract

CAI Z, Lin S, Jin N, Fu Y, et al
A Patient With Pulmonary Hypertension Carrying FLNA Loss-of-Function Variant.
Pulm Circ. 2025;15:e70110.
Abstract

GRYNBLAT J, Coulet F, Montani D
Cobalamin C deficiency: a rare but treatable genetic cause of pulmonary hypertension.
Orphanet J Rare Dis. 2025;20:357.
Abstract

HAN T, Huang Q, Zhai Z, Zhang X, et al
Nocturnal hypoxemia is associated with poor pulmonary hemodynamics in patients with chronic thromboembolic pulmonary disease.
Respir Res. 2025;26:239.
Abstract

DAN-ZENG ZG, Bai-Ma YJ, Huang J, Suo-Lang WJ, et al
Integrative proteomics and metabolomics reveal important pathways and potential biomarkers in high-altitude pulmonary hypertension.
Sci Rep. 2025;15:24999.
Abstract

NYHAN SM, Gadkari M, Brady T, Martinez Yus M, et al
Preoperative serum LOXL2 levels are elevated in patients with pulmonary hypertension undergoing mitral valve surgery in a prospective observational cohort study.
J Appl Physiol (1985). 2025 Jul 10. doi: 10.1152/japplphysiol.00287.2025.
Abstract

KOIZUMI S, Musha I, Toda K, Kawana H, et al
Management strategy for congenital hyperinsulinism with atrial septal defect and diazoxide-induced pulmonary hypertension.
Clin Pediatr Endocrinol. 2025;34:188-192.
Abstract

FU ZQ, Sun N, An L
A case of rapidly progressive fatal pulmonary hypertension in a patient with metastatic bladder cancer: reflections on the early recognition of pulmonary tumour thrombotic microangiopathy.
J Geriatr Cardiol. 2025;22:596-599.
Abstract

DAS S, Krithika KG
Anesthetic management of chronic thromboembolic pulmonary hypertension for surgical pulmonary thromboendarterectomy: A narrative review.
J Anaesthesiol Clin Pharmacol. 2025;41:418-426.
Abstract

YAKU H, Burkhoff D, Borlaug BA, Lala A, et al
Oral Levosimendan for the Treatment of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction: Rationale and Design of the LEVEL Trial: Rationale and Design of LEVEL.
J Card Fail. 2025 Jul 7:S1071-9164(25)00293.
Abstract

SYNN AJ, Nassikas NJ
Breathing Under Pressure? Air Pollution and Mortality in Pulmonary Hypertension.
Ann Am Thorac Soc. 2025 Jul 9. doi: 10.1513/AnnalsATS.202507.
Abstract

WANG DW, Katayama A, Ligon MM, Abuelkasem E, et al
Portopulmonary hypertension: diagnosis and preoperative management.
Curr Opin Anaesthesiol. 2025;38:445-451.
Abstract

GAZDA AJ, Ryan JJ
Pulmonary Vascular Oncology: A New Collaborative Field for Cancer-Related Pulmonary Hypertension.
Circ Cardiovasc Imaging. 2025 Jul 9:e018601. doi: 10.1161/CIRCIMAGING.125.018601
Abstract

VIRMANI S, Garg S, Malik I, Dash AC, et al
Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement.
Ann Card Anaesth. 2025;28:298-304.
Abstract

YU L, Chen X, Wang X, Cui R, et al
Efficacy and safety of high-flow nasal cannula versus noninvasive ventilation for pulmonary arterial hypertension-associated acute respiratory failure: A retrospective cohort study stratified by the severity of right ventricular dysfunction.
Medicine (Baltimore). 2025;104:e43185.
Abstract

PEREZ DEL VILLAR C, Prieto-Arevalo R, Garcia-Carreno J, Martinez-Legazpi P, et al
Validation of noninvasive indices of right ventricular diastolic function. Simultaneous echocardiography and pressure-volume catheterization studies.
Cardiovasc Ultrasound. 2025;23:15.
Abstract

YAO M, Zhong K, Zheng X, Yang Z, et al
Identification of LDHA as a Potential Therapeutic Target for Pulmonary Hypertension Through Modulation of Endothelial-To-Mesenchymal Transition.
J Cell Mol Med. 2025;29:e70692.
Abstract

WENG CT, Tsai YS, Hsu CH, Lee CH, et al
High occurrence of antiphospholipid antibody-associated thromboembolism in systemic lupus erythematosus with significant pulmonary hypertension: A monocentric retrospective study in southern taiwan.
J Formos Med Assoc. 2025 Jul 7:S0929-6646(25)00330.
Abstract

JUD P, Douschan P, Sassmann T, Silbernagel G, et al
Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study.
Rheumatol Int. 2025;45:166.
Abstract

CHEN YX, Deng ZH, She XW, Gao X, et al
Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR/ErbB2 heterodimerization in hypoxic pulmonary hypertension.
Sci Rep. 2025;15:24303.
Abstract

KARVASARSKI E, Park JS, Savaris S, Beale A, et al
Pre- and post-capillary exercise contributions to pulmonary hypertension in adults > 45 years.
J Appl Physiol (1985). 2025 Jul 7. doi: 10.1152/japplphysiol.00148.2025.
Abstract

MA C, Gong C, Wang B, Li Y, et al
Exploring the Causal Link Between Autoimmune Diseases and Pulmonary Arterial Hypertension: A Bidirectional Mendelian Randomization Study.
Glob Heart. 2025;20:58.
Abstract

KONDURI A, Sonnen AJ, Lim HM, Schumacher KR, et al
Prostacyclin Therapy as Adjunctive Treatment for Pulmonary Hypertension in Pediatric Heart Transplantation: A Case Report.
Pediatr Transplant. 2025;29:e70129.
Abstract

MUKHOPADHYAY I, Singh S, Das N, Tevatia A, et al
Diagnostic quagmires to miraculous resolutions: pulmonary hypertension in pregnancy.
BMJ Case Rep. 2025;18:e264211.
Abstract

WANG Y, Zhang Y, Iyer SK, Witschey WR, et al
Long-term prognostic value of native myocardial tissue relaxation parameters (T1, T2, and T1rho) in patients with precapillary pulmonary hypertension.
Int J Cardiovasc Imaging. 2025 Jul 5. doi: 10.1007/s10554-025-03451.
Abstract

JAFARI L, Wiedenroth CB, Kriechbaum SD, Grun D, et al
Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension govern right ventricle remodeling and recovery.
Nat Cardiovasc Res. 2025 Jul 4. doi: 10.1038/s44161-025-00672.
Abstract

BELAUNZARAN MA, Koenigsberg S, Mathavan A, Mathavan A, et al
Partial anomalous pulmonary venous return: diagnostic challenges and successful correction in a patient with progressive pulmonary hypertension.
BMJ Case Rep. 2025;18:e264779.
Abstract

R P, B C, D O, Hw F, et al
Composite score from the pulmonary hypertension-interstitial lung disease detection tool correlates with invasive right heart catheterization hemodynamics.
Respir Med. 2025;246:108241.
Abstract

BOUCHERAT O, Bonnet S, Provencher S, Potus F, et al
Anti-remodeling therapies in pulmonary arterial hypertension.
Trends Pharmacol Sci. 2025;46:674-691.
Abstract

JIANG DJ, Yang YJ, Wang YZ, Zhang X, et al
Whole exome sequencing unravels genetic architecture and its clinical implications in pediatric pulmonary arterial hypertension.
Int J Cardiol. 2025;437:133515.
Abstract

XIE H, Zhao X, Zhang N, Liu J, et al
Machine learning-based hemodynamics quantitative assessment of pulmonary circulation using computed tomographic pulmonary angiography.
Int J Cardiol. 2025;437:133457.
Abstract

PEREZ MARTINEZ BO, Rubick GV, Toiv A, Perkins S, et al
Impact of disease location and laterality on hemodynamic response following pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
JHLT Open. 2025;9:100314.
Abstract

JI Y, Li X, Wang R, Wang Z, et al
Bioinformatics Analysis Identifies a Potential Key Gene in the Pathogenesis of Pulmonary Hypertension-HSPH1.
Pulm Circ. 2025;15:e70127.
Abstract

SCALIA IG, Farina JM, Pietri MP, Ali NB, et al
Association of Pulmonary Hypertension With Outcomes in Kidney Transplant Recipients.
Kidney Int Rep. 2025;10:2394-2404.
Abstract

LI W, Zhang XC, Qian Y, Yu HR, et al
Prognostic Value of Cardiac MRI-derived Left Ventricular Layer-specific Strain in Pulmonary Arterial Hypertension.
Radiol Cardiothorac Imaging. 2025;7:e240334.
Abstract

ABMAN SH, Nikkho SM, Berger RMF, Del Cerro MJ, et al
Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective.
Pulm Circ. 2025;15:e70126.
Abstract

RUAN Y, Wei X, Li Q, Jin Z, et al
Effect of pulmonary hypertension on the prognosis of patients with severe aortic stenosis after transcatheter aortic valve replacement: a systematic review and meta-analysis.
BMC Cardiovasc Disord. 2025;25:515.
Abstract

MEDINA-MORALES E, Schiano TD
Hepatopulmonary Syndrome and Portopulmonary Hypertension.
Clin Liver Dis. 2025;29:503-525.
Abstract

LEIVA O, Liu O, Kanelidis A, Swat S, et al
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
JACC CardioOncol. 2025 Jul 3:S2666-0873(25)00237.
Abstract

QIU H, Chen W, Chen J, Jun L, et al
FABP4 Inhibitor Improves Right Ventricular Fibrosis in Metabolic Syndrome- Related Pulmonary Hypertension due to Left Heart Disease in Mice.
FASEB J. 2025;39:e70833.
Abstract

CHAN CC, Teixeira BL, Yang JZ, Poch DS, et al
Sex Differences Among Patients Treated With Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
Pulm Circ. 2025;15:e70128.
Abstract

Retraction: Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.
Front Public Health. 2025;13:1652830.
Abstract

NEWMAN J, Ghani H, Munagala S, Otter E, et al
Pulmonary Hypertension Global Patient Survey: A Call to Action 2025.
Pulm Circ. 2025;15:e70130.
Abstract

EICHSTAEDT CA, Maldonado-Velez G, Machado RD, Graf S, et al
Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar.
Hum Mutat. 2025;2025:2475635.
Abstract

MYRONENKO O, Curcic P, Douschan P, Zeder K, et al
Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.
Lung. 2025;203:79.
Abstract

ZHENG W, Wang Y, Li Y, Bai C, et al
Genetic adaptations of innate immune genes in Tibetans: Insights into protection against pulmonary hypertension and hepatitis B virus infection in high-altitude environments.
Genomics. 2025 Jul 12:111079. doi: 10.1016/j.ygeno.2025.111079.
Abstract

SANTOS RT, Onofre MESF, Barbosa VM, Rocha NN, et al
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension.
J Vis Exp. 2025;.
Abstract

SANTA-ANA-BAYONA MJ, Garcia-Cardenas M, Armendariz-Ferrari JC, Acosta-Gutierrez GH, et al
Cardiac Complications in Carney Complex: Right Ventricular Outflow Tract Obstruction and Pulmonary Hypertension.
CASE (Phila). 2025;9:152-156.
Abstract

KOIRALA PC, Koirala R, Karki L, Khadka M, et al
Common Echocardiographic Diagnoses in Patients at Tertiary Care Center: An Observational Study.
JNMA J Nepal Med Assoc. 2024;62:714-719.
Abstract

LO MUZIO FP, Caputo A, Statello R, Hu M, et al
Biventricular electromechanical dysfunction and molecular remodeling in a rat model of advanced pulmonary arterial hypertension.
J Transl Med. 2025;23:787.
Abstract

SUN L, Li H, Li X, Li Y, et al
Dysregulation of immune cells and platelet-monocyte aggregates in chronic thromboembolic pulmonary hypertension.
Respir Res. 2025;26:245.
Abstract

CONDLIFFE R, Kiely DG
Reaching for the summit in pulmonary arterial hypertension with sotatercept: Results of the ZENITH study.
Med. 2025;6:100750.
Abstract

LAFFAN SB, Loren K, Takahito K, Sandra T, et al
Brain Weight Effect of Ambrisentan in Juvenile Rat Toxicity Studies Associated With Breathing Sounds, Apnea, and Sustained Hypoxemia.
Birth Defects Res. 2025;117:e2504.
Abstract

THATRIMONTRICHAI A, Pakhathirathien P, Praditaukrit M, Maneenil G, et al
Persistent Pulmonary Hypertension of the Newborn in Very Low Birth Weight Infants: Risk Factors and Clinical Outcomes from a Matched Case-Control Study.
J Clin Med. 2025;14:4759.
Abstract

TUNCEZ A, Yalcin MU, Tezcan H, Altunkeser BB, et al
Assessment of Serum suPAR Levels in Patients with Group 1 and Group 4 Pulmonary Hypertension.
J Clin Med. 2025;14:4671.
Abstract

CHUAIKAEW K, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
Mortality Risk Factors and Survival Outcomes in Infants with Persistent Pulmonary Hypertension of the Newborn.
J Clin Med. 2025;14:4502.
Abstract

GUZELBAG AN, Bas S, Kangel D, Toprak MHH, et al
Computed Tomography Angiography in Pediatric Pulmonary Hypertension: Evaluating MPA-to-Aortic Ratios as Diagnostic Markers.
Diagnostics (Basel). 2025;15:1614.
Abstract

DAS R, Deliu N, Toshner MR, Villar SS, et al
StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
Trials. 2025;26:243.
Abstract

ZHANG Y, Qian T, Jiang W, Yuan H, et al
Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension.
Sci Rep. 2025;15:25187.
Abstract

LITTMAN D, Lovett J, Adelsheimer A, Bloom M, et al
Severe Pulmonary Hypertension Secondary to Pulmonary Artery Compression With Resolution Following Hodgkin Lymphoma Therapy.
JACC Case Rep. 2025;30:103950.
Abstract

YONG E, Latief J, Wang Y, Erlinge D, et al
A lumped parameter model of the coronary circulation incorporating time-varying resistance, intramyocardial pressure and vascular compliance.
J Biomech. 2025;189:112679.
Abstract

IKEDA M, Cho K, Furuse Y, Onda T, et al
Genetic features of alveolar capillary dysplasia with misalignment of pulmonary veins in Japanese infants.
Early Hum Dev. 2025;207:106287.
Abstract

SU J, Wang X, Liu L, Zhang X, et al
Exploring the influence of pulmonary pathological state on the in vivo fate of inhaled microparticles with different structural characteristics.
Int J Pharm. 2025;681:125813.
Abstract

PRISCO SZ, Blake M, Kazmirczak F, Moon R, et al
Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Circ Heart Fail. 2025 May 16:e012524. doi: 10.1161/CIRCHEARTFAILURE.124.012524.
Abstract

FUKUDA Y, Oda N, Izumizaki K, Tanaka A, et al
High Altitude Pulmonary Edema Associated with Climbing Mount Fuji.
Intern Med. 2025;64:2229-2233.
Abstract

KULKARNI T, Zisman DA, Shlobin OA, Kiely DG, et al
Study Design and Rationale for the PHINDER Study: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection.
Pulm Ther. 2025 Jul 25. doi: 10.1007/s41030-025-00307.
Abstract

LAVIOLA D, Manzi G, Recchioni T, Luise MC, et al
Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?
J Cardiovasc Dev Dis. 2025;12:271.
Abstract

GHANDAKLY EC, Banga A, Kaw R
Hemodynamic Definitions, Phenotypes, Pathophysiology, and Evaluation of Pulmonary Hypertension Related to Left Heart Disease.
J Cardiovasc Dev Dis. 2025;12:238.
Abstract

NEELAKANTAN S, Mendiola EA, Zambrano B, Vang A, et al
Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension.
Bioeng Transl Med. 2025;10:e70035.
Abstract

PENG G, Liu Z, Wang W
IDO-Dependent Tryptophan Metabolites and Endocan as Effective Diagnostic Biomarkers for Pregnancy with Pulmonary Hypertension.
Int J Womens Health. 2025;17:2205-2216.
Abstract

DIGNAM JP, Aubdool AA, Lowe VR, Perez-Ternero C, et al
Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension.
Pharmacol Res. 2025 Jul 22:107870. doi: 10.1016/j.phrs.2025.107870.
Abstract

RYO M, Ishida Y, Hamaguchi M, Hosokawa M, et al
Anesthesia Management Involving Remimazolam in a Patient With Pulmonary Hypertension and Right Ventricular Failure: A Case Report.
Cureus. 2025;17:e86568.
Abstract

LIAO XY, Li JJ, Zeng SY, Zhang ZW, et al
Successful interventional closure of patent ductus arteriosus in three pediatric cases with congenital heart disease and severe pulmonary hypertension: a case series and literature review.
Front Cardiovasc Med. 2025;12:1628666.
Abstract

DALAVINA J, Costa IP, FarahTeixeira de Carvalho E, Silva JL, et al
Severity Classification of Functional Impairment Based on ICF Qualifiers: A New Proposal for Assessing Individuals With Pulmonary Hypertension.
Physiother Res Int. 2025;30:e70090.
Abstract

HUANG Y, Bai Z, Wang L, Liu Z, et al
Systematic review and meta-analysis of nitrates/nitrites in patients with heart failure or pulmonary hypertension.
Eur J Med Res. 2025;30:661.
Abstract

RODRIGUEZ-HERRERA AJ, Setembre Batah S, Faci do Marco MJ, Gonzalez-Zambrano CM, et al
Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links.
Infect Dis Rep. 2025;17:84.
Abstract

KHANZADEH S, Aminizadeh S, Nourigheimasi S, Lucke-Wold B, et al
The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review.
Sarcoidosis Vasc Diffuse Lung Dis. 2025;42:14552.
Abstract

FUKUDA Y, Shimokawahara H, Miyagi A, Goten C, et al
Rescue balloon pulmonary angioplasty in patients with low cardiac output syndrome due to chronic thromboembolic pulmonary hypertension: A case series.
J Cardiol Cases. 2025;32:15-18.
Abstract

CHEN C, Dong Y, Song N, Qi J, et al
Pulmonary arterial hypertension caused by coadministration of dasatinib and voriconazole: A case report and literature review.
Medicine (Baltimore). 2025;104:e42927.
Abstract

ZHANG M, Guo X, Guo W, Wang Y, et al
Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?
BMC Pulm Med. 2025;25:348.
Abstract

WANG Y, Yin L, Zheng S, Liu A, et al
LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation With G3BP1 and MYH9.
Hypertension. 2025 Jul 22. doi: 10.1161/HYPERTENSIONAHA.124.24511.
Abstract

BARNIKEL M, Milger K, Mertsch P, Arnold P, et al
Classification and course of pulmonary hypertension associated with end-stage COPD.
ERJ Open Res. 2025;11:01141-2024.
Abstract

KHAN A, Asghar T, Ali KM, Saeed M, et al
Trends in mortality from pulmonary hypertension amongst population with congenital heart disease in the United States from 1999 to 2020: A CDC WONDER analysis.
Int J Cardiol Congenit Heart Dis. 2025;21:100602.
Abstract

SHI W, Kang Y, Wang X, Wang H, et al
Hereditary hemorrhagic telangiectasia with pulmonary hypertension: a report of three cases.
J Thorac Dis. 2025;17:4349-4359.
Abstract

PURA KRISHNAMURTHY K, Mahadevappa M, Srinivasan BR, Jayaprakash Narayan H, et al
Dasatinib Induced Pulmonary Hypertension and Third Space Effusion: A Case Series and Literature Review.
Hosp Pharm. 2025 Jul 17:00185787251348384. doi: 10.1177/00185787251348384.
Abstract

YAMASHITA J, Ogino H, Masaki K, Taniguchi Y, et al
Effects of pulmonary endarterectomy and balloon pulmonary angioplasty in older adults with chronic thromboembolic pulmonary hypertension: A sub-analysis of the CTEPH AC registry.
Int J Cardiol Heart Vasc. 2025;60:101751.
Abstract

LIU R, Li Y, Li B, Liu S, et al
Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial.
BMC Cardiovasc Disord. 2025;25:522.
Abstract

CASTILLO D, Francesqui J, Padilla M, Montani D, et al
Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Call for Awareness.
Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00231.
Abstract

VACHON S, Devanagondi R, Dylag A, Wang H, et al
The effectiveness of pulmonary hypertension screening in infants born preterm.
Early Hum Dev. 2025;209:106342.
Abstract

YEGAMBARAM M, Sun X, Lu Q, Flores AG, et al
c-Myc promotes metabolic reprogramming in pulmonary hypertension via the stimulation of glutaminolysis and the reductive tricarboxylic acid cycle.
Redox Biol. 2025;85:103765.
Abstract

FANG L, Yang T, Nijiati Y, Shahanati D, et al
Multi-omics analyses reveal that hesperidin ameliorates high-altitude pulmonary hypertension by restoring gut-lung axis homeostasis.
Phytomedicine. 2025;145:157069.
Abstract

ORDOG K, Horvath O, Toth S, Deres L, et al
Colchicine as a therapeutic possibility for the treatment of pulmonary arterial hypertension (PAH) in a rat model.
Biochem Pharmacol. 2025;239:117058.
Abstract

TANG Y, Pan Z, Wen J, Yang Z, et al
Epicardial adipose tissue associated with right cardiac chamber remodelling in patients with connective tissue disease evaluated by cardiac magnetic resonance: a cross-sectional study.
Clin Radiol. 2025;87:106958.
Abstract

ZIDAN BMRM, Zehravi M, Kareemulla S, Madhuri KSD, et al
High-altitude physiology: Understanding molecular, pharmacological and clinical insights.
Pathol Res Pract. 2025;272:156080.
Abstract

BORHANI A, Nia IY, Zandieh G, Mathai SC, et al
Semi-quantitative Analysis of Right Ventricular Myocardial First-pass Perfusion Using Cardiac Magnetic Resonance Imaging in Systemic Sclerosis and Pulmonary Arterial Hypertension.
Acad Radiol. 2025;32:4445-4455.
Abstract

RAMARAJ AB, Breitschopf HV, Holden KI, Gupta VS, et al
Factors Associated with Early-Childhood Ipsilateral Perfusion Abnormalities among Patients with Congenital Diaphragmatic Hernia.
J Pediatr. 2025 Apr 23:114622. doi: 10.1016/j.jpeds.2025.114622.
Abstract

WANG X, Yu C, Li M, Cai H, et al
Identification of serum C4BPA as a potential diagnostic marker of right ventricular remodelling via proteomic analysis.
ESC Heart Fail. 2025;12:2843-2854.
Abstract

SKOWASCH D, Pausch C, Huscher D, Pittrow D, et al
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis.
ESC Heart Fail. 2025;12:2726-2735.
Abstract

HARI GOPAL S, Martinek KF, Vacher C, Becker J, et al
Utility of urinary NT-proBNP in congenital diaphragmatic hernia: a prospective pilot study.
Pediatr Res. 2024 Oct 16. doi: 10.1038/s41390-024-03600.
Abstract

BLANCAS-NAPOLES CM, Cabrera-Becerra SE, Sierra-Sanchez VM, Ocampo-Ortega SA, et al
siRNA Targeting ECE-1 Partially Reverses Pulmonary Arterial Hypertensionassociated Damage in a Monocrotaline Model.
Curr Mol Pharmacol. 2024;17:e18761429283384.
Abstract

SAUER GM, Kas F, Mihai CM, Elhai M, et al
Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis.
Rheumatology (Oxford). 2025 Aug 1:keaf410. doi: 10.1093.
Abstract

AMEEN H, Karim A, Anjum A
Clinical insights on sacubitril/valsartan alters pulmonary arterial pressure in heart failure with maintained ejection fraction and pulmonary hypertension among PD patients.
Int Urol Nephrol. 2025 Aug 1. doi: 10.1007/s11255-025-04686.
Abstract

COSTA-RODRIGUEZ N, Vera-Rodriguez DJ, Falcon-Cordon S, Morales BR, et al
Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis.
Parasit Vectors. 2025;18:313.
Abstract

CAMERON JE, McElhinney DB, Liu E, Hopper RK, et al
Pharmacologic Management of Segmental Pulmonary Hypertension in Children After Unifocalization and Pulmonary Artery Reconstruction: Initial Experience.
Pulm Circ. 2025;15:e70134.
Abstract

VOLLMERS K, Scandurra J, Woolley JR, Giridharan GA, et al
Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70131.
Abstract

MEHMOOD AM, Hassan SMS, Malik A, Faizan M, et al
Rare Case of Laurence-Moon-Bardet-Biedl Syndrome With Pulmonary Hypertension: A Case Report.
Clin Case Rep. 2025;13:e70691.
Abstract

CHEN ZY, Cao Y, Yang J, He XH, et al
Case Report: A case of severe pulmonary hypertension combined with FBN1 mutation associated geleophysic dysplasia.
Front Pediatr. 2025;13:1642390.
Abstract

ISOMATSU S, Takeda K, Shionoya Y, Sugiura T, et al
A management of a patient with chronic thromboembolic pulmonary hypertension prior to surgical resection for lung cancer.
Respir Med Case Rep. 2025;57:102269.
Abstract

LEE SY, Jung HO, Kim KA, Oh GC, et al
Impact of the New Definition on the Prognosis of Patients With Pulmonary Hypertension Compared to the Classic Definition.
Korean Circ J. 2025 Jul 1. doi: 10.4070/kcj.2024.0416.
Abstract

REISER AE, Thiersch M, Gassmann M, Muckenthaler MU, et al
Reassessment of the Current Iron Deficiency Definition in Pulmonary Hypertension.
Pulm Circ. 2025;15:e70142.
Abstract

LIU PL, Xu ZW, Kuo WS, Hsu CH, et al
Pulmonary artery hypertension-induced vascular structure analysis using label-free fluorescence lifetime imaging.
Opt Express. 2025;33:31935-31948.
Abstract

DODSON MW, Allen-Brady K, Stevens J, Cirulis MM, et al
Rare variants in STAB2 in patients with chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2025;11:01322-2024.
Abstract

MONTANI D, Toshner M
The genetics of chronic thromboembolic pulmonary hypertension: no longer a stab in the dark.
ERJ Open Res. 2025;11:00551-2025.
Abstract

WREN JT JR, Shibbani K
Sound Waves Versus Pressure Waves: The Increasing Role of Echocardiography and Noninvasive Vasoreactivity Testing in Pediatric Pulmonary Hypertension Management.
Echocardiography. 2025;42:e70254.
Abstract

LIU J, Rong C, Wang Y, Wang B, et al
Pulmonary hypertension associated with rheumatoid arthritis: A case report and causal association verification through Mendelian randomization.
Medicine (Baltimore). 2025;104:e43116.
Abstract

ASHUR A, Levy A, Liel-Cohen N, Sergienko R, et al
Prognostic Value of Pulmonary Hypertension as an Incidental Finding Detected by Echocardiography in Patients Without Known Cardiovascular or Pulmonary Diseases.
J Clin Med. 2025;14:5044.
Abstract

CACIA M, Imbalzano E, Ciconte VA, Vatrano M, et al
Pulmonary Hypertension: Let's Take Stock!
Life (Basel). 2025;15:1137.
Abstract

PARIKH R, Dagher C, Farber HW
Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease.
Life (Basel). 2025;15:1089.
Abstract

COSTA-RODRIGUEZ N, Vera-Rodriguez DJ, Falcon-Cordon S, Morales BR, et al
Urinary NGAL as an Early Marker of Renal Dysfunction in Dogs with Heartworm Disease and Pulmonary Hypertension.
Animals (Basel). 2025;15:2003.
Abstract

KIM S, Seo Y, Oh MY, Kim MS, et al
Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia.
Biomedicines. 2025;13:1725.
Abstract

CARBONE RG, Puppo F, Thomas CA, Savarino V, et al
Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management.
Diagnostics (Basel). 2025;15:1821.
Abstract

GILLMEYER KR, Shusterman S, Rinne ST, Elwy AR, et al
Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study.
BMC Pulm Med. 2025;25:355.
Abstract

QIN J, Wang G, Han D
Erratum to "Selexipag in Patients with Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" [Current Problems in Cardiology 48(2023) 101466].
Curr Probl Cardiol. 2025 Jul 26:103127. doi: 10.1016/j.cpcardiol.2025.103127.
Abstract

ZHUO ML, Xu JL, Zhang W, Rao GW, et al
Efficacy of sildenafil combined with statins in treating pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Pathol Res Pract. 2025;273:156097.
Abstract

HERRERA E, Salamanca JF, Durango LF
The role of agitated saline contrast echocardiography in the evaluation of pulmonary hypertension.
Arch Peru Cardiol Cir Cardiovasc. 2025;6:90-95.
Abstract

INGRAM J, Stubbs H, Lua S, Brewis M, et al
Digital Inclusion in a Scottish National Pulmonary Hypertension Population.
Pulm Circ. 2025;15:e70135.
Abstract

DAGAN M, Nanayakkara S, Chan W, McGiffin DC, et al
Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.
EBioMedicine. 2025;118:105867.
Abstract

SHI Y, Xu Y, Li Y, Yan C, et al
ALKBH5 regulates ACSL4 to sensitize erastin-induced ferroptosis via YTHDF2-dependent m(6)A modification in hypoxic pulmonary hypertension.
Free Radic Biol Med. 2025 Jul 24:S0891-5849(25)00848.
Abstract

SHIMOKAWAHARA H, Nishizaki M, Inami T, Kubota K, et al
Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial.
Lancet Respir Med. 2025 Jul 23:S2213-2600(25)00127.
Abstract

KAOUS M, Ryoo Ali HJ, Ok CY, Iliescu C, et al
Relapse of Acute Myelogenous Leukemia With History of Myeloproliferative Neoplasm and Exacerbation of Pulmonary Hypertension.
JACC Case Rep. 2025;30:104136.
Abstract

KODESH A, Levie S, Garcia MJ
Transthoracic Echocardiography in Diagnosing Mixed Pulmonary Hypertension in a Patient With Bioprosthetic Mitral Valve Replacement.
JACC Case Rep. 2025;30:104146.
Abstract

ALGHAMDI KS, Maiter A, Hyde GA, Alnasser T, et al
Pulmonary Hypertension and the Role of MRI Flow Assessment: A Systematic Review.
Br J Radiol. 2025 Jul 25:tqaf182. doi: 10.1093.
Abstract

LEBAR K, Tantisuwat L, Pang J, Chicco AJ, et al
Distinct Right Ventricular Performance in Response to Acute Colchicine Treatment in Healthy and Diseased States.
Function (Oxf). 2025;6:zqaf021.
Abstract

SABRY M, Wieslander B, Hermida U, Fernandes JF, et al
Vortex duration in the pulmonary artery does not depend on vascular Afterload: a sign of adaptation?
Comput Biol Med. 2025;196.
Abstract

ALSUMALI A, McLaughlin V, Chevure J, Klok R, et al
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.
Adv Ther. 2025;42:3902-3921.
Abstract

KUWABARA Y, Yokokawa T, Lemay SE, Sauvaget M, et al
Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension.
Am J Pathol. 2025;195:1376-1393.
Abstract

WATZKER A, Alsumali A, Ferro C, Li XJ, et al
The Potential Impact of Sotatercept on Long-Term Disability in Commercially Insured Patients with Pulmonary Arterial Hypertension in the United States: An Exercise in Actuarial Modeling.
Adv Ther. 2025;42:3678-3690.
Abstract

KWAPISZEWSKA G, Rhodes C, Rabinovitch M, Simpson C, et al
Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective.
Am J Respir Cell Mol Biol. 2025;73:200-209.
Abstract

HEATH A, von Alvensleben I, Spielvogel JA, Freudenthal P, et al
Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia.
Exp Physiol. 2025;110:1060-1070.
Abstract

LEGCHENKO E, Chouvarine P, Hysko K, Qadri F, et al
Inhalation of the Novel Tryptophan Hydroxylase 1 Inhibitor TPT-004 Alleviates Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2025;73:288-298.
Abstract

ZHAO SS, Yuan C, Liu JL, Wu QC, et al
SETD2 drives METTL14-mediated m(6)A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.
Cell Mol Life Sci. 2025;82:302.
Abstract

THAL BR, Rako ZA, Kremer NC, Yogeswaran A, et al
Exercise haemodynamics in pulmonary hypertension - a prospective pressure-volume loop study on right ventricular adaptation and prognosis.
Eur J Heart Fail. 2025 Aug 7. doi: 10.1002/ejhf.3802.
Abstract

ZHANG T, Zhu L, Liu B, Liu J, et al
Binding of Hypoxia-Induced Mitogenic Factor/RELM-beta to Bone Morphogenetic Protein Receptor 2 Complex Promotes Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2025 Aug 7. doi: 10.1161/ATVBAHA.125.322652.
Abstract

MONTOYA L JP, Vasquez J, Uribe Gonzalez R, Guzman-Medina M, et al
From Pulmonary Hyperlucency to Pulmonary Hypertension: A Case Report of Swyer-James-MacLeod Syndrome.
Cureus. 2025;17:e87392.
Abstract

FARBER HW
My Introduction to Pulmonary Hypertension.
Pulm Circ. 2025;15:e70124.
Abstract

DEMONCHEAUX E
Unraveling Nonenzymatic Nitric Oxide Production and Its Impact on Pulmonary Hypertension.
Pulm Circ. 2025;15:e70152.
Abstract

QI X, Jun L, Wang D, Zhou H, et al
Right Ventricular Myocardial Global Longitudinal Strain Assessment of Right Ventricular Function in Patients with Pulmonary Embolism.
Kardiologiia. 2025;65:46-54.
Abstract

CHEN G, Zhang Z, Zhao X, Huang K, et al
Maternal and neonatal outcomes in pregnancies complicated with pulmonary hypertension: a retrospective cohort study.
Eur J Med Res. 2025;30:717.
Abstract

YANAKA K, Nakayama K, Taniguchi Y, Onishi H, et al
Difference in efficacy between pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
BMC Pulm Med. 2025;25:376.
Abstract

ISHAAYA E, Yee N, DeCato TW
Six-Minute Walk Testing: Performance, Properties, and Clinical Applications.
Clin Chest Med. 2025;46:467-479.
Abstract

BICHUETTE LD, Calderaro D, Lemos Neto PA, Fonseca EKUN, et al
Left Main Coronary Artery Angioplasty for the Treatment of Extrinsic Compression in Patients with Pulmonary Hypertension.
Arq Bras Cardiol. 2025;122:e20250002.
Abstract

RICH S
My Quest for Calcium Channel Blockers as the First Medical Treatment for Patients With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70151.
Abstract

BUTROUS G
The Emergence of Oral Sildenafil for Pulmonary Hypertension Management.
Pulm Circ. 2025;15:e70150.
Abstract

SANDERS R, Walsh T, Baird G, Atalay M, et al
Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.
medRxiv [Preprint]. 2025 Aug 2:2025.08.01.25332627.
Abstract

POYATOS P, Peinado VI, Blanco I, Osorio J, et al
Assessing the role of endothelium-protective drugs: Functional and molecular insights into chronic thromboembolic pulmonary hypertension derived endothelial cells.
Biomed Pharmacother. 2025;190:118425.
Abstract

KAVANAGH T, Kilpatrick T, Hardy B, Lee S, et al
Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Ann Card Anaesth. 2025 Aug 5. doi: 10.4103.
Abstract

RANA SS, Dilshad RA, Nawaz S, Usman M, et al
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease, With and Without Pulmonary Hypertension, on Survival: A Systematic Review.
Cureus. 2025;17:e87303.
Abstract

MA R, Cui J, Zheng Y, Tao H, et al
A nomogram model for predicting maternal cardiovascular complications and neonatal adverse outcomes in pregnant patients with pulmonary arterial hypertension.
Ann Med. 2025;57:2541093.
Abstract

OBA Y, Maduke T, Fakhouri EW, Goite Y, et al
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.
Cochrane Database Syst Rev. 2025;8:CD015824.
Abstract

KINTADA G, Prasad AK, Prasad AM, Agstam S, et al
Ballooned Out the Clot-Rescue Balloon Pulmonary Angioplasty in a Young Male Presenting With Acute on Chronic Thromboembolic Pulmonary Hypertension.
Catheter Cardiovasc Interv. 2025 Aug 4. doi: 10.1002/ccd.70067.
Abstract

RODOLFI S, Ng CCM, Ruiz Bejerano AM, Kanitkar M, et al
Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension.
Clin Exp Rheumatol. 2025;43:1492-1498.
Abstract

SUN L, Tian H, Liu J, Liu M, et al
The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary Hypertension.
Pulm Circ. 2025;15:e70118.
Abstract

DING R, Xie H, Zhang Y, Qin L, et al
Ginsenoside Rg1 Ameliorates Pulmonary Hypertension by Inhibiting cGAS/STING Mediated Cell Senescence.
Drug Des Devel Ther. 2025;19:6487-6504.
Abstract

KHURANA JK, Lipsitz S, Geisser DL, Moynihan KM, et al
Neighborhood Child Opportunity Index and Outcomes in Pediatric Pulmonary Hypertension.
Pediatr Cardiol. 2025 Aug 2. doi: 10.1007/s00246-025-03981.
Abstract

SU R, Pritazahra A, Saverimuttu SC, Lovering R, et al
MicroRNA regulation of PPARG Signalling: Therapeutic implications for pulmonary hypertension.
Comput Biol Med. 2025;196.
Abstract

ABUBAKER J, Shaikh AS, Hassan M, Ammar A, et al
National Institute Pulmonary Hypertension Registry (NIPHeR): Insights from the first pulmonary hypertension registry of Pakistan.
J Pak Med Assoc. 2025;75:1058-1066.
Abstract

BELHAKIM M, El Jaouhahri Z, Boudar A, Benaddi L, et al
Severe pertussis complicated by pulmonary hypertension in a Moroccan infant: a case report.
J Med Case Rep. 2025;19:379.
Abstract

ZOU Y, Ding Y
Insights into gas exchange, pulmonary artery capacity, and postural variations in chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
J Cardiol. 2025 Jul 30:S0914-5087(25)00194-7. doi: 10.1016/j.jjcc.2025.
Abstract

LI Y, Yang X, Zeng M, Luo T, et al
Meta-analysis evaluating the risks and outcomes of pulmonary hypertension in pregnant women.
Pregnancy Hypertens. 2025;41:101241.
Abstract

WU W, Kong F, Chen Z, Huang L, et al
Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2025;14:e042713.
Abstract

WANG Y, Guo Z, Ma X, Xu Q, et al
Integrated transcriptome and metabolome analysis reveals the therapeutic mechanism of Huang-Qi-Si-Wu-Tang in experimental pulmonary arterial hypertension.
Phytomedicine. 2025;145:157058.
Abstract

WU Q, Ye H, Zhou Z, Zhang M, et al
Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure.
Future Cardiol. 2025;21:803-814.
Abstract

WANG X, Zhu Z, Jia H, Lu X, et al
Critical role of mitochondrial dynamics in chronic respiratory diseases and new therapeutic directions.
Chin Med J (Engl). 2025;138:1783-1793.
Abstract

LI WH, Ma WJ, Zhang W, Zhao SN, et al
Programmed Cell Death: A Pivotal Player in Pulmonary Arterial Hypertension.
Eur J Pharmacol. 2025 Jul 8:177934. doi: 10.1016/j.ejphar.2025.177934.
Abstract

MA WJ, Li WH, Zhao XM, Zhang W, et al
Significance of ALDH3A2, a mitochondrial metabolism and glycolysis related gene, in pulmonary arterial hypertension.
Eur J Pharmacol. 2025;1003:177923.
Abstract

VERMA D, Estrada RA, Sahay S
The role of imaging in risk assessment for pulmonary arterial hypertension.
Curr Opin Cardiol. 2025;40:327-334.
Abstract

CHEN M, Pang L, Huang T, Liang W, et al
Integrating single-cell RNA-seq, bulk RNA-seq, and Mendelian randomization to elucidate the role of HLA-DPA1 expression levels and non-classical monocytes in the pathogenesis of idiopathic pulmonary arterial hypertension.
Int J Biol Macromol. 2025;319.
Abstract

HAJIPOUR M, Labarca G, Ayas N, Azarbarzin A, et al
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes.
Semin Respir Crit Care Med. 2025;46:221-232.
Abstract

PATEL K, Ananthanarayanan C, Gajjar T, Mishra A, et al
Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months- A Single Center Experience.
World J Pediatr Congenit Heart Surg. 2025;16:640-647.
Abstract

NIELSEN CTH, Holm Nielsen S, Sondergaard Korsholm S, Diederichsen ACP, et al
Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis.
Clin Exp Rheumatol. 2025;43:1439-1445.
Abstract

JHAVERI V, Lakshminrusimha S, Singh Y
Hemodynamics during noninvasive ventilation in neonates.
Semin Perinatol. 2025;49:152065.
Abstract

WANG Y, Yan B, Ma P, Zhou R, et al
Mechanism of action of aloperine in the treatment of pulmonary arterial hypertension based on network pharmacology and molecular docking methods.
Herz. 2025;50:287-294.
Abstract

SMITH V, Marjenberg Z, Volkmann ER
The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review.
Clin Exp Rheumatol. 2025;43:1516-1526.
Abstract

BYARD RW
A forensic overview of deaths in mountainous terrain.
Forensic Sci Med Pathol. 2025;21:952-956.
Abstract

EL ISKANDARANI M, Golamari R, Bettinotti BGM, Akiki E, et al
Pregnancy in patients with pulmonary hypertension: a systematic review and meta-analysis with meta-regression.
J Thorac Dis. 2025;17:5108-5121.
Abstract

TRIPIPITSIRIWAT A, Malhotra A, Robertson H, Kim NH, et al
The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.
J Clin Med. 2025;14:5442.
Abstract

ITO K, Kato S, Yasuda N, Sawamura S, et al
Integrating CT-Based Lung Fibrosis and MRI-Derived Right Ventricular Function for the Detection of Pulmonary Hypertension in Interstitial Lung Disease.
J Clin Med. 2025;14:5329.
Abstract

DING R, Xie H, Sang S, Qin L, et al
Astragaloside IV alleviates hypoxic pulmonary hypertension by inhibiting RELM-beta to reduce PINK1/Parkin-mediated mitophagy in pulmonary artery smooth muscle cells (PASMCs).
Br J Pharmacol. 2025 Aug 13. doi: 10.1111/bph.70166.
Abstract

PALEVSKY HI
The Genesis and Legacy of the NHLBI Patient Registry for the Characterization of Primary Pulmonary Hypertension (NIH-PPH Registry).
Pulm Circ. 2025;15:e70148.
Abstract

ZHANG H, Shao F, Gao C, Tian L, et al
Pulmonary Vascular Remodeling in Pulmonary Hypertension Mice Aggravated by Hypothyroidism.
Endocrinology. 2025;166:bqaf122.
Abstract

DRABIK L, Wasilewski G, Waligora M, Piatek J, et al
Unloading left ventricle and unlocking transplant options: Impella 5.5 in advanced heart failure with pulmonary hypertension.
Kardiol Pol. 2025 Aug 12. doi: 10.33963/v.phj.108032.
Abstract

SHIMA H, Tsujino I, Nakaya T, Nakamura J, et al
Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.
J Am Heart Assoc. 2025 Aug 12:e042186. doi: 10.1161/JAHA.125.042186.
Abstract

ALTAMIMI T, Almahdi M, Algarni SS, Alshreedah S, et al
Oxygenation indices and echocardiographic markers of pulmonary hypertension and ventricular dysfunction in congenital diaphragmatic hernia.
BMJ Paediatr Open. 2025;9:e003637.
Abstract

CAO X, Ma J, Chen K, Luo M, et al
Wheat Grain Moxibustion as an Adjuvant Therapy for Chronic Fatigue in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
J Vis Exp. 2025;.
Abstract

MA J, Cao X, Chen K, Dang K, et al
Electroacupuncture as an Adjuvant Therapy for Dyspnea in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
J Vis Exp. 2025;.
Abstract

DUAN J, Liu L, Guo S, Sun H, et al
Evaluation of pulmonary perfusion and ventilation in suspected chronic thromboembolic pulmonary hypertension via phase-resolved functional lung magnetic resonance imaging: correlations with hemodynamics and cardiopulmonary function.
Quant Imaging Med Surg. 2025;15:7169-7182.
Abstract

SATO H, Takahashi Y, Hasegawa T, Someya Y, et al
Feature-Tracking Method Can Estimate Right Ventricular Contractile Properties in Rats With Pulmonary Hypertension.
Circ Rep. 2025;7:685-691.
Abstract

YANG L, Hou W, Lan J, Liu R, et al
Self-Assembled Tetrahedral Framework Nucleic Acids Alleviate Pulmonary Hypertension by Regulating Calcium Homeostasis.
Adv Healthc Mater. 2025 Aug 11:e02810. doi: 10.1002/adhm.202502810.
Abstract

CHO S, Farghaly MAA, Ramey S, Abdalla A, et al
Pulmonary hypertension, inhaled nitric oxide, and retinopathy of prematurity: evidence from the U.S. national database.
Pediatr Res. 2025 Aug 9. doi: 10.1038/s41390-025-04323.
Abstract

ERMIS N, Ozhan O, Yildiz A, Ulutas Z, et al
Comparison of cilomilast, tadalafil, and both drug combinations in the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
BMC Cardiovasc Disord. 2025;25:591.
Abstract

KAKAVANDI S, Zare I, Mirshafiei M, Zhang M, et al
Antimicrobial PLGA-based micro/nanoparticles for nanomedicine of pulmonary diseases: From respiratory infections to pulmonary hypertension and fibrosis.
Int J Pharm. 2025 Aug 7:126054. doi: 10.1016/j.ijpharm.2025.126054.
Abstract

WANG FY, Yi J, Zhou LL, Tan JL, et al
Unlocking the gut-lung axis: Feixin decoction as a novel modulator in hypoxic pulmonary hypertension.
Phytomedicine. 2025;146:157118.
Abstract

KUZEL TG, El-Kersh K
Unilateral Absence of Pulmonary Artery Complicated With Severe Pulmonary Hypertension: Favorable Response to Parenteral Therapy.
JACC Case Rep. 2025;30:104549.
Abstract

LU GQ, Sun HY, Xu MY, Sun ZY, et al
Salidroside ameliorates monocrotaline-induced pulmonary arterial hypertension in rats by modulating BKCa channels.
Eur J Pharmacol. 2025;1004:177950.
Abstract

LI Y, Zhang Y, Chen Y, Qiao Z, et al
SIRT3 mediates Tubeimoside I's inhibition on pulmonary artery smooth muscle cell proliferation and oxidative stress in pulmonary arterial hypertension.
Eur J Pharmacol. 2025 Jul 18:177938. doi: 10.1016/j.ejphar.2025.177938.
Abstract

PALLOS LK, Matthey M, Hesse M, Fleischmann BK, et al
A "second hit" mouse model for group 2 and 3 pulmonary hypertension: Combination of aortic banding and hypoxia exposure.
Cardiovasc Res. 2025 Aug 26:cvaf147. doi: 10.1093.
Abstract

NOTO T, Ikeda N, Yamashita Y, Morimoto T, et al
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2.
Catheter Cardiovasc Interv. 2025 Aug 26. doi: 10.1002/ccd.70130.
Abstract

ZHAO P, Wang M, Liu Z, Zhang M, et al
Advances in biomimetic nano delivery systems for pulmonary hypertension therapy.
Acta Biomater. 2025 Aug 22:S1742-7061(25)00626.
Abstract

TALON A, Sista RR
Management of Patients with Pulmonary Hypertension: A Guide for Bedside Critical Care Nurses.
Crit Care Nurs Clin North Am. 2025;37:421-431.
Abstract

GRUBERT VAN IDERSTINE M, Kim S, Karur GR, Granton J, et al
Utility of machine learning for predicting severe chronic thromboembolic pulmonary hypertension based on CT metrics in a surgical cohort.
Eur Radiol. 2025 Aug 23. doi: 10.1007/s00330-025-11972.
Abstract

OHNO K, Suwa K, Akita K, Sato R, et al
Hemodynamics assessment using 4D flow CMR before and after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a retrospective observational study.
BMC Cardiovasc Disord. 2025;25:621.
Abstract

LANGENFELD TL, Sati M, Bocks ML, Agarwal AK, et al
Large Patent Ductus Arteriosus in an Adult With Severe Pulmonary Hypertension and Polycythemia: PDA With Severe Pulmonary Hypertension.
JACC Case Rep. 2025;30:104677.
Abstract

WIEWIORA M, Kukulski L, Nowowiejska-Wiewiora A, Kuczmik W, et al
Outcome predictors of general surgery procedures in patients with pulmonary hypertension.
Kardiol Pol. 2025 Aug 22. doi: 10.33963/v.phj.108235.
Abstract

HOLCIK S, Hawayi L, Dussah N, Barrowman N, et al
Risk Factors for Severe Respiratory Morbidity at 2 Years of Life in Children Born Extremely Preterm With Bronchopulmonary Dysplasia.
Pediatr Pulmonol. 2025;60:e71258.
Abstract

TAKANO R, Ueda J, Watanabe T, Tsukamoto Y, et al
Development of severe pre-capillary pulmonary hypertension 7 years after heart transplant.
JHLT Open. 2025;9:100274.
Abstract

KANNA S K, Thirthashree K, Bhuvaneswari V, Parinita S, et al
Platelet and Red Cell Indices: A Potential Biomarker for Predicting Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) Patients.
Cureus. 2025;17:e88401.
Abstract

WANG C, Chen M, Shi W, Xu Y, et al
Survival analysis of infants with bronchopulmonary dysplasia-associated pulmonary hypertension: a single-center study in China.
J Matern Fetal Neonatal Med. 2025;38:2546543.
Abstract

SIAGIAN SN, Panjaitan EH, Nugroho PP
Case Report: Non-reactive vasoreactivity testing in a patient with patent ductus arteriosus with pulmonary hypertension: is there still a way to turn things around?
Front Cardiovasc Med. 2025;12:1569963.
Abstract

WANG J, Zhang Y, Liu H, Liu L, et al
Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.
Int J Chron Obstruct Pulmon Dis. 2025;20:2869-2883.
Abstract

ELHAGE HASSAN M, Vinales J, Perkins S, Sandesara P, et al
Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.
Card Electrophysiol Clin. 2025;17:477-489.
Abstract

NASRI A, Bashir R, Lakhter V
Management of Complications of Balloon Pulmonary Angioplasty.
Card Electrophysiol Clin. 2025;17:461-471.
Abstract

SURESH MV, Aggarwal V, Raghavendran K
The Intersection of Pulmonary Vascular Disease and Hypoxia-Inducible Factors.
Card Electrophysiol Clin. 2025;17:429-438.
Abstract

JAIN N, Perkins S, Maligireddy AR, Rosenfield K, et al
Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.
Card Electrophysiol Clin. 2025;17:407-416.
Abstract

TANNU M, Krasuski RA
The Evolution of Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension.
Card Electrophysiol Clin. 2025;17:369-379.
Abstract

HOSOKAWA K, Yamasaki Y, Abe K
Technical Considerations for Performing Safe and Effective Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Card Electrophysiol Clin. 2025;17:355-368.
Abstract

ALENCAR AKN
Coronary Compression in Pulmonary Hypertension: A Treatable Threat Hidden in Plain Sight.
Arq Bras Cardiol. 2025;122:e20250352.
Abstract

JAVED R, Van Hasselt TJ, Rao N, Gowda H, et al
Persistent Pulmonary Hypertension Among Infants Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy: A Systematic Review and Meta-Analysis.
Ther Hypothermia Temp Manag. 2025 Aug 20. doi: 10.1177/21537658251370950.
Abstract

STAFLER P, Schamroth N, Elizur A, Prais D, et al
Left Main Bronchus Stenosis Leading to Bronchiectasis and Pulmonary Hypertension- Relieved by Stent Placement.
Pediatr Pulmonol. 2025;60:e71251.
Abstract

FIORENTU G, Bernardinello N, De Michieli L, Marra MP, et al
Pulmonary hypertension associated with sarcoidosis: current and future treatment landscape.
Future Cardiol. 2025 Aug 19:1-3. doi: 10.1080/14796678.2025.2549173.
Abstract

OKEKE CC, Ojo A, Okere MO, Ebiliekwe OE, et al
Pulmonary Hypertension Among Individuals Living With Hemoglobinopathies: A Systematic Review.
Cureus. 2025;17:e88234.
Abstract

HAYASHI K, Matsuo K, Aoki H
Successful treat-and-repair strategy in a 5 year old with partial anomalous pulmonary venous connection, atrial septal defect, and severe pulmonary hypertension.
Cardiol Young. 2025 Aug 19:1-3. doi: 10.1017/S1047951125101583.
Abstract

WANG X, Li C, Wang S, Zhu Z, et al
Utility of inhaled nitric oxide for pulmonary hypertension in cyanotic congenital heart disease: a cohort study with propensity score matching.
Med Gas Res. 2026;16:93-97.
Abstract

SONG Z, Ye T, Zhou Y, Yu F, et al
TRPV2 Inhibition Prevents Right Ventricular Remodeling and Arrhythmia in Experimental Pulmonary Hypertension.
FASEB J. 2025;39:e70949.
Abstract

GREGORY ELLIOTT C
FDA Approval of Epoprostenol to Treat Primary Pulmonary Hypertension.
Pulm Circ. 2025;15:e70149.
Abstract

MORTAZAVI MOGHADDAM SG, Nosrati F, Mahdizadeh F, Kazemi T, et al
Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients.
Pulm Circ. 2025;15:e70153.
Abstract

TORUN EG, Ozdemiroglu N, Cayhan V, Ece I, et al
Life-saving stepwise management of pulmonary hypertension in an infant with Down syndrome presenting with a large patent ductus arteriosus and giant hepatic arteriovenous malformation.
Cardiol Young. 2025 Aug 18:1-4. doi: 10.1017/S1047951125101662.
Abstract

SYED M, Humbert M, Kovacs G, Sahay S, et al
Overlapping pulmonary hypertension phenotypes in smokers: a call to action.
Lancet Respir Med. 2025 Aug 14:S2213-2600(25)00259.
Abstract

CAJAS LJ, Recalde Reyes J, Correa JA, Carvajal W, et al
Residence at high altitude as a risk factor for high probability of pulmonary hypertension in patients with systemic sclerosis: A case-control study.
Reumatol Clin (Engl Ed). 2025;21:501899.
Abstract

SHUAI J, He S, Wang Y, Zhen J, et al
Dysregulated tryptophan metabolism and gut microbiota in chronic hypoxia-induced pulmonary hypertension rats.
J Pharm Biomed Anal. 2025;266:117111.
Abstract

ABOFREKHA B, Shadi M, Jdaidani J, Rojas-Marte GR, et al
Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin.
JACC Case Rep. 2025;30:104827.
Abstract

RATRI AK, Saputri ON, Nugraha D, Nugraha RA, et al
Echocardiographic correlation of right ventricular-Pulmonary artery coupling to exercise tolerance in congenital heart disease-associated pulmonary hypertension.
Ann Pediatr Cardiol. 2025;18:26-32.
Abstract

NOH M, Mitra A, Krebes L, Schmitz W, et al
C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension.
Commun Biol. 2025;8:1199.
Abstract

CAI Z, Tu L, Tian S, Deng L, et al
IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2025;14:e040896.
Abstract

YE H, Zhang Y, Hu L, Feng Y, et al
Novel and Highly Potent Therapeutic Agent, Trametes Robiniophila Murr (Huaier), Mitigates Pulmonary Vascular Remodeling in Rodents.
J Am Heart Assoc. 2025;14:e041405.
Abstract

LIU B, Zhaxi Q, Danzeng Z, Ci B, et al
Elevated cytokine levels in patients with High-altitude pulmonary edema.
Cytokine. 2025;194:157005.
Abstract

CHEN P, Han Z, Ma Q
Molecular mechanisms and therapeutic developments of BMPR2 in pulmonary arterial hypertension.
Respir Investig. 2025;63:934-941.
Abstract

NICOLEAU S, Valle YR, Tura-Ceide O, Armour CH, et al
3D modelling of pulmonary arterial stenosis and endothelial dysfunction in CTEPH.
Lab Chip. 2025;25:4369-4384.
Abstract

CHEN Y, Zhang Q, Chen X, Xu Y, et al
Long noncoding RNA FGD5-AS1-encoded micropeptides improve right heart functions of pulmonary arterial hypertension through restricting the synthesis of hyaluronic acid.
Int J Biol Macromol. 2025;320.
Abstract

LOPEZ-VELAZQUEZ R, Lopez-Moran S, Ramirez-Rivera A, Rubio-Infante N, et al
Metabolic changes of peripheral blood mononuclear cells are related to the high cytokine levels in patients with pulmonary arterial hypertension.
Life Sci. 2025;378:123852.
Abstract

GOMAA DA, El-Haggar SM, El-Shanshory MR, El-Razaky O, et al
Clinical Study to Evaluate the Possible Efficacy and Safety of L-Arginine in Children with Sickle Cell Disease and Increased Tricuspid Regurgitant Jet Velocity: a Randomized Controlled Trial.
Paediatr Drugs. 2025;27:605-618.
Abstract

KUCHERENKO MM, Kukucka M, Sang P, Hegemann N, et al
Identification of pulmonary artery stiffening due to left heart disease by ultrasonography.
Cardiovasc Res. 2025;121:1433-1447.
Abstract

WESTHOFF M, Hardebusch T, Breithecker A, Steudel B, et al
Klippel-Trenaunay Syndrome with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
Pneumologie. 2025 Aug 29. doi: 10.1055/a-2681-5486.
Abstract

CHEN L, Zhou S, Wang J, Hu S, et al
Analysis of Clinical Characteristics of 54 Dead Pregnant Patients With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70123.
Abstract

RICCHI B, Jagana V, Singh E, Ochoa MT, et al
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.
Ther Adv Respir Dis. 2025;19:17534666251367312.
Abstract

SANTI M, Madonna R
Unbiased serum proteomics in heart failure and associated pulmonary hypertension: From biomarkers discovery to precision medicine.
Eur J Clin Invest. 2025 Aug 29:e70115. doi: 10.1111/eci.70115.
Abstract

GUO G, Zhu MX, Xu X, Li X, et al
PHPT1 acts as an inhibitor in high-altitude pulmonary hypertension via negative TRPV5 signaling regulation.
J Transl Med. 2025;23:968.
Abstract

SANTOS RT, Braga CL, de Sa Freire Onofre ME, da Silva CM, et al
Cardioprotective effects of extracellular vesicles from hypoxia-preconditioned mesenchymal stromal cells in experimental pulmonary arterial hypertension.
Stem Cell Res Ther. 2025;16:466.
Abstract

ZONENBERG A, Ptaszynska K, Szwedowicz A, Sawicka-Smiarowska E, et al
Linking cardiological parameters and choroidal changes in patients with precapillary pulmonary hypertension: a cross-sectional study.
Sci Rep. 2025;15:31693.
Abstract

AHMED S, Liu E, Eberhard B, Villela-Franyutti D, et al
The Obstetric Comorbidity Index (OB-CMI) and its association with ICU admission and length of hospital stay in pregnant patients with pulmonary hypertension: a retrospective cohort study (1996-2025).
Int J Obstet Anesth. 2025;64:104751.
Abstract

HAN W, Ban Q, Zhai D, Zhai Y, et al
Late Gadolinium Enhancement on Cardiac MRI and the Prognosis of Patients With Pulmonary Hypertension: A Meta-Analysis.
Echocardiography. 2025;42:e70278.
Abstract

KOLODZEY G, Peter A, Darago A, Balogh L, et al
Assessment of Right Ventricular Pressure in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Diagnostic Modalities and Balloon Pulmonary Angioplasty Outcomes.
Diagnostics (Basel). 2025;15:2050.
Abstract

FUMINI V, Bonora R, Busciglio A, Cartisano F, et al
Prenatal Rare 16q24.1 Deletion Between Genomics and Epigenetics: A Review.
Genes (Basel). 2025;16:873.
Abstract

STURZENEGGER N, Schneider SR, Furian M, Titz A, et al
The Effect of Eccentric Cycling on Cerebral and Muscle Tissue Oxygenation in Patients with Pulmonary Hypertension and Healthy Individuals: A Randomized Controlled Crossover Trial.
J Clin Med. 2025;14:5751.
Abstract

OLIVEROS E, Jonnalagadda A, Pietrowicz R, Mauri M, et al
Echo-Doppler Predictors of Residual Pulmonary Hypertension After Pulmonary Thromboendarterectomy.
J Clin Med. 2025;14:5705.
Abstract

JIANG X, Fei L, Yang Y, Han J, et al
Effects of Dietary Terpinen-4-ol on Oxidative Stress and Mitochondrial Biogenesis in the Liver of Broilers with Pulmonary Hypertension Syndrome.
Int J Mol Sci. 2025;26:7702.
Abstract

FANG J, Chen H, Jia Z, Dai J, et al
miRNAs in Pulmonary Hypertension: Mechanistic Insights and Therapeutic Potential.
Biomedicines. 2025;13:1910.
Abstract

SIDDA N, Bhat R, Tirlangi P, Pulagam VR, et al
Unmasking pulmonary veno-occlusive disease after vasodilator therapy in limited cutaneous systemic sclerosis.
BMJ Case Rep. 2025;18:e266231.
Abstract

SHI JZ, Zhu YJ, Zhang MJ, Yan Y, et al
Hypoxanthine Promotes Pulmonary Vascular Remodeling and Adenosine Deaminase Is a Therapeutic Target for Pulmonary Hypertension.
JACC Basic Transl Sci. 2025;10:101273.
Abstract

SCHAFER K
Increased Generation of Hypoxanthine: How Adaptation of Purine Metabolism Drives Vascular Remodeling in Pulmonary Hypertension.
JACC Basic Transl Sci. 2025;10:101320.
Abstract

CAO Y, Koide M, Goto M, Maeda T, et al
"Treat and repair" strategy for a giant pulmonary artery aneurysm caused by idiopathic pulmonary hypertension and compression of the left main coronary artery.
Indian J Thorac Cardiovasc Surg. 2025;41:1212-1217.
Abstract

WANG Z, Fu H, Li S
Revived role of reverse Potts shunt in management of paediatric severe pulmonary hypertension.
Cardiol Young. 2025 Aug 27:1-10. doi: 10.1017/S1047951125101352.
Abstract

KUSAKA K, Kubo S, Nakayamada S, Miyagawa I, et al
Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study.
Arthritis Res Ther. 2025;27:169.
Abstract

AKCA B, Erdil N
New-Onset Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Is Pulmonary Hypertension a Risk Factor?
Braz J Cardiovasc Surg. 2025;40:e20240352.
Abstract

CHENG CC, Hsu LF, Chung HH, Lee CW, et al
IPSC-Derived Conditioned Medium Reduces Oxidative Stress and Vascular Remodeling in Rat Models of Pulmonary Arterial Hypertension.
J Cell Physiol. 2025;240:e70085.
Abstract

JORNA LM, Nakladal D, van Heuveln JN, van der Feen DE, et al
SUL-150 Limits Vascular Remodeling and Ventricular Failure in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2025;26:7181.
Abstract

VANDENBROEK MM, Sharp MC, Thompson P, Fagbola E, et al
Circular RNA Profiling Identifies circ5078 as a BMPR2-Derived Regulator of Endothelial Proliferation and Stress Responses.
Arterioscler Thromb Vasc Biol. 2025;45:1546-1561.
Abstract

HUI M, Deng X, Wang J, Qian J, et al
The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
Clin Rheumatol. 2025;44:3581-3590.
Abstract

SALURSO E, Fiore GB, Vismara R
Ex Vivo Assessment of Transcatheter Edge-to-Edge Treatment Performance After Pathology Recurrence in Functional Tricuspid Regurgitation.
Ann Biomed Eng. 2025;53:2178-2191.
Abstract

LAWAL OS, Niihori M, James J, Hinkle AJ, et al
The Critical Role of HMGB1Cys106 in Regulating Sex-Specific p53 Signaling in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2025;73:396-414.
Abstract

GE RL
Medical Problems of Chronic Hypoxia in Highlanders Living on the Tibetan Plateau.
High Alt Med Biol. 2025;26:308-317.
Abstract

GENTLE SJ, Carlo WA, Ambalavanan N
Screening for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia: when, how often and does it matter?
Arch Dis Child Fetal Neonatal Ed. 2025 Sep 5:fetalneonatal-2024-328405.
Abstract

TAKANO R, Tatsuo A, Fujisaki S, Akao M, et al
Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
Open Heart. 2025;12:e003532.
Abstract

ABEN R, Burton T, Fathieh F, Nemati N, et al
Facilitating Earlier Diagnosis of Pulmonary Hypertension Using a Novel Noninvasive Diagnostic.
JACC Case Rep. 2025;30:104876.
Abstract

GARCIA-GOZALO M, Pellicer A, Bravo MC
Current Practices for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain.
Pediatr Pulmonol. 2025;60:e71259.
Abstract

ABDULAAL LL, Sharkey MMJ, Maiter AA, Alabed SS, et al
CT scoring system to Defined Thrombus Distribution in Chronic Thromboembolic Pulmonary Hypertension.
Br J Radiol. 2025 Sep 5:tqaf221. doi: 10.1093.
Abstract

ZICANS M, Sablinskis K, Cesnieks H, Rudzitis A, et al
Chronic Thromboembolic Pulmonary Hypertension in Latvia: Epidemiological Insights and Diagnostic Challenges From 2024.
Pulm Circ. 2025;15:e70159.
Abstract

HUMPL T, Berger RMF, Bonnet D, Beghetti M, et al
How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension).
Pulm Circ. 2025;15:e70146.
Abstract

TOUIL A, Bouden S, Maazaoui S, Rouached L, et al
Rituximab treatment for connective tissue diseases associated-pulmonary hypertension: a systematic literature review.
Expert Rev Respir Med. 2025 Sep 4. doi: 10.1080/17476348.2025.2557634.
Abstract

NICCUM M, Avitabile CM, Albizem D, Meluskey H, et al
Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model.
Pulm Circ. 2025;15:e70156.
Abstract

GOPALAKRISHNA H, Nguyen ML, Mironova M, Viana Rodriguez GM, et al
Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension.
World J Gastroenterol. 2025;31:109256.
Abstract

CASTILLO-TELLO C, Barron-Magdaleno C, Orihuela-Sandoval C, Gutierrez-Leon E, et al
Parkes Weber syndrome, a rare case of pulmonary hypertension: a case report.
Eur Heart J Case Rep. 2025;9:ytaf381.
Abstract

ZHENG R, Tan J, Cao X, Wang S, et al
Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension.
J Mol Med (Berl). 2025 Sep 3. doi: 10.1007/s00109-025-02589.
Abstract

YAMAMURA A
Growth factors involved in vascular remodeling in pulmonary arterial hypertension.
J Smooth Muscle Res. 2025;61:82-92.
Abstract

ETO M, Yamazawa T, Kurahara LH, Yamamura A, et al
Expanding diverse horizons in smooth muscle research: a symposium review of "Muscle and Pathology/Health: Frontiers of Translational Research" at the 66th Annual Meeting of Japan Society of Smooth Muscle Research.
J Smooth Muscle Res. 2025;61:59-64.
Abstract

DAGHER C, Akiki M, Clark M, Parikh R, et al
Neuropsychiatric reaction to treprostinil in pulmonary hypertension leading to treatment discontinuation.
BMJ Case Rep. 2025;18:e266704.
Abstract

RIBEIRO IC, Sieczkowska SM, Jashchenko R, Jara D, et al
Effectiveness and safety of home-based versus centre-based exercise programmes for pulmonary hypertension: a systematic review with meta-analysis.
Eur Respir Rev. 2025;34:250102.
Abstract

NA SW, Kim HY, Yoon JJ, Hong MH, et al
Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension.
Integr Med Res. 2025;14:101218.
Abstract

KRISHNAN S, Ramalingam V, Adigopula S, Gadeela N, et al
Prevalence of Pulmonary Hypertension in Patients With Pulmonary Langerhans Cell Histiocytosis: A Systematic Review and Meta-Analysis.
Cureus. 2025;17:e89111.
Abstract

POKIMA N, Gill S, Moradi R, Thida AM, et al
Pulmonary Hypertension in Sickle Cell Disease: A Case Series.
Cureus. 2025;17:e89012.
Abstract

HARDY L, D'Haenens A, Belmans A, Quarck R, et al
Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension.
Pulm Circ. 2025;15:e70136.
Abstract

LIU Y, Guo X, Liu P, Jia S, et al
Rehabilitation applications and progress in managing pulmonary hypertension.
Front Med (Lausanne). 2025;12:1659818.
Abstract

VERBELEN T, Fadel E, Wiedenroth CB, Jenkins DP, et al
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Technical challenges and controversies.
JHLT Open. 2025;10:100357.
Abstract

MA J, Li W, Xu S, Ren R, et al
Noninvasive assessment of pulmonary vascular resistance: a synergistic approach using computed tomography pulmonary angiography and echocardiography in pulmonary hypertension.
Quant Imaging Med Surg. 2025;15:8567-8578.
Abstract

FARANDZHA D, Gatzov P, Velchev V
Massive Right Atrium due to Severe Pulmonary Hypertension Mimicking Biatrial Enlargement on ECG.
Clin Case Rep. 2025;13:e70835.
Abstract

ABDALLAH N, Mohamoud A
Exploring the Relationship between Group 2 Pulmonary Hypertension and Complete Heart Block: A United States Population Based Study.
Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70134.
Abstract

FARAG MM, Ghazal HAE, Abdel-Mohsen AM, Rezk MA, et al
Nebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial.
Eur J Pediatr. 2025;184:586.
Abstract

SCHMERMUND BN, Rieth AJ, Rademann M, Borst PC, et al
Abnormal Left Atrial Strain by CMR is Associated with Left Heart Disease in Patients with Pulmonary Hypertension.
Circ Heart Fail. 2025 Aug 31. doi: 10.1161/CIRCHEARTFAILURE.125.013480.
Abstract

ABBAS MT, Farina JM, Mahmoud AK, Wraith RE, et al
Right ventricular strain enhances the REVEAL LITE score for predicting 1-Year mortality in pulmonary hypertension.
Int J Cardiovasc Imaging. 2025 Aug 30. doi: 10.1007/s10554-025-03506.
Abstract

DE CASTRO AL, Turck P, Tavares AMV, Gaspar CJ, et al
Evaluation of the use of the myocardial performance index as a parameter of cardiac function in two experimental models of heart disease: myocardial infarction and pulmonary hypertension.
Pflugers Arch. 2025 Aug 30. doi: 10.1007/s00424-025-03117.
Abstract

HUNGERFORD SL, Gulati G, Everett K, Kearney K, et al
Assessment of Ventriculo-Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis.
J Am Heart Assoc. 2025 Aug 29:e042831. doi: 10.1161/JAHA.125.042831.
Abstract

ARSHAD A, Melin M, Lund LH, Manouras A, et al
Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
Int J Cardiol. 2025;440:133729.
Abstract

EL-KERSH K, Zawadzki N, Watzker A, Zhang S, et al
A structured approach for identifying disease analogs for pulmonary arterial hypertension.
J Manag Care Spec Pharm. 2025;31:909-921.
Abstract

ALHARBI A, Biyari A, Basuwdan A, Alrodiman O, et al
Prognostic performance of the 3- and 4-strata ESC/ERS risk stratification models in Pulmonary Arterial Hypertension: A validation study in a Saudi Arabian cohort.
Respir Med. 2025;247:108257.
Abstract

LIU Z, Cui B, Ju H, Tan T, et al
Catestatin alleviates PASMC phenotypic switching-mediated pulmonary arterial remodeling in a rat model of MCT-induced pulmonary arterial hypertension by promoting endothelium-derived no synthesis.
Nitric Oxide. 2025;158:93-105.
Abstract

CONNELLY D, Delahanty J, Patel S, Ackerbauer KA, et al
Inhaled epoprostenol for management of acute respiratory failure and pulmonary vascular disease.
Pulm Pharmacol Ther. 2025;90:102374.
Abstract

RAVINDRAN JV, Chung T, Naoum C, Yiannikas J, et al
Prominent V waves in right heart catheterisation as a marker of left atrial stiffness in pulmonary hypertension.
Open Heart. 2025;12:e003399.
Abstract

BERGSTROM E, Pola K, Kjellstrom B, Toger J, et al
Increased contractility affects left ventricular kinetic energy in pulmonary hypertension.
Physiol Rep. 2025;13:e70563.
Abstract

ELATTAR S, Basha NR, Salem A, Abdulfattah AY, et al
Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives.
Cardiol Rev. 2025 Sep 12. doi: 10.1097/CRD.0000000000001036.
Abstract

WANG S, Yang P, Xi H, Yin X, et al
Case Report: Shared manifestation, distinct etiologies: severe pulmonary hypertension in both mother and neonate.
Front Pediatr. 2025;13:1612410.
Abstract

GU W, Li L, Ahmad A, Lv J, et al
A Machine Learning-Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients.
J Clin Hypertens (Greenwich). 2025;27:e70132.
Abstract

BRAND J, de Graaf W, Geiser T, Martinelli M, et al
Frailty in pulmonary hypertension: Establishing the frailty index and impact on survival.
Respir Med. 2025;248:108346.
Abstract

VAHDATPOUR C, Virk S, Ding H, Epstein S, et al
Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension.
Ann Am Thorac Soc. 2025 Sep 10. doi: 10.1513/AnnalsATS.202502.
Abstract

LELKOVA K, Hadova K, Katanova M, Babiakova J, et al
Pleural Effusion Formation Linked to Altered Transporter Expression Involved in Alveolar Fluid Clearance: Insights From the Monocrotaline Model of Pulmonary Hypertension.
Basic Clin Pharmacol Toxicol. 2025;137:e70096.
Abstract

CHIOU FR, Sung SH, Chiu JH, Guo CY, et al
Cardiac magnetic resonance parameters for prognostic stratification in pulmonary hypertension: A longitudinal study.
J Chin Med Assoc. 2025 Sep 10. doi: 10.1097/JCMA.0000000000001292.
Abstract

CAO JJL, Reddy YNV
Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.
Heart Fail Rev. 2025 Sep 9. doi: 10.1007/s10741-025-10553.
Abstract

LIN H, Sun F, Wang L, Gong SG, et al
[Anti-EJ antibody positive antisynthetase syndrome with pulmonary hypertention:a case report].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:853-855.
Abstract

BIRSIN Z, Salihoglu A, Tokdil KO, Pirdal BZ, et al
Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.
Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06583.
Abstract

HUDEC M, Januska J, Jiravsky O, Miklik R, et al
Impact of pulmonary hypertension dynamics and residual mitral regurgitation shortly after M-TEER on long-term outcomes: insights from a prospective registry.
Clin Res Cardiol. 2025 Sep 8. doi: 10.1007/s00392-025-02747.
Abstract

ERTAN HARPUTLU O, Kuran Aslan G, Akinci B, Bilge AK, et al
Investigation of different field tests in relation to balance, daily living activities, and quality of life in pulmonary hypertension.
Monaldi Arch Chest Dis. 2025 Sep 8. doi: 10.4081/monaldi.2025.3308.
Abstract

MAJMUNDAR M, Patel KN, Khawaja T, Doshi R, et al
Impact of mode of delivery on maternal and fetal outcomes in pregnant patients with heart failure or pulmonary hypertension.
Am J Prev Cardiol. 2025;23:101263.
Abstract

ZHANG X, Peng M, Ren R, Li W, et al
Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review.
Front Med (Lausanne). 2025;12:1604853.
Abstract

GONG X, Min F, Guo J, Zhang Z, et al
Mechanism of Tetrandrine in Ameliorating Hypoxic Pulmonary Hypertension Vascular Remodeling through Transcriptomics and Metabolomics.
Curr Drug Metab. 2025 Sep 3. doi: 10.2174/0113892002393801250812063417.
Abstract

DENG F, Sun J, Liu L, Zhang M, et al
The Predictive Value of Monocyte-to-HDL Cholesterol Ratio in Patients with Dilated Cardiomyopathy and Associated Pulmonary Hypertension.
Cardiovasc Hematol Agents Med Chem. 2025.
Abstract

SYNN AJ, Nardelli P, Renapurkar R, Quesada L, et al
Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.
Eur J Radiol. 2025;192:112405.
Abstract

HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
Int J Cardiol. 2025;441:133816.
Abstract

ZHANG C, Song Z, Zhao Y, Guo X, et al
The underexplored pulmonary toxicity of pyrrolizidine alkaloids: Emerging hazard from food contamination.
Chem Biol Interact. 2025;420:111709.
Abstract

GIULIANI L, D'Alto M, Di Poi E, Dagna L, et al
Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study.
Vascul Pharmacol. 2025;160:107529.
Abstract

SANTOS IA, Graca IS, Placido R, Nogueira G, et al
Kartagener's syndrome with congenital heart defect-an old rare disease with a new rare face.
Cardiol Young. 2025;35:1734-1739.
Abstract

PENCHARZ D, Pliszka R, Peters AM
The effect of Tc-99m-macroaggregated albumin administration on pulmonary vascular resistance.
Nucl Med Commun. 2025;46:1013-1017.
Abstract

ABDULELAH M, Ezenna C, Jenil-Franco A, Jamouss KT, et al
Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials.
Vascul Pharmacol. 2025;160:107520.
Abstract

SHEELA C, Bairy S, P A A, Koolwal S, et al
Cross-sectional study of pulmonary hypertension among patients with chronic obstructive pulmonary disease.
Monaldi Arch Chest Dis. 2025 Sep 16. doi: 10.4081/monaldi.2025.3534.
Abstract

MAO H, Li CM, Sun B, Ward C, et al
Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells.
Arterioscler Thromb Vasc Biol. 2025 Sep 18. doi: 10.1161/ATVBAHA.124.322189.
Abstract

TAN EFS, Gharti SB, Tan DGS
A Rare Case of Chronic Thromboembolic Pulmonary Hypertension in an Elderly With Atrial Septal Defect and Eisenmenger Syndrome.
Cureus. 2025;17:e90281.
Abstract

BIRARDAR B, Valakkada J, Ayappan A, Karamakar D, et al
Left Ventricular Myocardial Perfusion before Contrast Pool in Ventricular Cavity in Cardiac MRI in Adult Type Anomalous Left Coronary Artery from Pulmonary Artery with Pulmonary Hypertension.
Indian J Radiol Imaging. 2025;35:599-602.
Abstract

YANG D, Li Q, Yang F, Wang R, et al
Machine learning-based integration develops an immune-derived signature for diagnosing high-altitude pulmonary hypertension.
Front Med (Lausanne). 2025;12:1603140.
Abstract

XU G, Zhang R, Huang W, Du X, et al
Comparative effectiveness of statins for chronic obstructive pulmonary disease patients with pulmonary hypertension: systematic review and network meta-analysis.
Front Med (Lausanne). 2025;12:1640270.
Abstract

LACOSTE-PALASSET T, Aguado B, Grynblat J, Coulet F, et al
SOX17 in pulmonary arterial hypertension: from development to clinical phenotype.
Eur Respir Rev. 2025;34:250081.
Abstract

LEMAY SE, Kuwabara Y, Bonnet S, Potus F, et al
Cellular senescence in adult pulmonary hypertension: current state and future challenges.
Eur Respir Rev. 2025;34:250030.
Abstract

TANKERE P, Lajeune E, Mariet AS, Cottenet J, et al
Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.
ERJ Open Res. 2025;11:01387-2024.
Abstract

SUZUKI T, Iwahashi N, Abe T, Komura N, et al
Clinical Usefulness of Passive Leg Lifting During Right Heart Catheterization for Diagnosing Exercise-Induced Pulmonary Hypertension?- A Pilot Study.
Circ J. 2025 Sep 13. doi: 10.1253/circj.CJ-25-0515.
Abstract

ADACHI S, Nakano Y, Hirose M
Ray of Hope for Expanding Hemodynamics Estimation During Exercise Stress Testing in Patients With Pulmonary Hypertension.
Circ J. 2025 Sep 17. doi: 10.1253/circj.CJ-25-0660.
Abstract

CHEN MY, Wu CH, Cheng SM, Chen TY, et al
Effects of Web-Based Symptom Monitoring Program on Symptom Interference, Physical Activity, and Emergency Department Readmissions in Patients With Pre-Capillary Pulmonary Hypertension: Randomized Controlled Trial.
J Med Internet Res. 2025;27:e76883.
Abstract

WANG X, Tang Z, Wang Z
Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021.
Pediatr Pulmonol. 2025;60:e71277.
Abstract

AL-BADR MA, Abunada HH, Gill R, Fayed HS, et al
Bosentan Delivery via Nano Metal-Organic Framework nanoMIL-89 Restores Vascular Homeostasis in Pulmonary Arterial Hypertension.
Int J Nanomedicine. 2025;20:11045-11060.
Abstract

MA SS, Xing YJ, Zhang JW, Wang J, et al
[Research progress on the mechanism of T lymphocyte in pulmonary arterial hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:1089-1094.
Abstract

DERENZO M
Pulmonary thrombectomy and extracorporeal membrane oxygenation: a case study.
J Extra Corpor Technol. 2025;57:171-173.
Abstract

KACHHWAHA A, Karagyozyan DS, Aluzri N, Vandse R, et al
Perioperative Management of a Pregnant Patient With Severe Mitral Stenosis and Pulmonary Hypertension for Repeat Cesarean Section: The Role of Standby Extracorporeal Membrane Oxygenation.
Cureus. 2025;17:e89986.
Abstract

ALRAHIMI JS, Ismail Y, Balubaid H, AlZahrani A, et al
Echocardiographic Insights into Group 2 Pulmonary Hypertension: Unveiling its Prevalence in Advanced Heart Failure Reduced Ejection Fraction.
J Cardiovasc Echogr. 2025;35:142-148.
Abstract

ZHONG Y, Yang P, Troncone L, Kovalenko OV, et al
BMP9 regulates the endothelial secretome to drive pulmonary hypertension.
bioRxiv [Preprint]. 2025 Sep 11:2025.08.29.673113.
Abstract

DE LA CRUZ PM, Lockett A, Gomes MT, Banerjee S, et al
Pulmonary Hypertension Promotes Neuroinflammation and Neurodegeneration.
bioRxiv [Preprint]. 2025 Sep 8:2025.09.02.673803. doi: 10.1101/2025.09.02.673803
Abstract

WIEGAND JL, Thompson JA, Landeck BF, Fierstein JL, et al
Pulmonary Hypertension Outcomes After Closure of Atrial Septal Defect in Infants With Developmental Lung Disease.
Pulm Circ. 2025;15:e70164.
Abstract

VARGHESE NP, Ely E, Fombin R, Champion C, et al
Use of Dupilumab to Treat Cutaneous Complications of Continuous Prostacyclin Infusion in Pulmonary Hypertension: A Case Report and Review of Literature.
Pulm Circ. 2025;15:e70158.
Abstract

NIEMIEC M, Grabka M, Niemiec R, Filipecki A, et al
The impact of angiotensin receptor-neprilysin inhibitor on clinical status and hemodynamic parameters in patients with pulmonary hypertension due to heart failure with preserved left ventricular ejection fraction: a case series analysis.
Pol Arch Intern Med. 2025 Sep 15:17120. doi: 10.20452/pamw.17120.
Abstract

ZHU T, Xiao X, Li X, Liu Z, et al
Eupatilin alleviates right ventricular fibrosis in rats with pulmonary hypertension induced by monocrotaline.
Korean J Physiol Pharmacol. 2025 Sep 15. doi: 10.4196.
Abstract

SANDRIO S, Krebs J, Spanier T, Beck G, et al
Extracorporeal Life Support in a Porcine Model of Septic Endotoxemia with Acute Pulmonary Hypertension: An Experimental Study.
J Clin Med. 2025;14:6342.
Abstract

IANCU DG, Cristescu L, Mares RG, Varga A, et al
Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Diagnostics (Basel). 2025;15:2126.
Abstract

JUMAAR C, Pretorius A, Malefane L, Jacobs S, et al
In vitro models and approaches to study underlying pathways of pulmonary arterial hypertension: a review.
Biochem Biophys Res Commun. 2025;781:152503.
Abstract

CONDE-CAMACHO R, Tuta-Quintero E, Varon-Vega F, Mugnier J, et al
Association of hemodynamic and functional variables with pulmonary vasculopathy in lung transplant recipients living at high altitude: A retrospective study.
Sci Prog. 2025;108:368504251367283.
Abstract

BABU V, Little JA, Morris CR, Machado R, et al
Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity.
Proteomics Clin Appl. 2025;19:e70019.
Abstract

TUHY T, Coursen JC, Graves T, Patatanian M, et al
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension.
Circ Genom Precis Med. 2025 Jul 21:e004936. doi: 10.1161/CIRCGEN.124.004936.
Abstract

WU YS, Malik A, Wang C, Welch C, et al
Initial Survival and Short-term Pulmonary Comorbidities in Infants with Congenital Diaphragmatic Hernia of Differing Indices of Social Determinants of Health.
J Pediatr Surg. 2025 Jul 12:162460. doi: 10.1016/j.jpedsurg.2025.162460.
Abstract

SESCLEIFER AM, Chidiac C, Hellmann ZJ, McDermott KM, et al
REVISITING INHALED NITRIC OXIDE UTILIZATION IN CONGENITAL DIAPHRAGMATIC HERNIA: A NATIONAL COHORT STUDY OF MAJOR CHILDREN'S HOSPITALS IN THE UNITED STATES.
J Pediatr Surg. 2025 Jun 23:162423. doi: 10.1016/j.jpedsurg.2025.162423.
Abstract

HUNGERFORD SL, Everett K, Lau E, Burkhoff D, et al
Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.
Circ Heart Fail. 2025 Jun 2:e012611. doi: 10.1161/CIRCHEARTFAILURE.124.012611.
Abstract

KIM Y, Yeo Y, Kim M, Son YW, et al
A highly mobile adeno-associated virus targeting vascular smooth muscle cells for the treatment of pulmonary arterial hypertension.
Nat Biomed Eng. 2025;9:1418-1436.
Abstract

LE PAPE A, Guignabert C, Tu L, Mougenot N, et al
Altered Ventilation in Rats With Established Severe Monocrotaline-Induced Pulmonary Hypertension: The Role of the Dorsal Hypothalamus.
Compr Physiol. 2025;15:e70055.
Abstract

SHIRAHATA T, Nardelli P, Jesudasen S, San Jose Estepar R, et al
Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures.
ERJ Open Res. 2025;11:01057-2024.
Abstract

MCLEAN D, Rommel J, Steuter JA, Carroll WS, et al
Clinical validation of a machine-learned, point-of-care system to IDENTIFY pulmonary hypertension.
ERJ Open Res. 2025;11:01287-2024.
Abstract

HEKIMOGLU K, Gopalan D, Onur MR, Kahraman G, et al
Imaging in chronic thromboembolic pulmonary hypertension: review of the current literature.
Diagn Interv Radiol. 2025 Sep 23. doi: 10.4274/dir.2025.253249.
Abstract

CHIDA-NAGAI A, Terashita Y, Hirabayashi S, Yamazawa H, et al
Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors.
Pulm Circ. 2025;15:e70165.
Abstract

QIN Y, Sha Z, Qiao Y, Yan G, et al
Phospholysine phosphohistidine inorganic pyrophosphate phosphatase Suppresses Glycolysis and Proliferation of Pulmonary Artery Smooth Muscle Cells in Hypoxic Pulmonary Hypertension via Inhibition of lactate dehydrogenase A.
Eur J Pharmacol. 2025 Sep 20:178172. doi: 10.1016/j.ejphar.2025.178172.
Abstract

VAN HEERDEN J, Mbanze I, Louw E, Aremu O, et al
Technical Challenges in Studying Infectious Disease-Associated Pulmonary Hypertension in Low- and Middle-Income Countries with Limited Resources.
Infect Dis Rep. 2025;17:109.
Abstract

WANG X, Deng T, Zhu H, Peng J, et al
Chinese Herbal Medicine in Hypoxic Pulmonary Hypertension Treatment: Mechanisms, Progress, and Future Directions.
Drug Des Devel Ther. 2025;19:8265-8294.
Abstract

WARSAME R, Ofuya R, Thillai RS, Gollapinni U, et al
An Unusual Cause of Severe Pulmonary Hypertension: Compression of Pulmonary Arteries by Aortic Aneurysm and Thrombus Formation.
Cureus. 2025;17:e90653.
Abstract

DAR MM, Nagla I, Kishk R
Echocardiography-Unmasked Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS): A Fatal Case of Biventricular Failure.
Cureus. 2025;17:e90366.
Abstract

YE Y, Yin D, Wang Y, Lin J, et al
Acidosis and in-hospital mortality in patients with pulmonary hypertension: a retrospective cohort study based on the MIMIC-IV database.
Front Med (Lausanne). 2025;12:1654432.
Abstract

ALQARNI AA, Alghamdi SA, Aldhahir AM, Alqahtani JS, et al
Drugs targeting the NO-sGC-cGMP pathway in the treatment of patients with COPD-associated pulmonary hypertension: a systematic review.
Front Pharmacol. 2025;16:1641932.
Abstract

CAI C, Choy JS, He G, Widlansky ME, et al
Effects of pulmonary hypertension on right ventricular mechanics and coronary perfusion: Insights from computational simulations.
Comput Biol Med. 2025;197.
Abstract

LOUREIRO CMC, Ferreira EVM, Oliveira RKF, Cordeiro AAAC, et al
Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension.
Respir Physiol Neurobiol. 2025 Sep 18:104490. doi: 10.1016/j.resp.2025.104490.
Abstract

XU Y, Yan X, Feng T, Liu Y, et al
Network toxicology and molecular docking to investigate the association of perfluorooctane sulfonate and pulmonary arterial hypertension via adverse outcome pathways.
Ecotoxicol Environ Saf. 2025;303:119007.
Abstract

MANCA P, Nuzzi V, Lucchino A, Rugiano G, et al
Right ventricular global work efficiency: A reliable non-invasive estimate of right ventricular contractility.
ESC Heart Fail. 2025;12:3719-3730.
Abstract

SUN N, Wang YB, Huang J, Deng RW, et al
Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin-Mediated Regulation of ENO1.
Adv Sci (Weinh). 2025;12:e00096.
Abstract

CHANG SA
Pulmonary Hypertension Redefined: From Historical Thresholds to Prognostic Relevance.
Korean Circ J. 2025 Aug 13. doi: 10.4070/kcj.2025.0231.
Abstract

RAFALOWICZ A, Mierzejewski J, Czuba L, Lisowska A, et al
Intensification of diuretic therapy in pulmonary hypertension - a retrospective evaluation of hemodynamic and functional changes.
Adv Med Sci. 2025 Oct 1:S1896-1126(25)00041-0. doi: 10.1016/j.advms.2025.
Abstract

SHENG Y, Min F, Wang Y, Zhang X, et al
Crocin inhibits neutrophil migration and activation to treat hypoxic pulmonary hypertension through targeting HCK.
Phytomedicine. 2025;148:157334.
Abstract

ALESSANDRO MM, Luca R, Andrea Raffaele M, Fabrizio G, et al
Clinical outcomes of transcatheter edge-to-edge repair in patients with functional mitral regurgitation and pulmonary hypertension.
Eur J Clin Invest. 2025 Oct 3:e70130. doi: 10.1111/eci.70130.
Abstract

KHAN I, Ishaque G, Khan AA, Shafiq F, et al
Balloon Pulmonary Angioplasty Versus Riociguat in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Cardiol Rev. 2025 Oct 1. doi: 10.1097/CRD.0000000000001049.
Abstract

WANG X, Wang L, Yuan Y, Zhao X, et al
Neonatal early-onset sepsis caused by Streptococcus Gallolyticus subsp. Pasteurianus with severe pulmonary hypertension and leukemoid reaction: a case report.
BMC Pediatr. 2025;25:699.
Abstract

AY O, Gunes S, Erfidan E, Simsek A, et al
Neonatal pulmonary hypertension in the NICU: a 10-year single-center experience.
BMC Pediatr. 2025;25:724.
Abstract

ZHANG M, Chen X, Xu Y, Chen Y, et al
Efficacy and safety of treprostinil in pediatric pulmonary hypertension following fontan surgery: a real-world analysis.
BMC Pediatr. 2025;25:739.
Abstract

CAHYONO A, Irwanto, Rahman MA, Widjiati W, et al
Effects of sildenafil and metformin on endothelin-1 in the progression of pulmonary hypertension.
Open Vet J. 2025;15:3087-3096.
Abstract

MECHA MH, Million L, Asefa ET
Navigating the clinical complexity of acute heart failure in an untreated adult with dextrotransposition of the great arteries (D-TGA) and multiple cardiac anomalies: a case report and review of literature.
J Med Case Rep. 2025;19:476.
Abstract

MAHOMED AS, Burke-Gaffney A, Moledina S, Toe QK, et al
SOX17-silenced HPAECs upregulate NF-kappaB-induced CXCL10 and CXCL11: implications for lymphocyte chemotaxis in SOX17-PAH.
Sci Rep. 2025;15:34262.
Abstract

SATO A, Sekine M, Kawasaki H, Kanai M, et al
Optimal Therapeutic Strategy for Ventricular Septal Defect Closure in Extremely Preterm Infants with Chronic Lung Disease and Severe Pulmonary Hypertension.
Int Heart J. 2025;66:914-919.
Abstract

OTSUKA M, Sonoda S, Yamada T, Aoki S, et al
Pulmonary Hypertension Associated with Severe Interstitial Pneumonia Successfully Treated with Inhaled Treprostinil: A Case Report.
Intern Med. 2025 Oct 2. doi: 10.2169/internalmedicine.6206.
Abstract

CAO Z, Xiao Q, Li X, Zhang H, et al
Postmarketing analysis of sotatercept: identifying serious unlabelled events.
Open Heart. 2025;12:e003636.
Abstract

JEFFERSON L, Lima PDA, Archer SL
Macrophage plasticity and glucose metabolism: the role of immunometabolism in pulmonary arterial hypertension.
Clin Sci (Lond). 2025;138:CS20257363.
Abstract

RUTLAND C, Hall CS, Kolaitis NA, Kulkarni T, et al
Pulmonary Hypertension Associated with Interstitial Lung Disease: Screening and Epidemiology.
ATS Sch. 2025 Oct 1. doi: 10.34197/ats-scholar.2024-0135.
Abstract

GELLER A, Martinez Manzano JM, Kosak Lopez E, Wattanachayakul P, et al
Association of Estimated Plasma Volume Status With Invasive Hemodynamics and Adverse Clinical Outcomes in Patients With Pulmonary Hypertension and Chronic Kidney Disease.
Pulm Circ. 2025;15:e70157.
Abstract

WRAY J, Quyam S, Clisby H, Kelly V, et al
Exploring Health-Related Quality of Life in Children With Pulmonary Hypertension.
Pulm Circ. 2025;15:e70161.
Abstract

JAMES J, Niihori M, Varghese MV, McClain N, et al
Mitochondrial dysfunction-induced hemolysis: a precursor to vascular leakage and pulmonary hypertension.
Blood Vessel Thromb Hemost. 2025;2:100097.
Abstract

LANG JE, Hill KD
Chronic Lung Disease-Related Pulmonary Hypertension in Children.
Acta Paediatr. 2025 Sep 30. doi: 10.1111/apa.70320.
Abstract

BEURNIER A, Lacoste-Palasset T, Jais X, Savale L, et al
Beyond the shunt: Divergent insights from hyperoxia testing and contrast echocardiography in adults with pulmonary hypertension.
Physiol Rep. 2025;13:e70594.
Abstract

LAPOINTE A, Kipfmueller F, Patel N, Altit G, et al
Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.
Neoreviews. 2025;26:e660-e678.
Abstract

HACKNER D, Lange D, Grafe C, Andrassy J, et al
[Neuraxial anesthesia procedures in the perioperative management of pulmonary hypertension : A literature review with two case reports].
Anaesthesiologie. 2025 Sep 30. doi: 10.1007/s00101-025-01595.
Abstract

ZHOU JJ, Qiao E, He ZY, Yang YC, et al
Fibulin 5 mediates pulmonary artery smooth muscle cell dysfunction and vascular remodelling in congenital heart disease associated pulmonary arterial hypertension via TGF-beta1/PI3K/AKT signalling.
Respir Res. 2025;26:276.
Abstract

YANG Z, Lu C, Dong Z, Ji S, et al
[Rosa laevigata Michx. inhibits pulmonary arterial smooth muscle cell proliferation in hypertension by modulating the Src-AKT1 axis].
Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1889-1902.
Abstract

HU L, Liu Z, Yu J, Yang Z, et al
The Correlation Between NLR, RDW, and Pulmonary Hypertension in Patients With Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome.
Clin Respir J. 2025;19:e70128.
Abstract

LONG Y, Li W, Bai Y, Zhou D, et al
Bradycardia-Associated Pulmonary Hypertension.
JACC Case Rep. 2025 Sep 29:105540. doi: 10.1016/j.jaccas.2025.105540.
Abstract

LU A, Elsea K, Olsen DA, VanderWielen BA, et al
Regional Anesthesia in a Cirrhotic Patient With Coagulopathy and Pulmonary Hypertension: A Case Report.
Cureus. 2025;17:e91035.
Abstract

BUDZIAK S, Kloza M, Krzyzewska A, Baranowska-Kuczko M, et al
Can Sirtuin 1 Serve as a Therapeutic Target in Pulmonary Arterial Hypertension? A Comprehensive Review.
Molecules. 2025;30:3740.
Abstract

ZHAO Z, Li G, Ohmichi K, Li X, et al
Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model.
Nutrients. 2025;17:2927.
Abstract

REMISZEWSKI P, Ryszkiewicz P, Baranowska-Kuczko M, Pedzinska-Betiuk A, et al
Initial Body Weight as an Important Factor for Improving the Reliability and Translational Relevance of the Preclinical Monocrotaline-Induced Rat Pulmonary Hypertension Model.
Int J Mol Sci. 2025;26:8916.
Abstract

MUDGAL M, Bhatnagar AR, Kumar Vasudevan A, Priya Gajendiran A, et al
The Impact of Pulmonary Hypertension on Hospitalization Risk in Adults with Respiratory Syncytial Virus Infection.
Biomedicines. 2025;13:2272.
Abstract

BORSI E, Potre C, Ionita I, Samfireag M, et al
Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review of Prevalence, Clinical Phenotype, and Surgical Outcomes.
Biomedicines. 2025;13:2215.
Abstract

JENSEN EA
Bronchopulmonary dysplasia, pulmonary hypertension, and neonatal gastroesophageal reflux: Association, causation, or neither?
Semin Perinatol. 2025 Sep 25:152158. doi: 10.1016/j.semperi.2025.152158.
Abstract

YU X, Sun Y, Fu L, Xu Z, et al
Reversed Potts Shunt and Venopulmonary Extracorporeal Membrane Oxygenation Support in Sustained Pulmonary Hypertension Crisis.
JACC Case Rep. 2025;30:105153.
Abstract

SALAKO O, Singh A
Right Ventricular Phenotyping Can Lead to Pulmonary Vascular Therapy Response in Those with Pulmonary Hypertension with COPD: A Single-Center Cohort Study.
J Cardiovasc Dev Dis. 2025;12:366.
Abstract

LIN K, Sarnari R, Gordon DZ, Markl M, et al
Cine MRI-Derived Radiomics for the Detection of Functional Tricuspid Regurgitation in Pulmonary Hypertension: A Proof-of-Concept Study.
J Cardiovasc Dev Dis. 2025;12:353.
Abstract

GARRY JD, Kundu S, Alcorn C, Eden S, et al
Glucagon-like Peptide 1 Receptor Agonists and Risk of Pulmonary Hypertension.
medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25336100.
Abstract

LACHANT D, Agarwal N, Norton K, Haight D, et al
Sensor Estimated Home 6-Minute Walk Distance and Cardiac Effort in Pulmonary Hypertension and Heart Failure.
medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25336075.
Abstract

QUYAM S, Baker A, Calder A, Moledina S, et al
Porto-Pulmonary Hypertension in Children: Insights From a National Registry.
Pulm Circ. 2025;15:e70133.
Abstract

THOMAS C, Chandel A, Zineddin M, Tang C, et al
The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantation.
BMC Pulm Med. 2025;25:428.
Abstract

ZHANG Y, Wu L, Dong L
Breviscapine attenuates pulmonary vascular dysfunction and inflammatory injury in a rat model of acute pulmonary embolism.
Pak J Pharm Sci. 2025;38:1889-1897.
Abstract

ULLRICH FTH, Thaler MB, Schulze-Koops H
Telangiectasias as a Forerunner of Pulmonary Hypertension.
Dtsch Arztebl Int. 2025;122:507.
Abstract

MA Q, Liu HL, Wang WW
Pulmonary hypertension causing uveal effusion syndrome: a case report.
Int J Ophthalmol. 2025;18:2007-2010.
Abstract

MICHEL H, Ozkan E, Chin-Cheong K, Badura A, et al
Automated detection of neonatal pulmonary hypertension in echocardiograms with a deep learning model.
Pediatr Res. 2025 Sep 24. doi: 10.1038/s41390-025-04404.
Abstract

NOPP S, Spielvogel C, Bikdeli B, Alberich-Conesa A, et al
A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.
Sci Rep. 2025;15:32744.
Abstract

ALIKHAN R, Howard LS, Johnson M, Sweeney S, et al
Practical guide to management after an acute pulmonary embolism.
BMJ Open Respir Res. 2025;12:e003028.
Abstract

JIANG H, Gao H, Wang D, Zeng Q, et al
Interpretable Machine Learning Model for Pulmonary Hypertension Risk Prediction: Retrospective Cohort Study.
JMIR Med Inform. 2025;13:e74117.
Abstract

BISHARA JA, Evers P
Pre-existing pulmonary arterial hypertension decompensation associated with e-cigarettes in an adolescent.
Cardiol Young. 2025;35:1959-1961.
Abstract

SITBON O, Sahay S, Escribano Subias P, Zolty RL, et al
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
Adv Ther. 2025;42:5104-5123.
Abstract

FATHI M, Zarrinkavyani K, Biranvand Z, Abd MAA, et al
Effect of phloretin on antioxidant status, inflammatory cytokines, blood and biochemical indices, cecal microbial load, and growth performance in broiler chickens subjected to pulmonary arterial hypertension.
Poult Sci. 2025;104:105265.
Abstract

MOLSTROM S, Beske RP, Grand J, Obling LER, et al
Effect of oxygen targets on pulmonary hemodynamics after out-of-hospital cardiac arrest - A sub-study of the BOX cardiac arrest trial.
Resuscitation. 2025;215:110680.
Abstract

VERMAUT A, Aerts G, Willems L, Geudens V, et al
Pulmonary arteriole narrowing in end-stage cystic fibrosis lungs occurs with and without small airway disease.
J Cyst Fibros. 2025;24:946-953.
Abstract

ATESLI YAZICI A, Memic Sancar K, Kahraman S, Bulut U, et al
Evaluation of the acute effects of inhaled iloprost on aortic compliance in pulmonary arterial hypertension using invasive methods.
Herz. 2025;50:385-394.
Abstract

CHIA KSW, Carland JE, Brown K, Kotlyar E, et al
"A new realization of what I'm able to do": exercise interventions can impact knowledge, confidence and daily activity for people with pulmonary arterial hypertension (PAH).
Disabil Rehabil. 2025 Feb 24:1-10. doi: 10.1080/09638288.2025.2469777.
Abstract

IWASA T, Inuzuka R, Ono H, Sugitani Y, et al
Safety and Efficacy of Selexipag for Pediatric Pulmonary Arterial Hypertension in Japanese Patients?- An Open-Label Phase 2 Study.
Circ J. 2025;89:1701-1708.
Abstract

SHAO C, Xia W, Liu Y
Bioinformatic Analysis and Molecular Docking Identify Isorhamnetin Is a Candidate Compound in the Treatment of Pulmonary Artery Hypertension.
Anatol J Cardiol. 2025;29:52-65.
Abstract

XUE X, Zhang M, Xiao Y, Guo W, et al
[Clinical application advances of exercise right heart catheterization in the diagnosis and prognosis evaluation of pulmonary vascular diseases].
Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:965-969.
Abstract

BLANCO I, Torres-Castro R, Piccari L, Garcia AR, et al
Effects of pulmonary arterial hypertension therapies on arterial oxygenation in patients with pulmonary hypertension associated with lung disease: a systematic review and meta-analysis.
BMJ Open Respir Res. 2025;12:e003086.
Abstract

DARDI F, Bertozzi R, Ballerini A, Cennerazzo F, et al
Phenotyping of patients with mild pulmonary hypertension.
Open Heart. 2025;12:e003591.
Abstract

INCI E, Ozuynuk-Ertugrul AS, Ekici B, Koseoglu-Buyukkaya P, et al
Evaluation of Gene and microRNA Expression Patterns in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension as Rare Diseases.
Respir Med. 2025 Oct 8:108415. doi: 10.1016/j.rmed.2025.108415.
Abstract

ZOU X, Cai A, Cheng Y, Li X, et al
An integrated study on the role and underlying mechanism of QingFei Oral solution in pulmonary hypertension.
Phytomedicine. 2025;148:157311.
Abstract

CHEMLA D, Beurnier A, Gerges C, Jais X, et al
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertension.
Respir Med Res. 2025;88:101204.
Abstract

KAUR J, Kaur G, Kaur C, Kumar S, et al
Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach.
J Food Drug Anal. 2025;33:213-223.
Abstract

ZAZZERON L, Shimoda K, Lichtenegger P, Moore E BS, et al
Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice.
J Am Heart Assoc. 2025 Oct 9:e042608. doi: 10.1161/JAHA.125.042608.
Abstract

YAMADA K, Yaoita N, Satoh T, Yamamoto S, et al
Long-Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Int J Rheum Dis. 2025;28:e70431.
Abstract

LAHM T
What I Learned From the Study of Sex Differences in Pulmonary Hypertension: How Following the Data and the Kindness of Strangers Helped Me Overcome Self-Doubt and Imposter Syndrome.
Pulm Circ. 2025;15:e70168.
Abstract

VENUGOPAL V, Karmakar S, Yadav RK, Wani AR, et al
An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.
Respirol Case Rep. 2025;13:e70372.
Abstract

CHEN D, Tian D, Jin Q, Zhang L, et al
The potential of non-invasive remote dielectric sensing in predicting short-term prognosis of patients with pulmonary hypertension.
BMC Pulm Med. 2025;25:460.
Abstract

ZHU F, Zhang Y, Liang G, Nan J, et al
Diagnosis of Pulmonary Hypertension by Integrating Multimodal Data with a Hybrid Graph Convolutional and Transformer Network.
J Imaging Inform Med. 2025 Oct 8. doi: 10.1007/s10278-025-01705.
Abstract

TORBIC H, Tonelli AR
Navigating Options for Inhaled Treprostinil Therapy in Pulmonary Hypertension.
Respir Med. 2025 Oct 6:108398. doi: 10.1016/j.rmed.2025.108398.
Abstract

SHIMIZU D, Miyoshi K, Yamamoto H, Tanaka S, et al
Survival and functional outcomes of single lung transplantation in secondary pulmonary hypertension.
Respir Investig. 2025;63:1235-1242.
Abstract

MONTANEZ-AGUIRRE AA, Flores-Guerra JM, Obregon-Rosas S, Aranda-Fraustro A, et al
Group 4 pulmonary hypertension due to choriocarcinoma after molar pregnancy: case report and review.
Arch Cardiol Mex. 2025 Oct 8. doi: 10.24875/ACM.25000142.
Abstract

SANTOS NZF, Amaral CCL, Oliveira MVM, Delgado MA, et al
Anesthetic Management of Elective Cesarean Delivery in a Pregnant Patient With Dilated Cardiomyopathy and Pulmonary Hypertension: A Multidisciplinary Approach.
AANA J. 2025;93:375-378.
Abstract

MICKAEL C, Kumar R, Fonseca Balladares DC, Nolan K, et al
Role of conventional dendritic cells in schistosomiasis-induced pulmonary hypertension.
Clin Sci (Lond). 2025 Oct 1:CS20256896. doi: 10.1042/CS20256896.
Abstract

IKEDA M, Yamasaki Y, Sagiyama K, Hosokawa K, et al
Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy.
Pulm Circ. 2025;15:e70170.
Abstract

HUNTGEBURTH M, Kaemmerer-Suleiman AS, Hager A, Lammers AE, et al
[Pulmonary Hypertension in Adults with Congenital Heart Disease (ACHD) - Novel Aspects from the 7th World Symposium on Pulmonary Hypertension 2024].
Pneumologie. 2025;79:831-842.
Abstract

APITZ C, Lammers AE, Hager A, Uebing A, et al
[Pulmonary Hypertension in Childhood - An Update from the World Symposium on Pulmonary Hypertension 2024].
Pneumologie. 2025;79:819-830.
Abstract

WIEDENROTH CB, Bikou O, von Bonin S, Halank M, et al
[Chronic Thromboembolic Pulmonary Hypertension].
Pneumologie. 2025;79:808-818.
Abstract

YOGESWARAN A, Skowasch D, Foris V, Wilkens F, et al
[Pulmonary Hypertension Associated with Lung Diseases].
Pneumologie. 2025;79:797-807.
Abstract

SCHMIDT KH, Adler J, Bikou O, Felgendreher R, et al
[Pulmonary Hypertension Associated with Left Heart Disease].
Pneumologie. 2025;79:787-796.
Abstract

GRUNIG E, Milger K, Omlor A, Florea A, et al
[Treatment Algorithm of Pulmonary Arterial Hypertension].
Pneumologie. 2025;79:775-786.
Abstract

LICHTBLAU M, Harutyunova S, Klose H, von Bonin S, et al
[General Measures and Management of PAH in Special Conditions].
Pneumologie. 2025;79:762-774.
Abstract

OLSCHEWSKI H, Barnikel M, Pittrow D, Schwaiblmair M, et al
[Risk Stratification and Treatment Goals for Pulmonary Arterial Hypertension].
Pneumologie. 2025;79:751-761.
Abstract

PFEUFFER-JOVIC E, Schmidt KH, John T, Kramer T, et al
[Emerging Multimodality Imaging Techniques for the Pulmonary Circulation].
Pneumologie. 2025;79:741-750.
Abstract

PFEUFFER-JOVIC E, Schmidt KH, John T, Kramer T, et al
[Diagnostic Algorithm for Pulmonary Hypertension].
Pneumologie. 2025;79:732-740.
Abstract

DOUSCHAN P, Kaemmerer-Suleiman AS, Egenlauf B, Seyfarth HJ, et al
[Definition and Classification of Pulmonary Hypertension].
Pneumologie. 2025;79:723-731.
Abstract

TELLO K, Kremer N, Rieth AJ, Bikou O, et al
[Pathophysiology of the Right Ventricle and its Pulmonary Vascular Interaction].
Pneumologie. 2025;79:712-722.
Abstract

EICHSTAEDT CA, Olschewski A, Harbaum L, Cordes S, et al
[Pathobiology and Genetics].
Pneumologie. 2025;79:701-711.
Abstract

GRUNIG E, Eichstaedt CA, Benjamin N
[Innovations in the Field of Pulmonary Hypertension - Critical Assessment of the Results of the 7th World Symposium on Pulmonary Hypertension].
Pneumologie. 2025;79:699-700.
Abstract

LIU BY, Hu EC, Xue L, Wu WC, et al
Electrical-mechanical dyssynchrony in pre-capillary pulmonary hypertension.
Herz. 2025 Oct 6. doi: 10.1007/s00059-025-05343.
Abstract

ZHANG Y, Zhang M, Li T, Liu Y, et al
Emodin Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Directly Targeting TAK1.
Drug Des Devel Ther. 2025;19:8843-8864.
Abstract

IGARASHI-SUGIMOTO A, Tsujino I, Shima H, Nakamura J, et al
Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.
Respir Med. 2025 Oct 3:108395. doi: 10.1016/j.rmed.2025.108395.
Abstract

SALIBE-FILHO W, Nascimento YPP, Tatagiba LS, Aiello VD, et al
Use of direct anticoagulants in chronic thromboembolic pulmonary hypertension: An anatomopathological study of endarterectomy material.
Int J Cardiol. 2025;443:133951.
Abstract

ISLAM T, Hooper J, Zhang X, Garcia C, et al
A soft-stiff patterned bioengineering model reveals kinase pathways driving directional cell migration in pulmonary arterial hypertension.
Biomater Sci. 2025;13:5671-5684.
Abstract

LIU J, Liu J, Qiao Y, Zhong H, et al
Rhodiola crenulata extract inhibits cell pyroptosis to ameliorate pulmonary vascular remodeling in rats through the regulation of decadienylcarnitine/NLRP3/GSDMD axis.
J Ethnopharmacol. 2026;354:120439.
Abstract

NAKAYAMA Y, Eguchi S
The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.
Hypertens Res. 2025;48:2522-2526.
Abstract

JUNQI G, Chaohui L, Fengyou Y, Wei C, et al
Pulmonary Artery Denervation for Idiopathic Pulmonary Arterial Hypertension: A Case Report.
Catheter Cardiovasc Interv. 2025;106:2218-2223.
Abstract

CARBONERA S, Scelsi L, Greco A, Schirinzi S, et al
Pulmonary Arterial Hypertension Onset in an Adult Woman With a TBX4 Likely Pathogenic Variant Following Imatinib Administration: A Case Report.
Am J Med Genet A. 2025;197:e64178.
Abstract

ANTIGNY F, Crottes D, Vandier C, Capuano V, et al
Pulmonary arterial hypertension and cancer: exploring their resemblance as channelopathies.
Trends Mol Med. 2025;31:936-954.
Abstract

HUANG H, Hu C, Zhang R, Xu H, et al
Global Burden of Pulmonary Arterial Hypertension and Associated Heart Failure: Global Burden of Disease 2021 Analysis.
JACC Heart Fail. 2025;13:102385.
Abstract

KARGIN T, Bulbuloglu S
The Role Competence of Cardiovascular and Respiratory Nurses Regarding Pulmonary Hypertension: A Cross-Sectional Study.
Pulm Circ. 2025;15:e70173.
Abstract

EBRAHIMI BS, Khwaounjoo P, Chan HF, Argus F, et al
Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
Pulm Circ. 2025;15:e70176.
Abstract

LI H, Wang Y, Zhang Y, Chen X, et al
Transthoracic Ultrasound with Microbubble Therapy Modulates Gut Microbiota and Protects Against Hypoxia-Induced Pulmonary Hypertension in Mice.
J Appl Microbiol. 2025 Oct 16:lxaf255. doi: 10.1093.
Abstract

CORREALE M, Mercurio V, Bevere EML, Pezzuto B, et al
Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target.
Int J Mol Sci. 2025;26:9631.
Abstract

MCGANN KC, Wang CC, Trahanas JM, Bommareddi S, et al
The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2025;14:6862.
Abstract

BRAILLON A, Patural P, Laville D, Perros F, et al
Uncommon Cause of Pulmonary Hypertension: Imaging Diagnosis of Cardiac Myxoma Embolism.
Diagnostics (Basel). 2025;15:2420.
Abstract

BENJAMIN N, Schiffer V, Grunig E
Reply to "Could Sex Differences Refine Risk Stratification in Pulmonary Hypertension?".
J Am Soc Echocardiogr. 2025 Oct 13:S0894-7317(25)00588.
Abstract

CHHABRIA MS, Manek G, Persaud PN, Ennala S, et al
Utility of Inhaled Nitric Oxide Vasoreactivity Challenge in Pulmonary Hypertension Associated with Interstitial Lung Disease.
Ann Am Thorac Soc. 2025 Oct 15. doi: 10.1513/AnnalsATS.202502.
Abstract

ALTURAIF N, Alduraibi FK
CTD-PAH: an updated practical approach to screening, diagnosis, and management.
Ther Adv Respir Dis. 2025;19:17534666251385674.
Abstract

LU Y, Zhang J, Lan T, He J, et al
Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021.
Medicine (Baltimore). 2025;104:e44933.
Abstract

LI Q, Yu H, Xiong C, Gu Q, et al
Pulmonary arterial compliance as a long-term prognostic indicator in pulmonary arterial hypertension associated with adult congenital heart disease: results from a National multicenter prospective registry.
BMC Cardiovasc Disord. 2025;25:739.
Abstract

LI J, Shen Y, Qiu X, Lin X, et al
Combined Inhibition of FABP4/5 Ameliorates Pulmonary Hypertension by Reducing Pulmonary Vascular and Right Ventricular Fibrosis.
Am J Respir Cell Mol Biol. 2025 Oct 14. doi: 10.1165/rcmb.2024-0352.
Abstract

SARI A, Temiz Karadag D, Erdogan M, Yayla ME, et al
Screening for Pulmonary Hypertension in Connective Tissue Diseases: Literature Review and Multidisciplinary Consensus Statement.
Anatol J Cardiol. 2025 Oct 14. doi: 10.14744/AnatolJCardiol.2025.5301.
Abstract

LIN L, Shen B, Cui J, Gao Y, et al
Enhancing Quercetin's Potential: A Nanoliposome Delivery System for High Altitude Pulmonary Edema.
Drug Des Devel Ther. 2025;19:9151-9167.
Abstract

LUO G, Liu H, Li Z, Ji Z, et al
A multimodal multipath AI system for assessing PAH after VSD correction on echocardiography and chest radiography images.
Sci Rep. 2025;15:35676.
Abstract

MIHAI A, Recchioni T, Manzi G, Vizza CD, et al
Could Sex Differences Refine Risk Stratification in Pulmonary Hypertension?
J Am Soc Echocardiogr. 2025 Oct 11:S0894-7317(25)00587.
Abstract

CAETANO MG, Silveira GF, Guillarducci VT, Delgado MA, et al
Use of Combination of Nitric Oxide and Sildenafil in the Management of Severe Pulmonary Hypertension in Mitral Valve Replacement: A Case Report.
Ann Card Anaesth. 2025;28:511-513.
Abstract

QIN D, Yang S, Lin L, Lin D, et al
Clinical research on echocardiographic screening for pulmonary hypertension: TRV >2.8 m/s and mPAP >20 mmHg.
Quant Imaging Med Surg. 2025;15:9792-9804.
Abstract

BATTILANA B, Mengers J, Lang G, Haberecker M, et al
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension after bilateral lung transplantation.
JHLT Open. 2025;10:100385.
Abstract

MA W, Ma Y, Bai Y, Guo C, et al
TGF-beta-Smad2/3 signaling in high-altitude pulmonary hypertension in rats: Role and mechanisms via macrophage M2 polarization.
Open Med (Wars). 2025;20:20251279.
Abstract

RIOU M, Canuet M, Hirschi S, Turquier S, et al
Acute hemodynamic response to inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease: a case highlighting unresolved questions.
Respir Med Res. 2025;88:101210.
Abstract

SUN L, Li H, Li Y, Li X, et al
Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension.
J Transl Med. 2025;23:1074.
Abstract

SEMENKOVA G, Adzerikho I, Vladimirskaja T, Amaegberi N, et al
Essential role of neutrophils in the monocrotaline-induced pulmonary arterial hypertension in rats.
Biochem Biophys Res Commun. 2025;785:152643.
Abstract

WANG X, Guo Q
Targeting Ferroptosis Alleviates Pulmonary Arterial Hypertension, Insights from Transcriptomic and Experimental Analyses.
Adv Biol (Weinh). 2025;9:e00001.
Abstract

SU T, Tang Y, Liu Z, Hou L, et al
Resistant Secondary Hypertension and Severe Pulmonary Hypertension in a Young Adult due to a Rare Cause.
Clin Case Rep. 2025;13:e71174.
Abstract

FAN E, Ma J, Zhang Y, Yang B, et al
Diagnosis model for assessing chronic thromboembolic pulmonary hypertension in high-altitude pulmonary embolism patients: a machine learning approach.
Front Med (Lausanne). 2025;12:1666574.
Abstract

COLIN-ORTIZ JL, Zuniga-Gordillo R, Perez-Perez LF, Balcazar-Ochoa C, et al
Successful percutaneous closure of ventricular septal defects associated with pulmonary hypertension using different atrial septal defect Occluders: A report of two cases.
J Cardiol Cases. 2025;32:171-174.
Abstract

DOYLE R, Wilkinson M
Isolated Pulmonary Regurgitation without Right Heart Remodeling or Pulmonary Hypertension.
Am J Case Rep. 2025;26:e949786.
Abstract

GUAN M, Yang X, Fu L, Zhao X, et al
Factors affecting patient outcomes in pulmonary artery thromboendarterectomy under deep hypothermic circulatory arrest and cardiopulmonary bypass support----a single center's experience.
BMC Cardiovasc Disord. 2025;25:760.
Abstract

WEN W, Gong YQ, Liu H, Su ZC, et al
Adipose Mesenchymal Stem Cells Overexpressing Chemokine (CXCL6) Showed Strong Angiogenesis and Anti-Inflammatory Ability in the Treatment of Pulmonary Hypertension.
Tohoku J Exp Med. 2025 Oct 23. doi: 10.1620/tjem.2025.
Abstract

GHANI H, Thillai M, Jenkins D, Bussell E, et al
Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy.
Am J Respir Cell Mol Biol. 2025 Oct 22. doi: 10.1165/rcmb.2025-0121.
Abstract

GONG X, Sheng Y, Zhang G, Kang S, et al
Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis-Mediated Pulmonary Arterial Vascular Remodeling.
Can Respir J. 2025;2025:2884885.
Abstract

GUO J, Zhao J, Wang J, Li Y, et al
Impact of Lipid Profile Alterations on the Right Heart Function and Prognosis in Pre-Capillary Pulmonary Hypertension Patients: A Prospective Cohort Study.
Respirology. 2025 Oct 21. doi: 10.1002/resp.70145.
Abstract

JIANG ML, Yang YY, Li MY, Jiang XY, et al
Hypoxia promotes mitochondrial biogenesis in myocardium of broiler with pulmonary hypertension syndrome through AMPK/PGC-1 alpha pathway.
Res Vet Sci. 2025;197:105941.
Abstract

GUIMARAES-ERVILHA LO, Iasbik-Lima T, Soares LL, Faria JVL, et al
Effect of pulmonary arterial hypertension on the morphology and antioxidant defence of the ventral prostate of sedentary and exercised rats.
Int J Exp Pathol. 2025;106:e70007.
Abstract

SRINIVAS S, Kotinatot S, Janjua D, Alsaqban HQH, et al
High-output cardiac failure and severe pulmonary hypertension due to congenital hepatic hemangioma: a case report.
Pan Afr Med J. 2025;51:100.
Abstract

NAKANISHI H
From pulmonary to ocular protection: rethinking inhaled nitric oxide in preterm infants with pulmonary hypertension.
Pediatr Res. 2025 Oct 20. doi: 10.1038/s41390-025-04532.
Abstract

BUDHRAM B, Chung S, Humbert M, Horn E, et al
Contemporary Treatment Strategies in Pulmonary Hypertension: A Clinician's Guide.
Annu Rev Med. 2025 Oct 20. doi: 10.1146/annurev-med-042623-013335.
Abstract

HU S, Jiang J, Wang J, Li Q, et al
Transcriptome analysis identifies upregulation of GBP4 in sarcoidosis and pulmonary hypertension.
Chin Med J Pulm Crit Care Med. 2025;3:218-220.
Abstract

HUNG CT, Wang J
Temporal bias and residual confounding obscure the association between SGLT2 inhibitor use and improved clinical outcomes in pulmonary hypertension patients.
Ther Adv Respir Dis. 2025;19:17534666251388797.
Abstract

HUANG B, Hao Y, Wen Z, Dong J, et al
Role of lipid droplets in pulmonary arterial hypertension: focusing on pulmonary artery smooth muscle cell proliferation.
Lipids Health Dis. 2025;24:333.
Abstract

SCHRAMM H, Steringer-Mascherbauer R, Mascherbauer J
Intravenous Treprostinil in Precapillary and Postcapillary Pulmonary Hypertension Due to Cardiac Amyloidosis and Aortic Stenosis.
JACC Case Rep. 2025;30:105474.
Abstract

LEONE G, Ucakar B, Perros F, Frederick R, et al
Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension.
Eur J Pharm Sci. 2025;214:107287.
Abstract

CARMONA SEGOVIA ADM, Becerra-Munoz VM, Jimenez Arjona MJ, Naranjo Velasco V, et al
Real-life use of validated quality of life questionnaires in patients with pulmonary arterial hypertension in Spain: a cross-sectional study.
Eur J Cardiovasc Nurs. 2025;24:1172-1174.
Abstract

XING Y, Liu C, Zhang C, Zhou D, et al
Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.
Respir Res. 2025;26:303.
Abstract

WHITE RD, Demirer M, Sebro RA, Cortopassi IO, et al
Artificial intelligence improves detection and classification of pulmonary venous hypertension related to left ventricular diastolic dysfunction by chest radiography.
Sci Rep. 2025;15:38181.
Abstract

BOUCLY A, Beauvais A, Lacoste-Palasset T, Jevnikar M, et al
Evolving paradigms in pulmonary hypertension: Highlights of the 6(th) French Pulmonary Hypertension Network Meeting.
Respir Med Res. 2025;88:101215.
Abstract

MOON GS, Scheel PJ 3rd, Montovano M, Kaushik M, et al
A Novel Computational Pipeline for Acquiring Pressure-Volume Hemodynamics of the Right Ventricle in Pulmonary Hypertension.
JACC Heart Fail. 2025 Oct 31:102753. doi: 10.1016/j.jchf.2025.102753.
Abstract

ALTURAIF N, Lin E, Sundararaghavan A, Mercurio V, et al
Predicting outcomes in patients with pulmonary hypertension using right ventricular global longitudinal strain versus tricuspid annular plane systolic excursion (TAPSE) and fractional area change: a retrospective analysis.
J Cardiovasc Imaging. 2025;33:15.
Abstract

YANG Y, Yu H, Xiang Q, Wu J, et al
Assessment of a Grad-CAM interpretable deep learning model for HAPE diagnosis: performance and pitfalls in severity stratification from chest radiographs.
BMC Med Inform Decis Mak. 2025;25:402.
Abstract

LIU H, Lu JW, Wu CH, Ho YJ, et al
Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report.
In Vivo. 2025;39:3656-3664.
Abstract

LIU A, Wang H, Xi L, Du J, et al
Causal Effect of Pulmonary Hypertension on Brain Structure: A Mendelian Randomization Study Combined With Brain Magnetic Resonance Imaging.
Cureus. 2025;17:e95493.
Abstract

GUENTHER A, Tello S, Schoppe MC, Pons-Kuehnemann J, et al
Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry.
J Clin Med. 2025;14:7352.
Abstract

CHOJNACKA K, Singh Y, Gahlaut S, Blaz W, et al
Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management.
Biomedicines. 2025;13:2332.
Abstract

XIAODONG Z, Min W, Jinsong H, Yuemei L, et al
Prolonged intra-aortic balloon pump support successfully reversed severe pulmonary hypertension prior to heart transplantation.
J Cardiothorac Surg. 2025;20:402.
Abstract

JAIN S, Kaur A, Qadeer A, Ghosh V, et al
Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives.
Adv Respir Med. 2025;93:47.
Abstract

FISCUS G, Dagher C, O'Sullivan D, Carollo B, et al
Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices.
Adv Respir Med. 2025;93:41.
Abstract

GUAN Y, Wen X, Zhang X, Xu Z, et al
Novel Pulmonary Manifestations in Pediatric Late-Onset Congenital Central Hypoventilation Syndrome: A Case Series of PHOX2B-Associated Pulmonary Hypertension and Pulmonary Alveolar Hemorrhage.
Pediatr Pulmonol. 2025;60:e71347.
Abstract

KEMPTON H, Olsen N, Kearney K, Hayward CS, et al
Empiric Pulmonary Arterial Compliance Reflects the Resistance-Compliance Relationship and Predicts Mortality in Pulmonary Hypertension.
Pulm Circ. 2025;15:e70184.
Abstract

LU J, Zinzuwadia A, Sullivan J, Perez-Lopez P, et al
Echocardiographic Evaluation of Pulmonary Hypertension: A Contemporary Review of the American Society of Echocardiography (ASE) Guidelines and Emerging Modalities.
Curr Cardiol Rep. 2025;27:154.
Abstract

MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
[Survey on pulmonary arterial hypertension: a picture of the Italian reality].
G Ital Cardiol (Rome). 2025;26:833-839.
Abstract

KAMIGAICHI A, Tsutani Y, Tsuchiya A, Utsunomiya H, et al
Lobectomy Induces Exercise-Induced Pulmonary Hypertension and Effort Intolerance Compared With Sublobar Resection.
JTO Clin Res Rep. 2025;6:100903.
Abstract

MWIZERWA L, Joye R, Cousin VL, Malaspinas I, et al
Two case reports of idiopathic prenatal closure of the ductus arteriosus complicated at birth by severe pulmonary hypertension successfully treated without intubation.
Transl Pediatr. 2025;14:2374-2380.
Abstract

KOSANOVIC D
High Altitude-Induced Pulmonary Hypertension: Our Scientific Journey to Prove Cold Exposure Is Also an Important Cause.
Pulm Circ. 2025;15:e70186.
Abstract

ANNALISA C, Gianmarco S
Reply To: "Pulmonary Artery Dilatation in Different Causes of Pulmonary Hypertension".
Pulm Circ. 2025;15:e70175.
Abstract

BUTROUS G
Early Development of Sildenafil for Pulmonary Hypertension: A Retrospective Account.
Pulm Circ. 2025;15:e70188.
Abstract

CHERNYAEV AL
Northern Pulmonary Hypertension: Personal Experience and Brief History.
Pulm Circ. 2025;15:e70190.
Abstract

KAMENY R, Van Wormer S, Varghese NP
A Joint Perspective on End-of-Life Care in Pediatric Pulmonary Hypertension.
Pulm Circ. 2025;15:e70181.
Abstract

ZHENG W, Li T, Wei J, Yan Y, et al
Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression.
Korean J Physiol Pharmacol. 2025;29:779.
Abstract

WAKISAKA Y, Inai K, Harada G, Asagai S, et al
Persistence of pulmonary hypertension in patients with ventricular septal defect after intracardiac repair: insights from a long-term follow-up study.
Cardiol Young. 2025 Oct 27:1-5. doi: 10.1017/S1047951125110159.
Abstract

ZHOU Y, Xu L, Ou A, Gan S, et al
Identification of potential core genes in idiopathic pulmonary arterial hypertension: An observational study highlighting the role of VEGFA.
Medicine (Baltimore). 2025;104:e45398.
Abstract

LEHTINEN ML, Ropponen J, Kesavuori R, Wilkman E, et al
Bridging to a delayed pulmonary endarterectomy in massive acute-on-chronic pulmonary thromboembolism: a case report.
J Cardiothorac Surg. 2025;20:391.
Abstract

WATSON H, Patel B, Caccamo M
Pulmonary Hypertension in Left Heart Disease and Chronic Right Ventricular Failure.
Med Clin North Am. 2025;109:1345-1364.
Abstract

DENG X, Liu Y, Liang Y, Hu C, et al
The HIF1alpha-PUM1-KCNK3 axis drives pulmonary hypertension by destabilizing KCNK3 mRNA in pulmonary artery smooth muscle cells.
Biochim Biophys Acta Mol Basis Dis. 2025;1872:168092.
Abstract

MCKENNA AM, Pradhan NM, Farber HW, Hon SM, et al
Management of Pulmonary Hypertension in Pregnancy.
Curr Heart Fail Rep. 2025;22:30.
Abstract

PROHASKA CC, Yaqoob M, Reddy R, Samant M, et al
Evaluation and Management of Sepsis in Pulmonary Hypertension.
J Intensive Care Med. 2025 Oct 23:8850666251388409.
Abstract

HU S, Tan JS, Zhu S, Hua L, et al
Polygenic risk score and clinical factors predict incident idiopathic pulmonary arterial hypertension.
Respir Med. 2025;248:108404.
Abstract

LIU Z, Fu Q, Shao Y, Cao J, et al
Triangulation evidence for the causal effect of monocytes on pulmonary artery hypertension: a Mendelian randomization study and results from NHANES.
Respir Med. 2025;248:108388.
Abstract

REN Y, Gan C
Atypical presentation of ALCAPA in a young boy: a case report.
Cardiol Young. 2025;35:2187-2189.
Abstract

YU W, Liu M, Qin W, Liu J, et al
Artificial Intelligence Chest CT Imaging for the Diagnosis of Tuberculosis-Destroyed Lung with PH.
Respir Med. 2025 Sep 24:108377. doi: 10.1016/j.rmed.2025.108377.
Abstract

MERC P, Demi?r R, Zeren M, Si?nan UY, et al
Effects of kettlebell exercise training on functional capacity and metabolic costs of activities of daily living in patients with pulmonary arterial hypertension: A randomized controlled trial.
Respir Med. 2025;248:108371.
Abstract

LEI C, Su S, Yang Z, Huayu M, et al
Pharmacodynamic substances and molecular mechanisms of Tsantan Sumtang alleviating hypoxic pulmonary vascular remodeling.
J Ethnopharmacol. 2026;355.
Abstract

FRAZZETTO F, Piccinelli E, Pilati M, Rebonato M, et al
Use of atrial flow regulator device in children and patients with CHD: a literature review.
Cardiol Young. 2025;35:1975-1981.
Abstract

SAHAY S, Palevsky H, El-Kersh K, Restrepo-Jaramillo R, et al
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Respir Med. 2025;248:108318.
Abstract

COBER ND, McCourt E, Godoy RS, Deng Y, et al
Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension.
Cardiovasc Res. 2025;121:2095-2112.
Abstract

SUCHANEK V, Jakubicek R, Hrdlicka J, Novak M, et al
Fully automated Bayesian analysis for quantifying the extent and distribution of pulmonary perfusion changes on CT pulmonary angiography in CTEPH.
Eur Radiol. 2025;35:6996-7003.
Abstract

JING S, Qian J, Ying H, Mao P, et al
Activin A-Activated ALK4 Induces Pathogenic Th17-Involved Endothelial-Mesenchymal Transition in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
Arthritis Rheumatol. 2025;77:1533-1547.
Abstract

KUMARI J, Advani M, Purohit G
Correlation of spirometry findings and post-six-minute walk test oxygen desaturation in chronic simple silicosis patients with age, duration of silica exposure, smoking pack years, occupation and mean pulmonary artery pressure.
Monaldi Arch Chest Dis. 2025;95.
Abstract

PUTORTI F, Fabris T, Strosio M, Mesiani C, et al
Computed Tomography Scan Predictors and Prognostic Impact of Combined Pulmonary Hypertension in Patients with Aortic Valve Stenosis undergoing TAVI.
Am J Cardiol. 2025 Jun 3:S0002-9149(25)00344.
Abstract

ISHII T, Uchida K, Hosokawa S, Ishizaki R, et al
Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR).
Am J Cardiol. 2025 Aug 6:S0002-9149(25)00437.
Abstract

RAJA SG
Editorial: Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan-Insights from the Japanese Association of Congenital Heart Disease Registry.
Am J Cardiol. 2025 Aug 20:S0002-9149(25)00481.
Abstract

HAFEZ A, Ibrahim R, Pham HN, Rafie N, et al
Clinical Outcomes Related to Patent Foramen Ovale in Group 1 Pulmonary Hypertension.
Am J Cardiol. 2025 Aug 18:S0002-9149(25)00484.
Abstract

MA JI, Owunna N, Mounsey LA, Jiang NM, et al
Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.
Am J Cardiol. 2025 Oct 1:S0002-9149(25)00600.
Abstract

TABI M, Padkins M, Bushari LI, Thaden J, et al
Echocardiographic Predictors of Mortality in Cardiac Intensive Care Unit Patients with Pulmonary Hypertension.
Am J Cardiol. 2025 Oct 11:S0002-9149(25)00625.
Abstract

SEELEMANN ER, Panchakshari S, Labana PK, Wolverton MM, et al
Sexual dimorphism in right ventricular adaptation to pressure overload involves differential angiogenic response.
Am J Physiol Heart Circ Physiol. 2025;328:H496-H508.
Abstract

HAMADA T, Goda A, Yanagisawa Y, Takeuchi K, et al
Differential Right Ventricular Afterload during Exercise in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2025 Aug 4. doi: 10.1152/ajpheart.00477.2025.
Abstract

LECHUGA CG, Raza F, Colebank MJ, Korcarz CE, et al
Wave intensity analysis with exercise identifies impairments in pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2025 Sep 12. doi: 10.1152/ajpheart.00194.2025.
Abstract

SMITH MA, Guardado ES, Boehme J, Datar SA, et al
Microvascular preservation and cardiomyocyte hyperplasia underlie adaptive right ventricle development in congenital heart disease-pulmonary arterial hypertension.
Am J Physiol Heart Circ Physiol. 2025;329:H907-H919.
Abstract

RAO RJ, Yang J, Jiang S, El-Khoury W, et al
Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2025;328:L148-L158.
Abstract

ADAO R, Barreira B, Paternoster E, Morales-Cano D, et al
Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol. 2025;328:L253-L259.
Abstract

BIRNHUBER A, Biasin V, Jain PP, Kwiatkowski G, et al
Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness.
Am J Physiol Lung Cell Mol Physiol. 2025;328:L413-L429.
Abstract

COOKSON MW, Gonzalez T, Bye EM, Seedorf G, et al
Intraamniotic Vitamin D Preserves Lung Development and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia due to Intraamniotic sFlt-1.
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 24. doi: 10.1152/ajplung.00409.2024
Abstract

SINGH N, Oldham WM
Targeting Type-2 Inflammation in Pulmonary Hypertension: Lessons from a Novel Model.
Am J Physiol Lung Cell Mol Physiol. 2025 Apr 7. doi: 10.1152/ajplung.00109.2025.
Abstract

LEWIS CV, Nguyen TN, Porfilio TE, Burciaga SD, et al
Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia.
Am J Physiol Lung Cell Mol Physiol. 2025;328:L885-L900.
Abstract

MORA MASSAD K, Dai Z, Petrache I, Ventetuolo CE, et al
Lung endothelial cell heterogeneity in health and pulmonary vascular disease.
Am J Physiol Lung Cell Mol Physiol. 2025;328:L877-L884.
Abstract

GONYEA CR, Shen Y, Nelson KM, Bird RN, et al
The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH.
Am J Physiol Lung Cell Mol Physiol. 2025 May 30. doi: 10.1152/ajplung.00233.2024
Abstract

IMAKIIRE S, Kimuro K, Yoshida K, Masaki K, et al
Activated Factor X Inhibition Ameliorates NF-kappaB-IL-6?Mediated Perivascular Inflammation and Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2025 Jun 13. doi: 10.1152/ajplung.00303.2024
Abstract

THAPA S, Sarkar P, Gaber MW, Barrios R, et al
Adrenomedullin Overexpression Protects Mice from Experimental Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2025 Oct 13. doi: 10.1152/ajplung.00234.2025
Abstract

GILLMEYER KR, Johnson SW
Pulmonary Hypertension Care Delivery in the U.S.: Is It Time to Get with the Guidelines?
Am J Respir Crit Care Med. 2025 Feb 25. doi: 10.1164/rccm.202501-0107.
Abstract

LEARY PJ, Le RJ, Panjabi S, Hartney J, et al
Location of Care Delivery for Pulmonary Arterial Hypertension in the United States.
Am J Respir Crit Care Med. 2025;211:619-627.
Abstract

SUNTHARALINGAM J, Toshner MR, Blacker K, Howard LS, et al
How Can We Ensure Accessible and High-Quality Specialist Care for Pulmonary Hypertension Patients?
Am J Respir Crit Care Med. 2025.
Abstract

BOUCLY A, Song S, Keles M, Wang D, et al
Clustering Pulmonary Hypertension Patients Using the Plasma Proteome.
Am J Respir Crit Care Med. 2025.
Abstract

BORDAG N, Nagy BM, Zugner E, Ludwig H, et al
Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025.
Abstract

HARBAUM L, Klose H, Wilkins MR
From Blood to Vessel: Lipid Ratios in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025.
Abstract

LIU S, Shan X, Sun Y, Chen H, et al
Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025.
Abstract

ROTHMAN AMK, Villar SS, Middleton J, Roussakis AA, et al
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study.
Am J Respir Crit Care Med. 2025;211:1018-1027.
Abstract

MONTANI D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, et al
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR).
Am J Respir Crit Care Med. 2025;211:1028-1037.
Abstract

NATHAN SD, Kim HC, King CS, Aryal S, et al
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.
Am J Respir Crit Care Med. 2025;211:984-991.
Abstract

SIMOES DE JESUS D, Buffonge S, Abis G, Buccafusca R, et al
Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025.
Abstract

NAIDU SR, Desai AA
A Peek into Pulmonary Hypertension Through the Plasma Proteome.
Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202505-1063.
Abstract

CASSADY SJ, Gladwin MT
The Mirage of Individualized Therapy in the United States: Barriers in Pulmonary Hypertension Due to Sickle Cell Disease & Sarcoidosis.
Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202411-2126.
Abstract

DE BIE E, Correa-Jaque P, Jones R, Bogaard HJ, et al
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes.
Am J Respir Crit Care Med. 2025 Aug 11. doi: 10.1164/rccm.202412-2393.
Abstract

REDDY YNV, Asokan AK, Frantz RP, Hemnes A, et al
Metabolomic Evidence of Biological Overlap with Heart Failure with Preserved Ejection Fraction in a Subset of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2025;211:1701-1713.
Abstract

SHLOBIN OA, Piccari L
A 10,000-Foot View at Survival and Treatment with PDE5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025 Sep 8. doi: 10.1164/rccm.202508-1980.
Abstract

YOGESWARAN A, Hassoun PM, Saleh K, Funderich M, et al
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.
Am J Respir Crit Care Med. 2025;211:1855-1866.
Abstract

GLADWIN MT, Kato GJ, Machado RF
10-Year Longitudinal Study Clarifies Impact of Hemolysis and Pulmonary Hypertension on Patients with Sickle Cell Anemia.
Am J Respir Crit Care Med. 2025 Oct 10. doi: 10.1164/rccm.202509-2289.
Abstract

KOHLI A, DuBrock HM, Boland JM, Kennedy CC, et al
A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202505-1140.
Abstract

SAVALE L, d'Humieres T, Boucly A, Habibi A, et al
Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.
Am J Respir Crit Care Med. 2025;211:2096-2104.
Abstract

HILL NS
In PAH with high risk for death, sotatercept reduced a composite of death, lung transplantation, or PAH hospitalization >24 h at 9 mo.
Ann Intern Med. 2025;178:JC92.
Abstract

DEL GALDO F, Lescoat A, Conaghan PG, Bertoldo E, et al
EULAR recommendations for the treatment of systemic sclerosis: 2023 update.
Ann Rheum Dis. 2025;84:29-40.
Abstract

BOUCLY A, Mitrovic S, Carmagnat M, Savale L, et al
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15.
Ann Rheum Dis. 2025;84:1538-1548.
Abstract

CHAOUAT A, Valentin S, Adir Y
Phosphodiesterase-5 Inhibitors Show Promise in Improving Survival for Patients With COPD Pulmonary Hypertension: One Step Further But There Is Still a Long Way to Go.
Chest. 2025;167:16-18.
Abstract

LANGLEBEN D, Lesenko L, Fox BD, Eintracht S, et al
Ineffectiveness of Sotatercept Therapy in a Patient With Heritable Pulmonary Arterial Hypertension Associated With a Previously Unreported Missense Variant in GDF2, the Gene for Bone Morphogenic Protein-9.
Chest. 2025;167:e37-e39.
Abstract

MORRIS TA
Chronic Thromboembolism Phenotypes Aside From Pulmonary Hypertension: "CTE(X)".
Chest. 2025;167:322-323.
Abstract

D'ALTO M, Guazzi M
Unlocking the Hidden Pearls of Using Tricuspid Annulus Plane Systolic Excursion on Pulmonary Arterial Systolic Pressure Ratio in the Prognostic Assessment of Suspected But Unconfirmed or Mild Pulmonary Hypertension.
Chest. 2025;167:319-321.
Abstract

PLOEGSTRA MJ, Ferreira RJ, Lokhorst C, Gouwy E, et al
Physical Activity Measured by Hip-Anchored Accelerometry in Pediatric Pulmonary Hypertension: Association with Disease Severity & Estimation of Minimal Important Differences.
Chest. 2025 Feb 8:S0012-3692(25)00156-4. doi: 10.1016/j.chest.2025.
Abstract

JOHN T, Avian A, John N, Eger A, et al
Prognostic Relevance of Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio and Its Association With Exercise Hemodynamics in Patients With Normal or Mildly Elevated Resting Pulmonary Arterial Pressure.
Chest. 2025;167:573-584.
Abstract

INSEL M, El Aini T, Woodhead G, Wig R, et al
Post Pulmonary Embolism Phenotypes Described by Invasive Cardiopulmonary Exercise Testing.
Chest. 2024 Sep 3:S0012-3692(24)05134-1. doi: 10.1016/j.chest.2024.
Abstract

LECHUGA CG, Raza F, Colebank MJ, Korcarz CE, et al
Characteristic Pulmonary Impedance With Exercise Detects Abnormal Pulmonary Vascular Response and Uncoupling in Pulmonary Hypertension Resulting From Heart Failure With Preserved Ejection Fraction.
Chest. 2025 Feb 26:S0012-3692(25)00268-5. doi: 10.1016/j.chest.2025.
Abstract

CORDOVA FC, D'Alonzo G
Phosphodiesterase Inhibitor Therapy in Pulmonary Hypertension-Associated COPD: Revisiting an Old Controversy With Renewed Interest.
Chest. 2025;167:647-648.
Abstract

KUDELKO K, Sung YK, Ventetuolo CE, Kawut S, et al
National Consortium on Pulmonary Vascular Disease Fellowship Training Summary.
Chest. 2025;167:1191-1203.
Abstract

WALIGORA M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, et al
Effects of beta-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: A Multicenter Prospective Cohort Study: The Database of Pulmonary Hypertension in the Polish Population (BNP-P
Chest. 2025;167:1171-1181.
Abstract

MOUNSEY LA, Kalaria CJ, Kowal A, Hoenstine C, et al
Exercise hemodynamics and the evolving definition of precapillary pulmonary hypertension.
Chest. 2025 Apr 21:S0012-3692(25)00450-7. doi: 10.1016/j.chest.2025.
Abstract

BAILEY M, Frantz R, Minhas J, Cascino T, et al
The frequency and predictors of pulmonary rehabilitation referrals among patients with pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry.
Chest. 2025 Apr 28:S0012-3692(25)00547-1. doi: 10.1016/j.chest.2025.
Abstract

MCCARTHY BE, Feng R, Torigian DA, Tong Y, et al
Epicardial Adipose Tissue as an Independent Risk Factor for Mortality in Pulmonary Arterial Hypertension.
Chest. 2025;167:1481-1492.
Abstract

MATUSOV Y, Kolaitis NA, Geft D, DesJardin J, et al
How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension.
Chest. 2025 May 16:S0012-3692(25)00579-3. doi: 10.1016/j.chest.2025.
Abstract

WHITE RJ, El-Kersh K, Rosenkranz S, Franco V, et al
Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities.
Chest. 2024 Nov 30:S0012-3692(24)05604-6. doi: 10.1016/j.chest.2024.
Abstract

HUANG Z, Diao X, Huo Y, Zhao Z, et al
Deep Learning-Enhanced Non-Invasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization.
Chest. 2025 Jun 18:S0012-3692(25)00702-0. doi: 10.1016/j.chest.2025.
Abstract

AUSTIN ED
Measuring Activity in Pediatric Pulmonary Hypertension: Expanding Opportunities to Advance Clinical Trial Design and Impact.
Chest. 2025;168:13-15.
Abstract

LEARY PJ, Rayner SG, Branch KRH, Hogl L, et al
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial.
Chest. 2025;168:189-199.
Abstract

MUKHERJEE M, Jani VP, Osgueritchian R, Mombeini H, et al
Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Network.
Chest. 2025;168:502-519.
Abstract

CAO JY, Abdo RM, Wang N, Olsen N, et al
Prognostic Value of Main Pulmonary Artery Diameter in Pulmonary Arterial Hypertension.
Chest. 2025;168:476-487.
Abstract

JOSE A, Sood N, Elwing JM, Akkanti B, et al
"How I Do It": Pulmonary Hypertension Associated with Interstitial Lung Diseases.
Chest. 2025 Sep 10:S0012-3692(25)05167-0. doi: 10.1016/j.chest.2025.07.4107.
Abstract

SAVONITTO G, Barbisan D, Ameri P, Lombardi CM, et al
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.
Chest. 2025;168:749-762.
Abstract

SZWED P, Kurzyna P, Banaszkiewicz-Cyganik M, Kedzierski P, et al
Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension.
Chest. 2025 Oct 18:S0012-3692(25)05620-X. doi: 10.1016/j.chest.2025.
Abstract

ZHANG J, Gu X, Cheng TL, Qi YJ, et al
ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling.
Circ Res. 2025;136:719-734.
Abstract

KNOEPP F, Abid S, Houssaini A, Lipskaia L, et al
Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development.
Circ Res. 2025 Apr 4. doi: 10.1161/CIRCRESAHA.124.325475.
Abstract

ZHAKEER G, Zeng Y, E G, Maimaitiaili N, et al
T(reg) Cells Attenuate Pulmonary Venous Remodeling in PH-LHD via NLRC3 Signaling.
Circ Res. 2025;136:e113-e128.
Abstract

QIU F, Miao HR, Hui HL, Qiu LJ, et al
MHCII(hi)LYVE1(lo)CCR2(hi) Interstitial Macrophages Promote Medial Fibrosis in Pulmonary Arterioles and Contribute to Pulmonary Hypertension.
Circ Res. 2025 May 13. doi: 10.1161/CIRCRESAHA.125.326173.
Abstract

MEI J, Huang W, Meng Z, Wen S, et al
Super-Enhancer-Driven HCG20 Promotes Pulmonary Hypertension Through U2AF2 Splicing.
Circ Res. 2025 May 28. doi: 10.1161/CIRCRESAHA.125.326133.
Abstract

KIM Y, Maroli G, Woodcock CC, Kim H, et al
Deficiency of Smooth Muscle ADAR1 Exacerbates Vascular Remodeling and Pulmonary Hypertension.
Circ Res. 2025 Oct 22. doi: 10.1161/CIRCRESAHA.125.326235.
Abstract

DAI H, Lu X, Zhou X
Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
Circulation. 2025;151:e686.
Abstract

HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
Circulation. 2025;151:e763.
Abstract

LEMAY SE, Montesinos MS, Grobs Y, Yokokawa T, et al
Exploring Integrin alpha5beta1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
Circulation. 2025 Jan 20. doi: 10.1161/CIRCULATIONAHA.124.070693.
Abstract

YU Q, Tai YY, Tang Y, Zhao J, et al
Correction to: BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Circulation. 2025;151:e967.
Abstract

KHAN M, Suribhatla R, Spencer J, Daniel N, et al
Prevalence of Pulmonary Hypertension in Individuals With Heart Failure: A Systematic Review and Meta-Analysis.
Clin Cardiol. 2025;48:e70197.
Abstract

AGUADO B, Grynblat J, Budhram B, Ghigna MR, et al
Pulmonary veno-occlusive disease: a paradigm of diagnosis and therapeutic challenges in pulmonary hypertension.
Curr Opin Pulm Med. 2025 Jun 6. doi: 10.1097/MCP.0000000000001184.
Abstract

TAGARIELLO F, Elia D, Harari SA
Rare pulmonary diseases and pulmonary hypertension.
Curr Opin Pulm Med. 2025 Jun 27. doi: 10.1097/MCP.0000000000001188.
Abstract

MARON BA
Precision medicine in pulmonary hypertension: how close are we today?
Curr Opin Pulm Med. 2025 Jul 8. doi: 10.1097/MCP.0000000000001195.
Abstract

CULLIVAN S, McCourt L, Gaine S
Important negative trials in pulmonary hypertension.
Curr Opin Pulm Med. 2025 Jul 8. doi: 10.1097/MCP.0000000000001198.
Abstract

D'ALTO M, Vergara A, Orlando A, Naeije R, et al
The fluid challenge for identification of pulmonary hypertension associated with left heart disease.
Curr Opin Pulm Med. 2025;31:464-469.
Abstract

VENTETUOLO CE, Sherman-Roe AE
Sex differences in pulmonary (arterial) hypertension: does it matter?
Curr Opin Pulm Med. 2025;31:411-428.
Abstract

ZEDER K, Kovacs G
Current hot topics in pulmonary hypertension.
Curr Opin Pulm Med. 2025;31:409-410.
Abstract

JOHN T, Roschinsky T, Douschan P
Echocardiographic evaluation of the pulmonary circulation and right ventricular functional unit during exercise and its clinical value.
Curr Opin Pulm Med. 2025;31:456-463.
Abstract

KAWASHIMA M, Ijiri N, Konoeda C, Toyokawa G, et al
Extended use of central veno-arterial extracorporeal membrane oxygenation in lung transplantation for patients with pulmonary arterial hypertension.
Eur J Cardiothorac Surg. 2025 Aug 4:ezaf256. doi: 10.1093.
Abstract

VANHOOF B, Staal DP, Quarck RA, Van Langenhoven L, et al
Tricuspid Regurgitation and Pulmonary Haemodynamics After Pulmonary Endarterectomy.
Eur J Cardiothorac Surg. 2025;67:ezaf298.
Abstract

ALESSI AW, Westphal JA, Masuodi B, Graur A, et al
Safety of percutaneous thermal ablation of lung tumors in pulmonary hypertension.
Eur J Cardiothorac Surg. 2025 Sep 25:ezaf312. doi: 10.1093.
Abstract

ALENEZI F, Costelle A, Sharma P, Barrett M, et al
(129)Xenon MR Imaging and Spectroscopy Detects Response to Therapy in Pulmonary Hypertension.
Eur Respir J. 2025 Jan 30:2401651. doi: 10.1183/13993003.01651-2024.
Abstract

WRIGHT SP, Karvasarki E, Buchan TA, Gurtu V, et al
Contemporary pulmonary hypertension hemodynamic definitions stratify mortality risk in candidates for advanced heart failure therapies.
Eur Respir J. 2025 Jan 30:2401640. doi: 10.1183/13993003.01640-2024.
Abstract

AUSTIN ED
X-linked filaminopathy: another pulmonary hypertension syndrome.
Eur Respir J. 2025;65:2500073.
Abstract

KIKO T, Asano R, Yoshikawa Y, Endo H, et al
Survival trends in patients with chronic thromboembolic pulmonary hypertension: An observational study.
Eur Respir J. 2025 Mar 6:2402268. doi: 10.1183/13993003.02268-2024.
Abstract

LILEY J, Bunclark K, Newnham M, Cannon J, et al
Development of an open-source tool for risk assessment in pulmonary endarterectomy.
Eur Respir J. 2025;65:2401001.
Abstract

BALMAIN BN, Babb TG
Reply to: Unravelling the physiology of exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.
Eur Respir J. 2025;65:2500543.
Abstract

JHA AK
Unravelling the physiology of exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.
Eur Respir J. 2025;65:2500384.
Abstract

BOUCLY A, Montani D, Bauer F, Artaud-Macari E, et al
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities.
Eur Respir J. 2025;65:2400895.
Abstract

HOEPER MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, et al
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.
Eur Respir J. 2025;65:2401424.
Abstract

MESERVEY A, Al-Naamani N, Minhas J, Fritz JS, et al
Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis.
Eur Respir J. 2025 May 22:2402400. doi: 10.1183/13993003.02400-2024.
Abstract

SELMAN M, Buendia-Roldan I, Pardo A
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.
Eur Respir J. 2025;65:2402418.
Abstract

NAEIJE R, Chaouat A, Pinsky MR
Viewpoint: a critique of pulmonary vascular resistance to define severe pulmonary hypertension.
Eur Respir J. 2025;65:2500409.
Abstract

LANG IM
A reason to celebrate: multimodal treatments and recent improvements in the long-term outcomes of patients with chronic thromboembolic pulmonary hypertension.
Eur Respir J. 2025;66:2500562.
Abstract

PRESTON IR, Badesch D, Ghofrani HA, Gibbs JSR, et al
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA.
Eur Respir J. 2025;66:2401435.
Abstract

HARBAUM L, Thenappan T
Renal function dynamics in pulmonary hypertension trials: less than anticipated.
Eur Respir J. 2025;66:2501042.
Abstract

SITBON O, Boucly A, Weatherald J, Antigny F, et al
Drugs targeting novel pathways in pulmonary arterial hypertension.
Eur Respir J. 2025;66:2401830.
Abstract

BACCELLI A, Rinaldo RF, Haji G, Davies RJ, et al
Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertension.
Eur Respir J. 2025;66:2402026.
Abstract

KOVACS G, Zeder K, Olsson KM, Hoeper MM, et al
Pulmonary vascular resistance to define severe pulmonary hypertension: cutting the Gordian knot.
Eur Respir J. 2025;66:2501418.
Abstract

NAEIJE R, Chaouat A, Pinsky MR
Reply to: Pulmonary vascular resistance to define severe pulmonary hypertension: cutting the Gordian knot.
Eur Respir J. 2025;66:2501474.
Abstract

UYSAL OF, Hurst JR
Pulmonary hypertension in COPD exacerbation: a transient storm with long-term consequences?
Eur Respir J. 2025;66:2501508.
Abstract

RASTODER E, Sivapalan P, Hedsund C, Kamstrup P, et al
Pulmonary pressure increases during acute exacerbation in COPD and clinical outcome.
Eur Respir J. 2025;66:2500169.
Abstract

EL-HINDI S
Vardenafil vs. Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Newborns.
Indian J Pediatr. 2025 Oct 4. doi: 10.1007/s12098-025-05787.
Abstract

LANG IM, Brenot P, Bouvaist H, Fadel E, et al
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry.
J Am Coll Cardiol. 2025;85:2270-2284.
Abstract

BERTOLETTI L, Escal J, Boucly A, Turquier S, et al
Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension: A Registry Report and Updated Meta-Analysis.
J Am Coll Cardiol. 2025;86:982-995.
Abstract

FLORES-CONNER N, Brazil M, Whittle M, Shah A, et al
Severe Reversible Pulmonary Hypertension in a Patient with Shone Complex Presenting for Heart Transplantation.
J Cardiothorac Vasc Anesth. 2024 Dec 27:S1053-0770(24)01010.
Abstract

DUIJGHUISEN JJ, Hellemons ME, Horst MT
Preoperative Femoral Extracorporeal Membrane Oxygenation Cannulation Using an Ilioinguinal Block for Lung Transplantation Recipients With Severe Pulmonary Hypertension.
J Cardiothorac Vasc Anesth. 2025 Mar 4:S1053-0770(25)00206.
Abstract

MAUS T, Khoche S
Chronic Thromboembolic Pulmonary Hypertension-An Update for the Anesthesiologist.
J Cardiothorac Vasc Anesth. 2025 Jun 15:S1053-0770(25)00488.
Abstract

CORMICAN DS
2025 ASE Guidelines on Echocardiographic Evaluation of the Right Heart with Focus on Pulmonary Hypertension: A Welcome and Necessary Update.
J Cardiothorac Vasc Anesth. 2025 Jul 21:S1053-0770(25)00611.
Abstract

MORALES-DEMORI R, Ortoleva J, Aras S, Anders M, et al
Outcomes of Extracorporeal Membrane Oxygenation in Patients with COVID-19 and Pulmonary Hypertension: An ELSO Registry Analysis.
J Cardiothorac Vasc Anesth. 2025 Aug 6:S1053-0770(25)00653.
Abstract

AHMED U, Mahmood F, Nicoara A, Kiarad V, et al
Right Ventricular Function and Echocardiographic Pressure-Volume Loops: Overview and Perioperative Clinical Implications.
J Cardiothorac Vasc Anesth. 2025;39:2857-2865.
Abstract

ALFIREVIC A, Geube M, Mi J, Elgharably H, et al
Early Effect of Pulmonary Thromboendarterectomy on Right Ventricular-to-Pulmonary Artery Coupling.
J Cardiothorac Vasc Anesth. 2025;39:2989-2998.
Abstract

WANG S, Zhuo D, Lin J, Zhang C, et al
Key Genes and Biological Pathways in Pulmonary Arterial Hypertension Related to Endoplasmic Reticulum Stress Identified by Bioinformatics.
J Cardiovasc Pharmacol. 2025;85:108-119.
Abstract

CHEN X, Xu L, Xue B
Efficacy and safety of Treating Pulmonary Arterial Hypertension With Imatinib:A meta-analysis of randomized controlled trials.
J Cardiovasc Pharmacol. 2025 Jan 2. doi: 10.1097/FJC.0000000000001665.
Abstract

ZHU M, Xu F, Zhu L, Chen Q, et al
FAP Promotes Pulmonary Artery Hypertension via Activation of the PTEN/PI3K/Akt Pathway.
J Cardiovasc Pharmacol. 2025 Jul 17. doi: 10.1097/FJC.0000000000001735.
Abstract

ROSENKRANZ S, Ghofrani HA, Hoeper MM, Langleben D, et al
Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials.
J Heart Lung Transplant. 2025;44:135-146.
Abstract

WELLER S, Li S, Masha L
Increases in donor/recipient predicted heart mass ratios do not result in large donor right ventricles.
J Heart Lung Transplant. 2025;44:690-692.
Abstract

GOMBERG-MAITLAND M, Badesch DB, Gibbs JSR, Grunig E, et al
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.
J Heart Lung Transplant. 2025;44:609-624.
Abstract

BRAKSATOR M, Kurzyna M, Kopec G, Pruszczyk P, et al
Hemodynamic, echocardiographic, and demographic profiles of patients with chronic thromboembolic pulmonary hypertension and atrial fibrillation: A multicenter cohort study.
J Heart Lung Transplant. 2025 Apr 1:S1053-2498(25)01858.
Abstract

REDDY SA, Pepke-Zaba J
Evaluating the Influence of Atrial Fibrillation in Chronic Thromboembolic Pulmonary Hypertension.
J Heart Lung Transplant. 2025 Apr 11:S1053-2498(25)01909.
Abstract

NAKATA C, Goda A, Takeuchi K, Takeuchi S, et al
Prevalence of Occult HFpEF and Age-Specific Efficacy of Passive Leg Raise in Pulmonary Hypertension.
J Heart Lung Transplant. 2025 May 28:S1053-2498(25)01954.
Abstract

ALVES-JR JL, Costa ELV, Hoette S, Fernandes CJCDS, et al
Right ventricular-pulmonary arterial coupling in schistosomiasis associated pulmonary arterial hypertension.
J Heart Lung Transplant. 2025;44:1024-1032.
Abstract

PYA Y, Bekbossynova M, Medressova A, Latremouille C, et al
Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart.
J Heart Lung Transplant. 2025;44:1161-1164.
Abstract

FUKUSHI K, Goda A, Kohno T, Takeuchi S, et al
Revised Definition of Pulmonary Hypertension Subtypes Enhances Prognostic Stratification in Hospitalized Heart Failure Patients.
J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02037.
Abstract

KOLAITIS NA, Singer JP, Bartolome S, Chakinala MM, et al
The landscape of referrals for lung transplantation in pulmonary arterial hypertension: a report from the Pulmonary Hypertension Association Registry.
J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02055.
Abstract

WIEDENROTH CB, Jenkins D, Brenot P, Lang IM, et al
Management of chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2025;44.
Abstract

JAIS X, Tapson V, Fernandes TM, Fadel E, et al
Diagnosis of chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2025;44.
Abstract

MOHAMA D, Worapongsatitaya P, Celestin B, Kazmirczak F, et al
Comparison of the prognostic value of right atrial echocardiographic parameters in pulmonary arterial hypertension.
J Heart Lung Transplant. 2025;44:1343-1347.
Abstract

NAGARAJ S, Suhotliv A, Yakkali S, Steinberg K, et al
Hemodynamic Effects of Sotatercept Administration in Pulmonary Hypertension- Insights from Remote Monitoring.
J Heart Lung Transplant. 2025 Aug 4:S1053-2498(25)02174.
Abstract

ANDARELLI JN, Issard J, Lacoste-Palasset T, Mallak I, et al
Combined Multimodal Therapy in High-Risk Patients with Chronic Thromboembolic Pulmonary Hypertension and Both Distal and Proximal Lesions: A Prospective Observational Cohort Study.
J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02211.
Abstract

SCHNEIDER H, Ius F, Muller C, Salman J, et al
Paediatric Lung Transplantation for Childhood Interstitial Lung Disease: Indications and Outcome.
J Heart Lung Transplant. 2025 Apr 8:S1053-2498(25)01899.
Abstract

STEWART DJ, Mehta S, Chandy G, Hirani N, et al
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.
J Heart Lung Transplant. 2025;44:1663-1667.
Abstract

ASGHAR U, Man HJ, McInnis M, Ladak AM, et al
Endothelin-1 Overexpression in Pulmonary Endarterectomy Specimens of CTEPH patients is associated with Pulmonary Hypertension Development.
J Heart Lung Transplant. 2025 Sep 25:S1053-2498(25)02274.
Abstract

DARIE AM, Doi A, Levvey BJ, Shingles H, et al
Lung transplantation for chronic thromboembolic pulmonary hypertension - a case series.
J Heart Lung Transplant. 2025 Oct 7:S1053-2498(25)02305.
Abstract

LAU EM, Gerges C
Lung transplantation for chronic thromboembolic pulmonary hypertension (CTEPH): a treatment of last resort.
J Heart Lung Transplant. 2025 Oct 15:S1053-2498(25)02324.
Abstract

ABREU P, Moon R, Mendelson JB, Markowski T, et al
Proteomic and metabolomic profiling nominates druggable targets and biomarkers for pulmonary arterial hypertension-associated myopathy and exercise intolerance in male monocrotaline rats.
J Heart Lung Transplant. 2025;44:1798-1808.
Abstract

HJALMARSSON C, Thakur T, Weiss T, Bjorklund E, et al
Risk assessment models and survival in pulmonary arterial hypertension: A SPAHR analysis.
J Heart Lung Transplant. 2025;44:1787-1797.
Abstract

MULLALY R, Smith A, Murphy C, Armstrong S, et al
Characteristics and outcomes of preterm infants with early pulmonary hypertension.
J Perinatol. 2025 Apr 11. doi: 10.1038/s41372-025-02295.
Abstract

WREN JT JR, Patel N, Harting MT, McNamara PJ, et al
Hemodynamic precision to guide surgical timing for neonates with congenital diaphragmatic hernia: a narrative review.
J Perinatol. 2025 Mar 19. doi: 10.1038/s41372-025-02265.
Abstract

BHATT DR, Braun D, Dizon RA, Shi JM, et al
Retrospective study of preterm infants exposed to inhaled nitric oxide in Kaiser Permanente Southern California: morbidity, mortality and follow-up.
J Perinatol. 2024 Jul 18. doi: 10.1038/s41372-024-02051.
Abstract

HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
Abstract

MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
Abstract

JACQUET J, Marcos E, Lipskaia L, Gros V, et al
[Senescence of the pulmonary endothelial cells: VEGF, a new target in pulmonary pathologies and aging].
Rev Mal Respir. 2025;42:134-137.
Abstract

ALSULAYYIM AS, Alasmari AM, Price LC, McCabe C, et al
Dietary nitrate supplementation enhances exercise capacity in WHO Group 3 pulmonary hypertension: a double-blind, placebo-controlled, randomised crossover study (EDEN-OX2).
Thorax. 2025 Feb 8:thorax-2024-222019. doi: 10.1136/thorax-2024-222019.
Abstract

KIKO T, Tsuji A, Ueda J, Ohta-Ogo K, et al
Vasodilator-induced selective pulmonary oedema in sarcoidosis-associated pulmonary hypertension with pulmonary venous stenosis.
Thorax. 2025 Feb 27:thorax-2024-222190. doi: 10.1136/thorax-2024-222190.
Abstract

KHOR YH, Palm A, Wong AW, Guler SA, et al
Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.
Thorax. 2025;80:378-384.
Abstract

NATHAN SD
Early phase clinical trials in pulmonary hypertension: how small is big enough?
Thorax. 2025 Jun 1:thorax-2025-223535. doi: 10.1136/thorax-2025-223535.
Abstract

CZEPIEL K, Nagy N, Panjalingam T, Kalinowski A, et al
Randomised, placebo-controlled trial of oral hymecromone in adults with pulmonary hypertension.
Thorax. 2025 Jun 1:thorax-2024-222725. doi: 10.1136/thorax-2024-222725.
Abstract

SONG Y, Li F, Xie W, Zhao L, et al
Is it truly chronic thromboembolic pulmonary hypertension? A case of pulmonary hypertension with proptosis.
Thorax. 2025 Jun 15:thorax-2024-222953. doi: 10.1136/thorax-2024-222953.
Abstract

SHIROTA Y, Ohmori S, Engel JD, Moriguchi T, et al
GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.
PLoS One. 2024;19:e0315446.
Abstract

KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
Correction: Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
PLoS One. 2025;20:e0317857.
Abstract

GHAZAIEAN M, Darvishi-Khezri H, Najafi B, Karami H, et al
Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: A systematic review and meta-analysis.
PLoS One. 2025;20:e0318751.
Abstract

YOON DW, Yoon YE, Hwang IC, Lee W, et al
CT imaging biomarkers to predict severity and prognosis of pulmonary hypertension.
PLoS One. 2025;20:e0313235.
Abstract

MARTINEZ-PUIG P, Baez-Gutierrez N, Rodriguez-Ramallo H, Abdelkader-Martin L, et al
Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.
PLoS One. 2025;20:e0318739.
Abstract

LUIJTEN D, Rodenburg T, Bogaard HJ, Kianzad A, et al
The value of vector ECG in predicting residual pulmonary hypertension in CTEPH patients after pulmonary endarterectomy.
PLoS One. 2025;20:e0317826.
Abstract

VIJAYAKUMAR S, Louis DW, Corneau E, Erqou S, et al
Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings.
PLoS One. 2025;20:e0321964.
Abstract

MIDDLETON RC, Karpov OA, Fournier M, Kreimer S, et al
Impact of cardiosphere-derived cells on the maladapted right ventricular muscle in a rat sugen/hypoxia model of pulmonary hypertension with right ventricular dysfunction.
PLoS One. 2025;20:e0321895.
Abstract

SCHIPS TG, Kavalkovich KW, Yung LM, Ibrahim S, et al
In vitro and in vivo characterization of wild type BMP9 and a non-osteogenic variant in models of pulmonary arterial hypertension.
PLoS One. 2025;20:e0329089.
Abstract

CHEN R, Guo D, Pan J, Pang L, et al
Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators.
PLoS One. 2025;20:e0330832.
Abstract

CHEN W, Zhang L, Qi H
CD44 as a novel therapeutic target in pulmonary arterial hypertension: Insights from multi-omics integration and molecular docking.
PLoS One. 2025;20:e0332817.
Abstract

RIENGVIRODKIJ N, Taechikantaphat M, Ampapol P, Kovorakul T, et al
Clinical improvement in canine pulmonary hypertension with Perna canaliculus oil (PCSO-524) add-on therapy: Effects on exercise tolerance and cough.
PLoS One. 2025;20:e0333526.
Abstract

SINNATAMBY T, LaBranche J, Farr-Jones M, Fenske T, et al
Obstructive airway disorders affecting individuals with hereditary hemorrhagic telangiectasia: A database review.
PLoS One. 2025;20:e0331690.
Abstract

BERGOT E, Fertin M, Dewavrin MG, Prevot G, et al
Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose.
PLoS One. 2025;20:e0331008.
Abstract

BERREBEH N, Mbouamboua Y, Thuillet R, Ottaviani M, et al
Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling.
Proc Natl Acad Sci U S A. 2025;122:e2410229122.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.

;